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Abstract 
Background: Posttraumatic stress disorder (PTSD) is a psychiatric condition that occurs 
following a severe traumatic event, and is associated with distressing intrusive memories, 
avoidance of trauma reminders, hyperarousal, and negative (alterations in) cognitions and 
mood. A key theoretical model posits that symptoms persist, in part, due to impaired 
extinction of conditioned fear. Recent evidence suggests that the fear extinction account of 
PTSD is a complex multifaceted framework of important biological and cognitive features, 
including sleep quality, catastrophic negative appraisals, noradrenaline activity, and cortisol 
output. Little research, however, has examined these factors in relation to fear extinction in a 
PTSD population. Thus, the overall aim of the current thesis was to investigate factors that 
may moderate the relationship between fear extinction learning and PTSD symptom severity, 
thereby providing a greater understanding of the variables that shape the role of fear 
extinction learning in PTSD. 
 
Method: The current thesis includes a narrative review of relevant literature and four 
empirical studies, each assessing the moderating role of different key variables: (1) hours-
since-waking (as a proxy for homeostatic sleep pressure); (2) catastrophic negative 
appraisals; (3) noradrenaline activity; and (4) cortisol output. These empirical studies used a 
cross-sectional sample of participants with PTSD, compared to trauma-exposed and non-
exposed controls. Participants completed a standardized fear conditioning and extinction 
paradigm, providing skin conductance response as the primary index of conditioned 
responding. The PTSD Checklist was used as a diagnostic instrument to ascertain PTSD 
status and also provided an ordinal measure of PTSD symptom severity. 
 
  xiii 
Results: PTSD was associated with a number of fear extinction learning impairments, 
including altered responding to the CS+/- during the late extinction phase, and slower 
extinction learning during the early extinction phase, compared to trauma-exposed and non-
exposed controls. Moderation analyses revealed that hours-since-waking and cortisol 
reactivity were significant moderators between fear extinction learning and PTSD symptom 
severity. Additionally, catastrophic negative appraisals and fear extinction learning were both 
associated with PTSD symptom severity, however there was no moderation interaction. 
Endogenous noradrenaline activity did not moderate the relationship between fear extinction 
and PTSD symptoms. 
 
Conclusions: The findings presented in the current thesis have a number of implications for 
the theoretical account of impaired fear extinction learning in PTSD, and for the 
implementation of exposure-based therapies for PTSD. In particular, we suggest that 
exposure therapies may be more beneficial if scheduled earlier in the day, rather than later; 
and recent findings that elevating cortisol leads to greater exposure therapy response in PTSD 
may be successful via enhancing fear extinction to safety signals. Finally, the results of the 
current thesis also suggest important biological and cognitive elements in PTSD symptoms, 
which may benefit from targeted treatment strategies. 
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Chapter 1 
Introduction 
 
  
Chapter 1: Introduction 2 
 
1.1 Posttraumatic Stress Disorder 
 In the current international climate, traumatic events are plentiful, with each event 
carrying unique psychological consequences. One particular psychiatric outcome of such 
events is posttraumatic stress disorder (PTSD). In the United States alone, almost half a 
million veterans sought treatment for PTSD in 2006, with an estimated cost of 3 billion 
dollars (Haagen, Smid, Knipscheer, & Kleber, 2015; Institute of Medicine (IOM), 2008). 
Symptoms of PTSD include distressing intrusive memories, avoidance of trauma reminders, 
hyperarousal, and negative cognitions and mood (American Psychiatric Association, 2013). 
PTSD is a unique psychiatric condition, in that we know the specific catalyst for the 
disorder’s etiology: the traumatic event. While the incidence of trauma exposure is quite 
high, only 10-15% of trauma survivors develop PTSD (Kessler, Sonnega, Bromet, Hughes, 
& Nelson, 1995; Ramchand et al., 2010). This leads to an important foundational question: 
why does PTSD develop in some, while others remain resilient? 
 On the basis of Pavlov’s classical conditioning theory (Pavlov, 1927), symptoms of 
intrusive memories (and to some degree, avoidance behaviors and hyperarousal) have been 
theorized as conditioned emotional fear responses arising from the trauma (Mineka & 
Oehlberg, 2008). Indeed, fear conditioning is considered one of the primary explanations for 
the development of fear-related PTSD symptoms (e.g., Mineka & Oehlberg, 2008; Pitman, 
1988; Pitman et al., 2012), and while conditioning can explain the onset of PTSD symptoms, 
the majority of trauma survivors recover without treatment (Bryant, 2003, 2011). Therefore, 
other processes must be involved in the clinical persistence of symptoms. A key biological 
model of PTSD proposes that impaired extinction of such associative fears may explain 
persistent symptomatology (Pitman et al., 2012). Indeed, prospective studies have identified 
impaired fear extinction ability as a pre-trauma risk factor for PTSD in firefighters and 
combat veterans (Guthrie & Bryant, 2006; Lommen, Engelhard, Sijbrandij, van den Hout, & 
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Hermans, 2013). Further, a recent meta-analysis found that PTSD is consistently associated 
with slower extinction of conditioned fear to a threat signal, and impaired inhibition of fear 
to safety signals during the acquisition of fear (Duits et al., 2015). In this meta-analysis, the 
authors highlight an important need to further investigate fear extinction learning in PTSD, 
as extinction is considered to underlie treatment success (Duits et al., 2015; Graham & 
Milad, 2011). 
 
1.2 The Importance of Understanding Fear Extinction: Relation to Treatment 
 Cognitive behavioral therapy (CBT) for PTSD often involves consciously engaging 
with traumatic memories with the aim of correcting catastrophic beliefs about the trauma 
and to reduce the fear response to trauma-related memories. Exposure therapy is the most 
recommended treatment option for PTSD (Foa, Keane, Friedman, & Cohen, 2009; Karlin et 
al., 2010; Susskind, Ruzek, & Friedman, 2012; Yehuda et al., 2015). Exposure-based 
therapies act on the principle of fear extinction by correcting catastrophic emotional 
responses to memories and reminders of the trauma, as well as reducing avoidance of 
triggers for trauma-related emotions (Foa & Kozak, 1986). Despite the well-established 
efficacy of prolonged exposure therapy for PTSD, initial treatment sessions involve 
recounting the trauma memory, which may result in severe symptom expression (Yehuda et 
al., 2015). Unfortunately, the severity of symptom expression in early stages of treatment 
can lead to high rates of treatment drop-out (Schnurr et al., 2007; Simmons, Norman, 
Spadoni, & Strigo, 2013; Yehuda et al., 2015). With impaired fear extinction forming the 
theoretical foundation of PTSD symptom persistence and treatment, it is important to 
investigate the factors that may shape the relationship between impaired fear extinction and 
PTSD symptomatology. The current thesis presents a series of investigations into the role of 
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fear extinction learning in PTSD, and additional factors that may moderate the relationship 
between fear extinction and PTSD. 
1.3 Aim of the Present Thesis and Outline of Chapters 
 Despite the proven efficacy of prolonged exposure therapy as a treatment option for 
PTSD (Yehuda et al., 2015), approximately 30% of patients only display partial recovery 
(Foa et al., 1999; Foa & McLean, 2016). As fear extinction is the underlying principle and 
goal of exposure-based therapies, factors known to aid or impair extinction ability may have 
important implications for maximizing treatment response (Graham, Callaghan, & 
Richardson, 2014). As such, the overall aim of the present thesis was to investigate a 
number of factors that may moderate the relationship between fear extinction learning and 
PTSD symptoms, in an experimental framework. 
 Chapter two presents a comprehensive narrative review of the relationship between 
key biological and cognitive risk factors for PTSD, and their associations with impaired fear 
extinction learning and memory. Specifically, this narrative review discusses the central role 
that impaired fear extinction appears to play in linking risk factors to PTSD. Due to the 
extensive nature of this review and the relevance for the subsequent empirical chapters, this 
peer-reviewed article has been included as the primary literature review for the current 
thesis. Chapter two as presented has been published: 
 
Zuj, D. V., Palmer, M. A., Lommen, M. J. J., & Felmingham, K. L. (2016). The centrality of 
fear extinction in linking risk factors to PTSD: A narrative review. Neuroscience and 
Biobehavioral Reviews, 69, 15-35. doi:10.1016/j.neubiorev.2016.07.014. 
 
In the narrative review article presented in Chapter two, a number of key variables 
are discussed that share connections with impaired fear extinction and PTSD. The 
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subsequent chapters detail investigations into a select few of these variables, to examine any 
interactions between these factors and impaired fear extinction in participants with current 
PTSD, compared to trauma-exposed and non-trauma-exposed controls. Regarding Chapter 
three, previous research in healthy males suggests that time-of-day plays an important role in 
the extinction of conditioned fear, with extinction better learned and generalized in the 
morning compared to the evening (Pace-Schott et al., 2013). This finding suggests that time-
of-day may moderate fear extinction, with extinction worsening over the course of the day. 
Further, this effect has not been investigated in PTSD. Chapter three addresses this question 
by hypothesizing that PTSD would be associated with impaired fear extinction learning, and 
that this relationship would become stronger with increased hours-since-waking. Chapter 
three as presented has been published: 
 
Zuj, D. V., Palmer, M. A., Hsu, C. K., Nicholson, E. L., Cushing, P. J., Gray, K. E., & 
Felmingham, K. L. (2016). Impaired fear extinction associated with PTSD increases 
with hours-since-waking. Depression and Anxiety, 33, 203-210. 
doi:10.1002/da.22463. 
 
 The cognitive theory of PTSD (Ehlers & Clark, 2000) proposes that negative 
appraisals of the trauma and its sequelae are key features of persistent PTSD symptoms. 
Further, intrusive memories and conditioned fear responses triggered by trauma reminders 
are thought to reinforce negative appraisals, thereby maintaining anxiety levels and a sense 
of current threat. Longitudinal evidence has found that PTSD symptoms can be predicted by 
poor pre-trauma fear extinction learning (Guthrie & Bryant, 2006), and maladaptive pre-
trauma negative appraisals (Bryant & Guthrie, 2007). Therefore, impaired extinction 
capacity pre-trauma and heightened negative appraisals may interact to potentiate fear 
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responses following trauma. Chapter four investigates the possible interaction between fear 
extinction learning and negative appraisals in PTSD. Specifically, negative appraisals are 
assessed as a moderator between fear extinction and PTSD. In doing so, this study attempts 
to integrate two prevailing models of PTSD: the cognitive theory of PTSD (Ehlers & Clark, 
2000), and the biological fear extinction account of PTSD (e.g., Mineka & Oehlberg, 2008; 
Pitman et al., 2012). This study is currently under peer-review: 
 
Zuj, D. V., Palmer, M. A., Gray, K. E., Hsu, C. K., Malhi, G. S., Bryant, R. A., & 
Felmingham, K. L. Negative appraisals and fear extinction are independently related 
to PTSD symptoms. Journal of Affective Disorders [JAD_2016_1657]. 
 
PTSD is a disorder that includes heightened arousal and fear, and as such, certain 
stress hormones have been implicated in PTSD and fear extinction. The stress response 
typically involves two waves of neurochemical release. The first wave involves increased 
noradrenergic signaling for the purpose of activating sympathetic arousal structures to 
engage with the stressor (Antov, Melicherová, & Stockhorst, 2015). The hypothalamic-
pituitary-adrenal (HPA) axis is the premier neuroendocrine system in the mammalian brain, 
and its end-product, cortisol, is involved in the second wave of the stress response, aimed at 
returning sympathetic arousal structures to homeostasis (Joëls & Baram, 2009). Chapter five 
examines the role of endogenous salivary noradrenaline in moderating the relationship 
between fear extinction learning and PTSD, while Chapter six examines endogenous 
salivary cortisol as a moderator. 
PTSD is consistently associated with hyperactive noradrenergic signaling (for a 
review see Zoladz & Diamond, 2013), and behavioral studies in healthy controls have 
revealed that increased noradrenaline release prior to fear acquisition results in a conditioned 
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fear memory that is resistant to extinction (Antov, Wolk, & Stockhorst, 2013). This finding 
suggests that the relationship between impaired fear extinction and PTSD symptoms may 
become stronger as basal noradrenaline levels increase. Chapter five addresses this question, 
and is currently in preparation for submission for peer-review: 
 
Zuj, D. V., Palmer, M. A., Malhi, G. S., Bryant, R. A., & Felmingham, K. L. Endogenous 
noradrenaline does not interact with PTSD-related fear extinction learning 
impairments. 
 
Regarding the second wave of the stress response, a recent meta-analysis found 
consistent evidence of low cortisol output in PTSD, after taking methodological variations 
into account (Morris, Compas, & Garber, 2012). Further, studies show that PTSD patients 
demonstrate enhanced suppression of cortisol in response to dexamethasone administration, 
which is suggested as evidence of low cortisol activity and hypersensitive glucocorticoid 
receptors (Yehuda et al., 1993). Chapter six presents an investigation into the role of cortisol 
activity in the relationship between fear extinction learning and PTSD symptoms. Based on 
previous research, we hypothesized that better fear extinction learning ability would be 
associated with lower PTSD symptoms, and that this relationship would be stronger for 
participants with greater cortisol output. Chapter six as presented has been published: 
 
Zuj, D. V., Palmer, M. A., Malhi, G. S., Bryant, R. A., & Felmingham, K. L. (2017). 
Endogenous cortisol reactivity moderates the relationship between fear inhibition to 
safety signals and posttraumatic stress disorder symptoms. 
Psychoneuroendocrinology, 78, 14-21. doi:10.1016/j.psyneuen.2017.01.012 
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 Chapter seven concludes with a general discussion that summarizes the key findings, 
implications, and limitations of the current thesis. Directions for future research in fear 
extinction and PTSD are also discussed. 
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2.1 Abstract 
Recent prospective studies in emergency services have identified impaired fear extinction 
learning and memory to be a significant predictor of posttraumatic stress disorder (PTSD), 
complementing a wealth of cross-sectional evidence of extinction deficits associated with 
the disorder. Additional fields of research show specific risk factors and biomarkers of the 
disorder, including candidate genotypes, stress and sex hormones, cognitive factors, and 
sleep disturbances. Studies in mostly nonclinical populations also reveal that the 
aforementioned factors are involved in fear extinction learning and memory. Here, we 
provide a comprehensive narrative review of the literature linking PTSD to these risk 
factors, and linking these risk factors to impaired fear extinction. On balance, the evidence 
suggests that fear extinction may play a role in the relationship between risk factors and 
PTSD. Should this notion hold true, this review carries important implications for the 
improvement of exposure-based treatments, as well as strategies for the implementation of 
treatment.   
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2.2 Introduction 
Epidemiological studies indicate that over half of the population in the United States 
will be exposed to a serious traumatic event in their lifetime (Kessler, Sonnega, Bromet, 
Hughes, & Nelson, 1995). One particular psychiatric outcome of trauma exposure is 
posttraumatic stress disorder (PTSD), characterized by distressing re-experiencing, 
avoidance, negative (alterations in) cognitions and mood, and hyperarousal symptoms 
(American Psychiatric Association, 2013). Further, PTSD is associated with considerable 
psychological distress, elevated risk of suicide, and comorbid psychiatric disorders. Despite 
high rates of trauma exposure, only 10-15% of individuals develop PTSD (Kessler et al., 
1995; Ramchand et al., 2010), constituting approximately 3% of the population in the 
United States (Kessler, Chiu, Demler, Merikangas, & Walters, 2005). PTSD is unique 
among psychiatric disorders, as we know the triggering event; however it is unclear why the 
disorder develops in some but not in others. Research indicates that the majority of trauma 
survivors show severe symptoms of acute stress disorder (ASD) and PTSD in the weeks 
following trauma, however these rates drop dramatically in the following months (for a 
review, see Bryant, 2003). Therefore, the normative response to trauma is recovery. A 
significant body of scientific research has uncovered important neurobiological, cognitive, 
and psychological correlates of the disorder. A compelling and unresolved issue is what 
discriminates those who develop PTSD from those who experience trauma but remain 
resilient? This highlights the importance of identifying key risk and resilience factors, 
biomarkers, and underlying mechanisms that may mediate/moderate the relationship 
between a traumatic event and PTSD symptoms. 
A prevailing model suggests that the impaired extinction of conditioned fear in the 
aftermath of trauma is critical in the development and maintenance of PTSD (e.g., Mineka & 
Oehlberg, 2008; Pitman et al., 2012). There is substantial evidence of greater fear 
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conditioning and impaired fear extinction in patients with PTSD (Blechert, Michael, 
Vriends, Margraf, & Wilhelm, 2007; Norrholm et al., 2011; Zuj et al., 2016). However, to 
examine the role of fear extinction in the development of PTSD, longitudinal prospective 
studies are required that examine these processes prior to and following trauma exposure. 
Recent prospective studies have revealed that impaired fear extinction prior to trauma 
exposure predicts increased PTSD symptom severity (Guthrie & Bryant, 2006; Lommen, 
Engelhard, Sijbrandij, van den Hout, & Hermans, 2013; Orr et al., 2012). The use of 
prospective studies has allowed the identification of other key risk factors identified in 
PTSD development, including candidate genotypes (Matsuoka, Nishi, Noguchi, Kim, & 
Hashimoto, 2013), stress and sex hormones (Bryant et al., 2011; Videlock et al., 2008), 
cognitive factors (Vasterling et al., 2012), and sleep disturbances (Bryant, Creamer, 
O'Donnell, Silove, & McFarlane, 2010). Interestingly, the connection between these risk 
factors and impaired extinction learning in PTSD has not received much attention yet. To 
date, certain links have been identified between fear extinction and candidate genotypes 
(Johnson, McGuire, Lazarus, & Palmer, 2012), stress and sex hormones (Milad et al., 2010; 
Mueller & Cahill, 2010), cognitive factors (Raes, De Raedt, Verschuere, & De Houwer, 
2009), and sleep disturbances (Spoormaker et al., 2010). On balance, the evidence points to 
impaired fear extinction as a shared factor that may link these biomarkers and risk factors to 
PTSD, although we acknowledge certain inconsistencies in the literature. In this review, we 
outline the evidence that suggests a fundamental role of fear extinction, and review an 
important question: is fear extinction the central factor that links known risk factors to 
PTSD? 
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2.2.1 Focus of this review. 
 Impaired fear extinction learning and memory appear to be key variables that link 
risk factors to PTSD susceptibility, and the aim of this review is to highlight these 
convergences. This paper will address this issue by providing a comprehensive review of the 
pre-trauma risk and resilience factors of PTSD development, and the evidence linking these 
factors to impaired fear extinction processes. Classic PTSD signs and symptoms include fear 
and anxiety, catastrophic cognitions, anger, substance abuse, shame, and guilt. It is 
important to note that this review focuses on the fear-related symptoms of PTSD (e.g., 
intrusive memories and re-experiencing symptoms), which are often considered primary 
symptoms. First, an overview of the current fear conditioning and extinction model of PTSD 
will be provided, including a brief review of convergent animal and human research on the 
neural networks of fear extinction relating to PTSD, and a summary of emerging prospective 
studies in fear extinction and PTSD. Second, prospective and cross-sectional studies 
examining risk and resilience factors in PTSD across varying domains of genetics, stress and 
sex hormones, cognitive function, and sleep will be reviewed. Third, we highlight the 
converging literature bases of known risk factors and impaired fear extinction learning 
and/or its retention. Based on this, we propose a model in which extinction is the central 
variable linking risk factors to PTSD, and discuss the current empirical evidence for this 
model. Finally, we discuss considerations for future research to investigate this model. 
Should further investigations into the role of fear extinction as a mechanism between risk 
factors and PTSD hold true, these findings would carry important implications for further 
research and clinical practice. These implications include advances for theory building and 
the development of interventions aimed at boosting PTSD resilience in susceptible 
populations (e.g., emergency services and military personnel). 
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2.3 The Fear Conditioning and Extinction Model of PTSD 
The fear conditioning model is central in explaining the development of PTSD. This 
model is based on Pavlov’s (1927) seminal work in classical conditioning, where a learned 
association between a previously neutral stimulus (e.g., a light, termed the conditioned 
stimulus; CS) and an aversive stimulus (unconditioned stimulus; US), leads to heightened 
US-expectancy of the CS. After learning, the CS alone generates a conditioned fear response 
in absence of the US. This principle operates when people experience trauma events. For 
example, an individual involved in a motor vehicle accident (US) is likely to experience a 
natural response of fear and heightened arousal (the unconditioned response; UCR). 
Following the event, aspects of the trauma that were not associated with the accident before 
(e.g., the car), may act as a trigger to activate the trauma memory, eliciting the CR. 
While fear conditioning processes can explain the acquisition of conditioned fear, 
most traumatized individuals recover and do not go on to develop PTSD (reviewed in 
Bryant, 2003). Indeed, the majority of individuals report ASD/PTSD symptoms within the 
initial weeks following trauma in the form of acute stress disorder (Bryant, 2011), however 
only a small percentage of these do not recover, and go on to display persistent symptoms. 
This rapid reduction in PTSD symptoms may be attributed partially to fear extinction 
learning, which has led current models to emphasize fear extinction processes in the 
maintenance of PTSD (e.g., Mineka & Oehlberg, 2008; Pitman et al., 2012; VanElzakker, 
Kathryn Dahlgren, Caroline Davis, Dubois, & Shin, 2013). Fear extinction refers to a 
process of new learning in which repeated exposure to a CS in the absence of an aversive 
consequence (the US) leads to a reduction in conditioned fear responses. In the context of 
trauma, this typically involves experience of benign trauma reminders. In this sense, the 
minority of trauma survivors who experience persistent conditioned emotional responses 
and chronic PTSD can be regarded as suffering impaired fear extinction (Davis & Myers, 
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2002; Kolb & Mutalipassi, 1982). Therefore, a prevailing model of PTSD is that a central 
component of the disorder results from impaired fear extinction (Mineka & Oehlberg, 2008; 
Pitman et al., 2012; Shin & Liberzon, 2010). 
2.4 Empirical Evidence for Impaired Fear Extinction in PTSD 
Recently, research indicates that the persistence of PTSD symptoms nine months 
post-deployment in Dutch soldiers can be predicted by an impaired ability to inhibit learned 
fear, as indexed by an increased startle response to a CS in the presence of a safety signal 
(Sijbrandij, Engelhard, Lommen, Leer, & Baas, 2013). Compared to trauma-exposed 
controls without PTSD and healthy controls, participants with PTSD demonstrate a robust 
psychophysiological increase in arousal to the CS+ during the extinction phase, indicative of 
a reduced ability to extinguish conditioned fear (Blechert et al., 2007; Norrholm et al., 2011; 
Orr et al., 2000; Peri, Ben-Shakhar, Orr, & Shalev, 2000; Zuj et al., 2016). Further, 
participants with PTSD have also shown an impaired ability to inhibit conditioned fear 
responses to a CS that has not been reinforced by the US (Jovanovic et al., 2010; Jovanovic 
et al., 2009). These findings suggest that PTSD symptoms are associated with impairment in 
regulating fear responses previously associated with an aversive stimulus, as well as 
responses to safety signals. 
Participants often display over-expressed conditioned fear during the early stage of 
extinction learning, termed fear load (Norrholm et al., 2015). Fear load, as measured by fear-
potentiated startle, has been observed in PTSD (Norrholm et al., 2011), and later identified 
to be significantly correlated with intrusive fear memories of a traumatic event (Norrholm et 
al., 2015). Importantly, the authors argue that fear load may be a quantifiable intermediate 
phenotype with a significant role in the etiology of fear-related psychopathology (Briscione, 
Jovanovic, & Norrholm, 2014; Norrholm et al., 2015). 
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Some studies have demonstrated little difference in within-session extinction 
learning between PTSD subjects and controls (Milad et al., 2008; Milad, Pitman, et al., 
2009) but rather found poor recall of extinction memories in PTSD 24 hours after extinction 
learning (Milad et al., 2008; Milad, Pitman, et al., 2009; Shvil et al., 2014). Shvil et al. 
(2014) used a two-day paradigm to assess fear conditioning and extinction learning on day 
one, and fear extinction recall on day two. The results showed impaired recall of fear 
extinction learning in PTSD, however this result was sex-specific, with men showing poorer 
extinction recall compared to women with PTSD (Shvil et al., 2014). Additional studies 
using a similar two-day paradigm have found further support for impaired fear extinction 
recall in PTSD, albeit without sex differences (Milad et al., 2008; Milad, Pitman, et al., 
2009). Together, these findings indicate that impairments may not be limited to extinction 
learning, but rather to the consolidation of extinction memories, or availability for recall. It 
is worth noting here, however, that there are certain methodological differences in the fear 
conditioning and extinction paradigms discussed here, compared to studies discussed in 
above paragraphs. For example, there are specific differences between paradigms regarding 
the use of partial or full CS-US reinforcement schedules, the addition of contextual 
contingencies, pharmacological challenge interventions, and the measurement of 
conditioned responses via skin conductance response (SCR), fear-potentiated startle, and 
self-report US-expectancy ratings (e.g., Milad et al., 2008; Norrholm et al., 2011; Soeter & 
Kindt, 2012). It is possible that these differences in experimental paradigms may account for 
alternate findings. 
The continued expression of fear or spontaneous return of fear following extinction 
learning suggests that extinction is formed as a new memory that competes with the original 
conditioning memory, rather than overriding the conditioning trace (for a brief review, see 
Pace-Schott, Germain, & Milad, 2015a). However, it remains unclear whether PTSD is 
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associated with impairments in the learning, consolidation, or retrieval of extinction 
memories, or a combination of all of these processes. Nevertheless, evidence is clear that 
PTSD is associated with impaired mechanisms of fear extinction. 
2.5 The Neurobiology of Fear Conditioning and Extinction 
Research in neuroimaging of rodents and humans has led to considerable advances in 
our understanding of the neural pathways involved in fear expression. This section will 
provide a brief discussion of the evidence from animal studies, followed by translational 
evidence in human neuroimaging studies (for a comprehensive review, see Pitman et al., 
2012). Finally, this section will present convergent evidence for the role of this neural 
network in human neuroimaging studies using fear conditioning and extinction paradigms in 
PTSD subjects. 
 
2.5.1 Animal studies. 
The amygdala has been referred to as the neural ‘hub of fear’ (Milad & Quirk, 2012), 
with different regions of the amygdala playing key roles in the acquisition of fear. 
Specifically, the basolateral amygdala (BLA) receives sensory information on the CS-US 
association, as well as the presence of contextual contingencies, and the central nucleus (CE) 
sends afferent projections to behavioral and endocrine systems to express fear (Holmes & 
Singewald, 2013; LeDoux, 2000; Pape & Pare, 2010; Pare & Duvarci, 2012; Pare, Quirk, & 
Ledoux, 2004). For example, the CE projects to the periaqueductal grey to regulate freezing 
behaviour in rodents and the lateral hypothalamus to regulate blood pressure (Medina, Repa, 
Mauk, & LeDoux, 2002). Evidence also links the prelimbic system of the medial prefrontal 
cortex (mPFC) to the expression of conditioned fear. That is, freezing behavior in rodents is 
correlated with neuronal activity in the prelimbic cortex (Burgos-Robles, Vidal-Gonzalez, & 
Quirk, 2009). Similarly, inactivation of the prelimbic cortex is associated with reduced 
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expression of conditioned fear (Corcoran & Quirk, 2007), supporting the notion that the 
amygdala receives excitatory projections from the prelimbic cortex to express fear. 
Emerging evidence also suggests that activation of the basomedial amygdala (BMA) in mice 
plays a significant role in the reduction of freezing and anxiety behaviors (Adhikari et al., 
2015). Furthermore, the ventral mPFC exerts top-down control over the BMA to regulate 
this process. 
The amygdala sends afferent projections to sympathetic arousal centres to express 
fear, however the mPFC and the hippocampus play a larger role in mediating this process as 
the CS ceases to predict the US during fear extinction. Greater activation of the infralimbic 
cortex is associated with enhanced extinction recall (Milad & Quirk, 2002) and electrical 
stimulation of infralimbic neurons resulted in reduced conditioned fear responses (i.e., 
reduced freezing in rodents; Milad, Vidal-Gonzalez, & Quirk, 2004). In further support, 
lesions to the infralimbic cortex are associated with increased extinction recall (Laurent & 
Westbrook, 2009; Quirk, Russo, Barron, & Lebron, 2000). Presentation of a CS in an 
extinguished context has been associated with reduced conditioned freezing and enhanced 
cFos expression (an indicator of increased neuronal activity) in the infralimbic cortex 
(Hefner et al., 2008; Knapska & Maren, 2009). Alternatively, presentation of the CS in a 
non-extinguished context however, has resulted in high levels of conditioned freezing and 
greater cFos activity in the prelimbic cortex (Knapska & Maren, 2009). These findings 
suggest that the infralimbic cortex acts in opposition to the prelimbic cortex, with greater 
activity inhibiting the amygdala, and thereby inhibiting fear expression. 
The hippocampus has been implicated in the contextual modulation of extinction 
learning. Corcoran and Maren (2001) found that when hippocampal activity went 
uninterrupted, rats showed context-specific freezing behavior. Fear expression was reduced 
in the extinction context, but elevated in non-extinguished contexts, supporting the notion 
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that extinction learning is context specific. In a separate experiment, inactivation of the 
dorsal hippocampus resulted in reduced freezing to the CS when placed in either the 
extinguished or unextinguished context (Corcoran & Maren, 2001), indicating a role for the 
dorsal hippocampus in identifying safe versus threatening contexts. It is argued that the 
hippocampus projects directly to the BLA and indirect connections via the mPFC to relay 
contextual contingencies on the CS-US relationship (Orsini, Kim, Knapska, & Maren, 2011; 
Orsini & Maren, 2012). Therefore, when the CS no longer predicts the US, the hippocampus 
and infralimbic cortex send inhibitory projections to the amygdala, reducing the expression 
of conditioned fear and demonstrating successful fear extinction retention (for a 
comprehensive review on the hippocampus and contextual fear conditioning and extinction, 
see Maren, Phan, & Liberzon, 2013). 
 
2.5.2 Human studies.  
A remarkable aspect of fear conditioning and extinction is the potential for 
translational work from rodents to humans, with the goal of improving clinical interventions 
and treatment (Milad & Quirk, 2012; Quirk & Mueller, 2008; Rothbaum & Davis, 2003). 
Activation of the amygdala is enhanced during the acquisition of fear (Cheng, Knight, 
Smith, Stein, & Helmstetter, 2003; Cheng, Richards, & Helmstetter, 2007; LaBar, Gatenby, 
Gore, LeDoux, & Phelps, 1998; Morris & Dolan, 2004). Consistent with animal studies, the 
BLA receives sensory information on the CS-US contingency during fear conditioning and 
projects this information to sympathetic arousal structures (for a comprehensive review, see 
LeDoux, 2000). Neuroimaging studies have found the dACC in humans to be the functional 
homologue of the prelimbic system in rodents (VanElzakker et al., 2013). Cortical thickness 
and activation of the dACC is positively correlated with SCR during the acquisition of fear, 
as well as presentations of the CS+ (Milad, Quirk, et al., 2007). Further studies have also 
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found increased dACC activation during fear conditioning (Buchel, Morris, Dolan, & 
Friston, 1998; Cheng et al., 2003; Knight, Smith, Cheng, Stein, & Helmstetter, 2004; 
Linnman, Rougemont-Bucking, Beucke, Zeffiro, & Milad, 2011; Phelps, Delgado, Nearing, 
& LeDoux, 2004). 
The ventromedial PFC (vmPFC) is suggested to be homologous to the rodent 
infralimbic cortex (Milad, Rauch, Pitman, & Quirk, 2006; Milad, Wright, et al., 2007). 
Showing parallels with the proposition that the infralimbic cortex may inhibit the amygdala 
in rodents (e.g., Milad & Quirk, 2002), Motzkin, Philippi, Wolf, Baskaya, and Koenigs 
(2014) recently showed that vmPFC lesions in human subjects prevented the inhibition of 
amygdala activity in viewing aversive images, resulting in greater amygdala activity. 
Similarly, Milad, Wright, et al. (2007) found that the recall of extinction learning was 
positively correlated with activation of the vmPFC. Milad, Wright, et al. (2007) used an 
ABB conditioning and extinction design, whereby fear was acquired in context A, but 
extinguished in context B, with extinction recall also occurring in context B the next day. 
Extinction recall on day two was associated with increased hippocampal activation, 
suggesting an important role of the hippocampus in differentiating the acquisition versus 
extinction contexts (Milad, Wright, et al., 2007). Previous fMRI research using only one 
context for stimulus presentations found no evidence of hippocampal activation in 
association with vmPFC activation during extinction recall (Phelps et al., 2004). Milad, 
Wright, et al. (2007) speculate that this difference is due to contextual signaling in the 
hippocampus, with this signaling only occurring in instances of multiple contexts with 
different extinction contingencies. Indeed, Lang et al. (2009) identified increased 
hippocampal activation where multiple contextual conditioning/extinction contingencies 
were employed, supporting previous animal studies (Corcoran & Maren, 2001). 
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2.6 Neuroimaging of Fear Conditioning and Extinction in PTSD 
Neuroimaging studies in clinical PTSD samples provide additional support for the 
role of aforementioned neural structures in the acquisition and extinction of conditioned 
fear. During fear acquisition, participants with PTSD show significantly greater amygdala 
activation compared to trauma-exposed controls (Linnman, Zeffiro, Pitman, & Milad, 2011; 
Milad, Pitman, et al., 2009) and trauma non-exposed controls (Bremner et al., 2005). 
Although increased amygdala activation is found during fear acquisition in healthy subjects 
(Cheng et al., 2003; Cheng et al., 2007; LaBar et al., 1998; Morris & Dolan, 2004), it is 
possible the amygdala is hyperactive in PTSD. In support, increased avoidance symptoms 
correlate with increased amygdala, vmPFC, and hippocampus activity during both fear 
acquisition and extinction in United States military veterans with PTSD (Sripada, Garfinkel, 
& Liberzon, 2013). 
PTSD is associated with hyperactivity in the dACC during fear acquisition and 
extinction learning (Rougemont-Bücking et al., 2011), and extinction recall 24 hours later 
(Milad, Pitman, et al., 2009; Rougemont-Bücking et al., 2011). Rougemont-Bücking et al. 
(2011) used a two-day paradigm measuring fear conditioning, extinction (day one), and 
extinction recall (day two) with fMRI scanning in PTSD subjects. PTSD subjects and 
healthy trauma-exposed controls acquired fear conditioned responses in context A, with 
extinction learning and recall occurring in context B. PTSD subjects showed greater dACC 
activation during conditioning, and reduced vmPFC activity during late extinction learning. 
A specific limitation of these findings, however, is that there were no between-group 
differences in SCR (a measure of conditioned responses) at any stage of conditioning or 
extinction. Although it is, therefore, difficult to attribute activation in these neural regions to 
greater conditioned responses, neural activity does support the proposed function of these 
regions at different stages of conditioning and extinction (Milad, Quirk, et al., 2007; Milad, 
Chapter 2: Fear extinction, risk factors, and PTSD: A narrative review 25 
 
Wright, et al., 2007). Further, Shvil et al. (2014) recently found that greater left rostral 
dACC activity was associated with poor fear extinction recall in men with PTSD, with no 
effects in women with PTSD and trauma-exposed healthy controls. 
 Milad, Pitman, et al. (2009) used a two-day paradigm (explained above, see 
Rougemont-Bücking et al., 2011) with fMRI scanning in PTSD subjects and trauma-
exposed controls. PTSD was associated with greater amygdala activity during fear 
acquisition on day one, and decreased hippocampal and vmPFC activity during fear 
extinction recall on day two. Furthermore, extinction recall was associated with increased 
dACC activity in PTSD subjects, compared to trauma-exposed controls (Milad, Pitman, et 
al., 2009). Importantly, these findings support previous research of hippocampal 
involvement when contextual contingencies are involved. That is, PTSD subjects showed 
lower hippocampal activation during recall of extinction memories in the extinction context, 
rather than the conditioning context (Milad, Pitman, et al., 2009). In support, PTSD subjects 
show lower activity in the parahippocampal gyrus during extinction learning in a different 
context to an acquisition context (Rougemont-Bücking et al., 2011). Furthermore, a recent 
fMRI study found increased hippocampal activity during context presentations in extinction 
learning (Sripada et al., 2013). Alternatively, PET scans during fear conditioning and 
extinction have revealed increased blood flow in the left hippocampus during extinction 
learning in PTSD subjects compared to controls, although context was not manipulated in 
this study (Bremner et al., 2005). These findings implicate a role for the hippocampus in 
contextual contingencies in fear extinction learning and recall, however further research is 
required to shed light on whether this structure is only involved in contextual modulation, or 
other processes of conditioning and extinction. 
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2.7 Fear Extinction Learning in Twin Studies of PTSD 
An important question regarding the neurobiology of PTSD is whether impaired 
neural signaling is a consequence of a traumatic event, or a biological risk factor that 
predisposes an individual to overly conditioned fear responding, an inability to extinguish 
conditioned fear, or both of these factors. An underlying vulnerability factor cannot be 
considered so, unless it precedes the onset of PTSD (Kremen, Koenen, Afari, & Lyons, 
2012). While this presents a particular issue in differentiating consequences from sequelae 
due to the unpredictable nature of trauma exposure, some studies have examined certain 
factors in twins discordant for combat-exposure, with some combat-exposed twins being 
diagnosed with PTSD and others reporting no symptoms. As monozygotic twins share 100% 
of their genetic makeup, it would be expected that both twins share specific risk factors 
(both cognitive and biological) with the only differentiating factor being trauma exposure 
and PTSD diagnosis. Specifically, it would be hypothesized that both twins show similar 
impairments in fear extinction learning, however trauma exposure mediates the display of 
PTSD symptoms. 
One study has examined fear extinction learning in a monozygotic co-twin design. 
Milad et al. (2008) measured fear extinction learning and extinction recall in a sample of 14 
monozygotic twin pairs discordant for PTSD diagnosis, and combat exposure from the 
Vietnam War. Seven twin pairs were discordant for PTSD diagnosis and combat exposure, 
and the remaining seven were only discordant for combat exposure with neither twin 
diagnosed with PTSD. This study revealed no between-group differences on 
psychophysiological arousal measures during fear acquisition and extinction recall one day 
later, compared with their co-twin, or twin pairs discordant for combat exposure. However, 
the authors revealed that PTSD diagnosis significantly interacts with combat exposure 
during extinction recall, suggesting that impaired extinction recall is a consequence of 
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combat exposure, leading to PTSD, rather than a pre-trauma risk factor. As far as we are 
aware, this idea has not received any attention since. 
 
2.8 Impaired Fear Extinction Learning as a Prospective Risk Factor of PTSD 
While trauma-exposure is unpredictable in the general population, researchers have 
investigated fear extinction learning in people working in high-risk occupations. Despite 
evidence that impaired fear extinction learning may be a consequence of trauma (Milad et 
al., 2008), recent evidence has found impaired pre-trauma extinction learning to be a 
significant predictor of post-traumatic stress symptoms in trainee fire-fighters (Guthrie & 
Bryant, 2006). Guthrie and Bryant (2006) assessed trainee fire-fighters on PTSD symptoms 
and diagnosis, and a standardized fear conditioning and extinction task during cadetship 
(prior to trauma exposure), and reassessed within two years of commencing fire-fighting 
duties. This study revealed that greater EMG startle responses during extinction (reflecting 
impaired fear extinction learning) predicted higher PTSD symptoms following trauma 
exposure (Guthrie & Bryant, 2006). To our knowledge, this is the first study to examine pre-
trauma fear extinction as a predictor of PTSD symptoms. 
In support of pre-trauma fear extinction impairments predicting greater PTSD 
(Guthrie & Bryant, 2006), Orr et al. (2012) investigated fear conditioning and extinction in 
police and fire-fighter recruits. Participants underwent testing during training (prior to 
trauma exposure), and again several months after job-related trauma exposure. 
Psychophysiological measures during conditioning and extinction included SCR and 
electromyogram (EMG) responses to aversive stimuli. Logistic regression showed reduced 
extinction of forehead EMG responses to be a significant pre-trauma risk factor of greater 
post-traumatic stress symptoms (Orr et al., 2012). Additionally, at follow-up, 
psychophysiological assessments were conducted while participants recited the traumatic 
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experience. Regression identified increased SCR to loud tones as a pre-trauma risk factor for 
higher physiological reactivity during the recital of the traumatic event (Orr et al., 2012). 
This second finding indicates that greater psychophysiological reactivity to aversive, or 
negative stimuli may be a trait-like factor in the development of negative trauma reactions. 
That is, individuals may have a predisposed tendency to display elevated 
psychophysiological reactions to aversive or negative stimuli. These findings add further 
support for the notion that impaired fear extinction learning can predict higher post-
traumatic stress symptoms in at-risk populations. 
Finally, a recent study extended previous findings to military populations by 
assessing pre-deployment Dutch military soldiers on a fear conditioning and extinction 
paradigm (Lommen et al., 2013). Consistent with the aforementioned studies (Guthrie & 
Bryant, 2006; Orr et al., 2012), Lommen et al. (2013) found impaired fear extinction to be 
significantly predictive of post-traumatic stress symptoms two months post-deployment to 
Afghanistan. Extinction performance was assessed by increased US-expectancy ratings to 
the CS+. A limitation of this study is the absence of a psychophysiological measure of 
arousal, however US-expectancy ratings are a commonly used measure of associative 
learning in fear conditioning and extinction paradigms (e.g., Blechert et al., 2007; Norrholm 
et al., 2011; Sijbrandij et al., 2013), are an externally valid measure of human fear 
conditioning (Boddez et al., 2013), and do not influence psychophysiological recordings 
(Blechert, Michael, Williams, Purkis, & Wilhelm, 2008). Therefore, these findings indicate 
consistent results across several measures of arousal and threat expectancy, with impaired 
pre-trauma fear extinction as measured using elevated skin conductance response (Orr et al., 
2012), elevated EMG corrugator responses (Guthrie & Bryant, 2006), and subjective 
expectancy ratings (Lommen et al., 2013) found to be predictive of increased PTSD 
symptoms. While preliminary, these findings provide compelling evidence that an 
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underlying pre-trauma deficit in extinguishing conditioned fear is an important variable in 
the etiology of PTSD symptoms. 
 
2.9 Convergent PTSD Risk Factors in Fear Extinction 
Here, the present review aims to demonstrate the apparent interactions between 
PTSD, biomarkers and risk factors, and impaired fear extinction. Previous comprehensive 
reviews (e.g., Bomyea, Risbrough, & Lang, 2012; Zoladz & Diamond, 2013) have assessed 
evidence of multiple risk factors of PTSD, concluding there is significant variability due to 
gender, early trauma history, comorbidity, and dynamic biomarkers. The following sections 
discuss empirical evidence of the relationship between risk factors (genetics, neuroendocrine 
system, sex hormones, cognition and neuropsychological factors, and sleep) and PTSD, and 
their relation to impaired fear extinction learning and memory. It should be noted that due to 
the breadth of information presented here, specific references to recent reviews are provided 
where necessary for greater discussions of risk factors that cannot be discussed in the current 
review. 
 
2.9.1 Genetics. 
With advances in understanding DNA methylation and epigenetic influences on gene 
expression, genomics is claimed to be one of the most promising fields of understanding 
PTSD susceptibility (Zoladz & Diamond, 2013). While research into genetic risk factors of 
PTSD is still in its infancy with limited genome-wide association studies, researchers have 
identified potential candidate genotypes involved in PTSD. Convergent translational 
findings are emerging from animal, epigenetic, and gene × environment studies in PTSD, 
focusing specifically on candidate genotypes such as brain-derived neurotrophic factor 
(BDNF), catechol-O-methyltransferase (COMT), the functional polymorphism of the 
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serotonin transporter (5-HTTLPR), FK506 binding protein 5 (FKBP5), and pituitary 
adenylate cyclase-activating polypeptide (PACAP). Furthermore, in many instances, 
genotype polymorphisms do not solely pose risk for PTSD, but rather interact with 
environmental factors to increase the likelihood of PTSD development. Bomyea et al. (2012) 
highlight the importance of studying gene × environment interactions, as stressors during 
childhood have the potential to reveal biological risk factors, with significant consequences 
on neural systems. 
Research has identified that in some cases, PTSD development can be linked to 
familial factors (Gilbertson et al., 2006), with approximately one-third of the variability in 
PTSD symptoms explained by genetic factors (True et al., 1993). Similarly, twin studies 
have identified that between 35-45% of variability in fear conditioning and extinction can be 
explained by genetic influences (Hettema, Annas, Neale, Kendler, & Fredrikson, 2003). 
Research has identified that candidate genotypes play a significant role in the cellular 
networks of fear memories, and are likely contributors to impaired extinction learning (see 
Johnson et al., 2012 for a review). 
 
BDNF. BDNF is a member of the neurotrophin family, playing a key role in 
synaptic plasticity. Specifically, BDNF is concentrated in regions of the central nervous 
system implicated in PTSD and fear extinction, such as the amygdala, prefrontal cortex, and 
hippocampus (Rakofsky, Ressler, & Dunlop, 2012). A recent prospective longitudinal study 
examined serum BDNF levels in motor vehicle accident survivors soon after trauma, and 
six-months post-trauma (Matsuoka et al., 2013). The results show a positive correlation 
between serum BDNF levels six-months post-trauma and PTSD severity. Furthermore, the 
PTSD group displayed significantly higher BDNF levels soon after hospital admission, 
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indicating that increased BDNF levels soon after trauma could be a biomarker for greater 
PTSD symptoms.  
Matsuoka et al. (2013) identified elevated serum BDNF levels post-trauma as a risk 
factor for increased PTSD symptoms six-months later. These findings have been supported 
in cross-sectional research showing higher serum BDNF levels in PTSD relative to controls 
(Hauck et al., 2009; Hauck et al., 2010). Further, Berger et al. (2010) examined the 
relationship between PTSD symptoms and serum BDNF over the course of a 12-week 
treatment program using the SSRI escitalopram. The results of this study show low serum 
BDNF levels at baseline were associated with greater reduction of PTSD symptoms at the 
end of treatment. Alternatively, studies have identified lower BDNF levels (serum and 
plasma) in PTSD compared to trauma-exposed and healthy controls (Angelucci et al., 2014; 
Dell'Osso et al., 2009). It could be argued, however, that plasma BDNF levels do not 
accurately reflect cortical levels, as there is evidence that plasma BDNF follows a circadian 
rhythm, with greater levels early in the day (Begliuomini et al., 2008), and fluctuations with 
the menstrual cycle in females (Begliuomini et al., 2007). 
Translational research shows an important role of BDNF in the fear network. In 
animal studies, BDNF knock-out mice, characterized by an approximate 50% reduction in 
BDNF levels, show impaired fear extinction (Psotta, Lessmann, & Endres, 2013), and 
similarly infusing BDNF into the hippocampus increases neuronal activity in the infralimbic 
cortex during extinction training, and facilitates extinction learning (Rosas-Vidal, Do-
Monte, Sotres-Bayon, & Quirk, 2014). Additionally, Peters, Dieppa-Perea, Melendez, and 
Quirk (2010) injected BDNF into the infralimbic mPFC of rats, resulting in attenuated fear 
conditioned responses without undergoing extinction learning. 
A single nucleotide polymorphism (SNP) with an amino acid change from a valine to 
a methionine at position 66 (val66met) in BDNF has recently been implicated in disorders of 
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fear regulation (Frielingsdorf et al., 2010). Studies have identified carriers of the BDNF 
val66met met-allele show slow, impaired extinction learning ability (Soliman et al., 2010), 
and increased vmPFC and amygdala activity during extinction trials (Lonsdorf et al., 2015; 
Soliman et al., 2010). Further, Felmingham, Dobson-Stone, Schofield, Quirk, and Bryant 
(2013) identified that PTSD patients with the met66 allele show poorer response to exposure 
therapy (based on the processes of fear extinction learning) compared to val/val carriers. The 
role of the val66met SNP in fear extinction has been further reviewed in Notaras, Hill, and 
van den Buuse (2015). 
 
COMT. COMT is a key enzyme in the prefrontal cortex and hippocampus, working 
in the degradation of synaptic dopamine levels, as well as epinephrine and norepinephrine 
(Bomyea et al., 2012). A common SNP coding at position 158 (val158met) is important in 
the activity of this enzyme. According to Chen et al. (2004), carriers of the val158 allele 
show increased COMT activity, resulting in greater elimination of dopamine and reduced 
prefrontal functioning. Alternatively, the met158 allele appears to be associated with 
reduced COMT activity, and therefore increased synaptic dopamine levels (Tunbridge, 
Harrison, & Weinberger, 2006). Val/met heterozygotes are believed to demonstrate 
intermediate levels of COMT activity (Tunbridge et al., 2006), and therefore may show 
balanced levels of dopamine within the synapse. Therefore, individuals homogenous for 
either the val or met allele of the COMT gene may be at an increased risk for PTSD, 
potentially caused by increased or decreased COMT activity in the synapse.  
A prospective study by Clark et al. (2013) in members of the United States National 
Guard deployed to Iraq revealed that homozygous variants of COMT interact with trauma 
exposure to increase risk for PTSD development. Specifically, val/met allele carriers 
developed fewer PTSD symptoms under high trauma exposure compared with val/val or 
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met/met carriers. All participants in this study were white males, potentially limiting 
generalization to females and other ethnic groups (Clark et al., 2013). Nevertheless, research 
in Ugandan refugees identified the met/met allele to demonstrate a high risk for PTSD 
development independent of trauma severity (Kolassa, Kolassa, Ertl, Papassotiropoulos, & 
De Quervain, 2010). Further, Kolassa et al. (2010) revealed the val/val allele shows a dose-
response relationship with trauma exposure to predict PTSD. These findings are supported 
by research in victims of urban violence, with carriers of the met allele showing increased 
PTSD symptoms (Boscarino, Hoffman, Rukstalis, & Stewart, 2011; Valente et al., 2011). It 
is possible that reduced or increased levels of synaptic dopamine degradation in the 
prefrontal cortex confer risk for PTSD development by inhibiting prefrontal function during 
trauma exposure. 
Risbrough, Ji, Hauger, and Zhou (2014) recently demonstrated that mice with the 
COMT met/met allele show increased cued fear, and impairments in the recall of extinction 
memories compared to val-carriers. In humans, met-carriers of the COMT val158met allele 
have been linked to impaired fear extinction learning. Lonsdorf et al. (2009) found 
extinction was associated with greater fear-potentiated startle to the CS+ in the met/met 
genotype, compared to val-carriers. Importantly, the met/met genotype in PTSD has been 
associated with an impairment to inhibit fear towards the CS-, which represents a safety 
signal compared to the CS+ (Norrholm et al., 2013; Wendt et al., 2014). Norrholm et al. 
(2013) demonstrated that performance in fear extinction learning was most impaired in 
met/met carriers with a current diagnosis of PTSD, compared with trauma-exposed controls. 
Furthermore, panic disorder patients with the met/met genotype also appear to show little 
symptom relief from exposure therapy, compared to val-carriers (Lonsdorf et al., 2010), 
indicating that exposure therapy may not be the most beneficial form of treatment for met-
carriers.  
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Serotonin genes. Selective serotonin reuptake inhibitors (SSRIs) are a commonly 
used, first line treatment method in PTSD, suggesting altered activity of genes encoding 
serotonin (5-HT) levels in PTSD (Thakur, Joober, & Brunet, 2009). The functional 
polymorphism of the serotonin transporter (5-HTTLPR) gene regulates the availability of 5-
HT in the synapse, with carriers of the low expression (“short”) allele showing reduced 5-
HT transcription efficiency compared to the high expression (“long”) allele (Lesch et al., 
1996). In many instances, specific genotypes may not be directly involved in the etiology of 
a disorder (medical or psychiatric), but rather interact with environmental influences to 
increase the likelihood of an individual developing a specific condition. 5-HTTLPR appears 
to be one such gene, as the short allele of 5-HTTLPR has been shown to interact with trauma 
exposure and other factors to predict PTSD development.  
In the fall of 2004, catastrophic hurricanes on the coast of Florida presented a unique 
situation for trauma researchers to examine a large population with experience of repeated 
stressors/traumas. Kilpatrick et al. (2007) interviewed 589 individuals affected by Florida 
hurricanes regarding hurricane exposure and social support, and collected DNA samples 
(including the 5-HTTLPR genotype). 5-HTTLPR showed no relationship with PTSD alone, 
however there was a significant interaction between the short allele, high hurricane exposure 
and low social support in predicting PTSD diagnosis. This link was not evident in 
participants with the long allele, low hurricane exposure and high social support. These 
findings have received further support, indicating that the 5-HTTLPR short allele interacts 
with environmental stressors to predict PTSD risk, including high crime and unemployment 
rates (Koenen et al., 2009). In a recent meta-analysis, it was revealed that the 5-HTTLPR 
short allele had a significant association with PTSD, but only in participants with high 
trauma-exposure (Gressier et al., 2013). Lee et al. (2005) also found a significantly higher 
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occurrence of PTSD diagnosis in individuals with two short alleles, compared to carriers of 
at least one long allele. 
A recent study in Israeli Defence Force soldiers involved the collection of 
prospective data before and during military deployment on the association between 
attentional threat bias, serotonin genes and PTSD risk (Wald et al., 2013). In opposition to 
the previous findings, the results show a significant interaction with the combination of high 
combat exposure, low expression 5-HTTLPR, and attentional threat bias as protective 
factors for PTSD, rather than risk factors. The relationship between 5-HTTLPR and threat 
bias may be evident only in military samples, due to attention to threat being considered a 
normal behavior in infantry soldiers (Wald et al., 2013). Alternatively, Mellman et al. (2009) 
found no association between 5-HTTLPR and PTSD, however, PTSD was significantly 
associated with the low expression (G) allele of the 5HT2 receptor antagonist, which is 
prominent in some pharmacological treatments. This presents an interesting possibility that 
PTSD risk may be due to the interaction of multiple genes involved in 5-HT activity.  
The 5-HTTLPR-s allele has also been associated with a stronger conditioned fear 
trace. Findings are thus far consistent, with carriers of the 5-HTTLPR-s allele showing 
significantly stronger startle potentiation during the conditioning phase compared to carriers 
of the l/l-allele (Hermann et al., 2012; Lonsdorf et al., 2009; although see Lonsdorf et al., 
2010). Similarly, studies have replicated these findings in healthy volunteers, but only in 
carriers of the risk allele (G-allele) for the corticotropin releasing hormone receptor 1 
(CRHR1 rs878886; Heitland, Groenink, Bijlsma, Oosting, & Baas, 2013) and the risk allele 
(T-allele) for the NPS receptor gene (NPSR1 rs324981; Glotzbach-Schoon et al., 2013). 
These findings indicate that 5-HTTLPR-s interacts with other gene SNPs to promote a 
biological predisposition for impaired extinction of fear. Wendt et al. (2014) found that 
carriers of the short and long allele demonstrate comparable fear learning ability, however at 
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re-conditioning, 5-HTTLPR-s allele carriers showed greater fear potentiated startle levels 
representing a stronger conditioning trace. These findings posit that carriers of the 
5HTTLPR s-allele may develop a conditioning trace that increases in strength, and is 
resistant to extinction learning. 
 
FKBP5. FKBP5 plays a significant role in the molecular networks of glucocorticoid 
receptor (GR) sensitivity and translocation, regulating cortisol activity and inhibiting 
negative feedback activity in the hypothalamic-pituitary-adrenal (HPA) axis (Bomyea et al., 
2012). Specific SNPs of FKBP5 have been found to be important in gene × environment 
interactions, namely: rs9296158, rs3800373, rs1360780, and rs9470080 (Binder et al., 2008; 
Mehta et al., 2011; Xie et al., 2010). For example, Xie et al. (2010) found that the rs9470080 
SNP interacts with early-life trauma to significantly predict PTSD development. Alone, 
FKBP5 SNPs show no direct effects on PTSD development or symptom severity (Binder et 
al., 2008; Xie et al., 2010), and appear to only interact with childhood trauma, with no G × E 
interactions with other forms of trauma (Binder et al., 2008). Research has, however, 
identified 12-weeks of cognitive behaviour therapy for PTSD is associated with an increase 
in FKBP5 expression levels (Levy-Gigi, Szabo, Kelemen, & Keri, 2013; Szabo, Kelemen, & 
Keri, 2014; Yehuda et al., 2013). Wilker et al. (2014) found that carriers of the SNP 
rs1360780 T allele presented a significant risk of symptom relapse 10-months after 
exposure-therapy, with non-carriers showing a continuous reduction in symptoms. These 
findings highlight a significant role for FKBP5 in GR systems following childhood trauma, 
and in treatment outcome for PTSD. 
To our knowledge, only one study has investigated FKBP5 in fear extinction and the 
retention of fear. Sawamura et al. (2016) recently used an animal model of PTSD to examine 
dexamethasone in extinction learning, and retention of extinction one day later. The authors 
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found dexamethasone to be associated with a dose-dependent enhancement of extinction 
learning and retention. Furthermore, dexamethasone treatment was associated with reduced 
FKBP5 mRNA expression in the amygdala after extinction learning and retention. It was 
suggested that dexamethasone worked to enhance extinction learning and retention via 
dynamic FKBP5 regulation in the HPA axis. In support, the glucocorticoid receptor is 
critical in managing the stress response, and it is believed that the glucocorticoid receptor is 
regulated via the FKBP5 gene (Zannas & Binder, 2014). 
 
PACAP-PAC1. PACAP is a protein encoded by the ADCYAP1 gene, and important 
in the activation of stress circuitry within the central and peripheral nervous systems (Uddin 
et al., 2013). The ADCYAP1 and ADCYAP1R1 (responsible for encoding the PAC1 
receptor) genes have recently been associated with sex-specific PTSD risk in women, but 
not men. Ressler et al. (2011) found that a single SNP (rs2267735) within the ADCYAP1R1 
gene was a significant predictor of PTSD diagnosis and posttraumatic stress symptoms in 
highly traumatized African American women. A follow-up study by Almli et al. (2013) 
supported these findings with a significant genotype × trauma interaction, showing that the 
combination of ADCYAP1R1 gene and high trauma exposure predicted PTSD. Further, 
while Uddin et al. (2013) found no evidence of a direct effect of ADCYAP1R1 on PTSD 
development, they did find that ADCYAP1R1 interacts with high levels of childhood 
maltreatment to promote PTSD risk. Samples with relatively lower trauma-exposure have 
failed to find an association between the gene and PTSD (Chang et al., 2012), suggesting an 
underlying risk factor in the presence of high trauma exposure. On the basis of these 
preliminary findings, it is possible that the PACAP-PAC1 pathway (and associated genes) 
may be used to confer risk for increased PTSD symptoms in women with increased trauma-
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exposure, however prospective longitudinal studies are required to test this hypothesis (Dias 
& Ressler, 2013).  
Ressler et al. (2011) investigated mRNA changes in the ADCYAP1R1 allele of 
PACAP in the mouse brain during fear conditioning. The results show a significant increase 
in the amygdala ADCYAP1R1 mRNA during conditioning, with a similar relationship in the 
mPFC. Recently, Schmidt et al. (2015) infused PACAP-38 into the CA1 region of the 
hippocampus or the BLA of rats prior to a contextual fear extinction task. The results 
indicated that PACAP-38 infused in the amygdala resulted in a significantly greater 
percentage of freezing during a recall test (24 hours after extinction learning). These results 
indicate that fear acquisition processes in the amygdala and consolidation/retrieval processes 
in the mPFC (Myers & Davis, 2007) and contextual extinction recall in the hippocampus 
(Schmidt et al., 2015) may be moderated by PACAP expression in these structures. 
Translating these findings to humans would further clarify the role of PACAP in fear 
memory.  
 
Summary. Research in biomarkers of PTSD, and particularly genetic biomarkers, 
has been claimed to be the most promising field of advancing our understanding of PTSD 
risk (Zoladz & Diamond, 2013). Prospective and cross-sectional research has consistently 
linked increased serum BDNF to greater PTSD symptoms, and the BDNF val66met met-
allele is associated with poorer therapeutic and experimental extinction learning. 
Homozygous variants of the COMT gene (i.e., met/met and val/val carriers) are associated 
with greater PTSD risk and significantly poorer fear extinction learning. There is consistent 
evidence that the 5-HTTLPR-s allele interacts with environmental stressors and high 
trauma-loads to increase risk for PTSD, and the s-allele is associated with stronger fear 
acquisition, however research in fear extinction is currently limited. FKBP5 SNPs appear to 
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interact specifically with childhood trauma to promote PTSD risk, and dexamethasone 
administration enhances extinction learning and retention via FKBP5 mRNA regulation in 
the HPA axis. Research is currently consistent that PACAP-encoding genes interact with 
high-stress environments to promote PTSD risk, and animal research shows PACAP 
administration to the rat amygdala leads to a reduction in fear extinction recall. 
 
2.9.2 Neuroendocrine system. 
As PTSD is a disorder primarily characterized by increased anxiety, stress and 
arousal, a logical assumption is that this disorder may involve irregularities in cycling 
hormones associated with the stress response. Specifically, stress hormones (i.e., cortisol 
and noradrenaline) are critical in the fear network and regulating fear responding. This 
assumption has led researchers to investigate neuroendocrine functioning in PTSD. 
Understanding neuroendocrine abnormalities in PTSD carries important implications for 
pharmacological treatments (for a comprehensive review on the pharmacological 
enhancement of exposure therapy, see Singewald, Schmuckermair, Whittle, Holmes, & 
Ressler, 2015). 
 
Hypothalamic-pituitary-adrenal (HPA) axis and cortisol. The HPA axis is the 
mammalian brain’s premier neuroendocrine centre, which acts to regulate the release of 
hormones in different situations, including stress. Following stress exposure, the 
hypothalamus secretes a number of hormones and neuropeptides that stimulate the release of 
adrenocorticotropic hormone (ACTH) from the pituitary. ACTH facilitates cortisol release 
from the adrenal glands to promote a physiological environment for accommodating a 
stressful event. Cortisol release acts in a negative feedback loop to return the HPA axis to 
homeostasis in preparation for any subsequent activation (Munck & Guyre, 1986).  
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The assumption that the HPA axis is particularly sensitive to stressful responding in 
some situations has led to extensive research on the relationship between cortisol and PTSD 
diagnosis (Bomyea et al., 2012). With cortisol levels increasing synonymously with stress, 
investigators believed that PTSD might be associated with hyperactivity of naturally cycling 
cortisol levels (Zoladz & Diamond, 2013). Rather, PTSD has been associated with lower 
basal cortisol levels. Yehuda et al. (2009) found that after roughly 14 sessions of 
psychotherapy, cortisol levels differentiated non-responders to treatment from responders in 
survivors of the September 11 terrorist attack, with non-responders displaying reduced 
urinary cortisol levels. These findings indicate that lower cortisol levels may be used as a 
marker of treatment-resistant PTSD. Some studies have found results to support the notion 
that PTSD is associated with lower levels of naturally cycling cortisol levels compared to 
trauma-exposed and healthy controls (Bicanic et al., 2013; Wahbeh & Oken, 2013; Yehuda 
et al., 2007; although see Groer, Kane, Williams, & Duffy, 2014; Shalev et al., 2008).  
It is important to understand whether cortisol levels (a reflection of HPA axis 
activity) are an underlying biological risk factor for PTSD, or a product of trauma exposure 
(McFarlane, Atchison, & Yehuda, 1997), and hence require prospective investigation. A 
recent longitudinal study examined salivary cortisol levels in the morning and afternoon 
following hospital admission in 48 traumatic accident survivors (McFarlane, Barton, 
Yehuda, & Wittert, 2011). PTSD symptomatology was assessed six months post-trauma, 
revealing a significant, negative correlation between morning cortisol levels and PTSD 
symptoms six months later. Interestingly, afternoon cortisol levels were positively correlated 
with PTSD symptoms. These findings are in partial support of previous longitudinal studies 
in adults showing low peri-trauma cortisol levels to predict PTSD symptomatology at 
follow-ups (Delahanty, Raimonde, & Spoonster, 2000; McFarlane et al., 1997), and that 
cortisol increases in the remission of PTSD symptoms in Holocaust survivors (Yehuda, 
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Morris, et al., 2007). Interestingly, a prospective study in children found a sex-specific 
relationship between increased peri-trauma cortisol levels and increased PTSD symptoms 
six weeks later in boys, but not girls (Delahanty, Nugent, Christopher, & Walsh, 2005), thus 
presenting an interesting question regarding the differential effects of trauma exposure on 
the maturing sympathetic nervous system and HPA axis. 
The above findings note some important implications for future research, notably 
regarding the inconsistency surrounding lower versus higher cortisol levels in PTSD 
samples, and in prospective prediction of PTSD. Indeed, some of these inconsistencies may 
be grounded in wide methodological variations in the collection and subsequent analysis of 
hormone samples (i.e., differences between blood, urine, and salivary collection methods). 
In addition, time-of-day is an important factor to take into account when measuring cortisol, 
which may explain differing morning versus afternoon levels in the recent prospective study 
by McFarlane et al. (2011). That is, cortisol experiences a surge shortly after waking, known 
as the cortisol awakening response (van Zuiden et al., 2011), which may bias findings. 
Research suggests that increased cortisol enhances the formation of extinction 
memories (Bentz et al., 2013; Merz, Hamacher-Dang, & Wolf, 2014; Pace-Schott et al., 
2013), although these findings are somewhat mixed (see Raio, Brignoni-Perez, Goldman, & 
Phelps, 2014; Tabbert et al., 2010). Using a contextual fear conditioning task, Merz et al. 
(2014) found that following stress-induction (promoting an increase in cortisol levels), 
participants displayed reduced fear responses in the extinction context and attenuated 
responses in the acquisition context. Alternatively, Raio et al. (2014) found that following an 
acute stress task, participants displayed significantly worse recall of extinction memory 
compared to those who did not undergo the stress task. Evidence for the role of cortisol in 
the consolidation of extinction memories is somewhat mixed.  
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Studies have also examined the effect of acute stress tasks and cortisol administration 
on the efficacy of exposure-based treatments for specific phobias. Soravia et al. (2006) 
investigated oral cortisol consumption and response to exposure therapy in a sample of 
participants with a spider phobia. The results indicate that cortisol led to a reduction in 
spider fear that was maintained at retest two days later, compared to placebo treatment 
(Soravia et al., 2006). These findings suggest that cortisol administration facilitated and 
enhanced fear extinction learning, which has received further support in phobias of heights 
(de Quervain et al., 2011) and spiders (Soravia et al., 2014). To our knowledge, research has 
not yet examined these effects in a clinical PTSD sample. 
 
Noradrenaline. Evidence suggests that noradrenaline (NA) interacts with cortisol 
during the presentation of emotional stimuli to enhance the consolidation of emotional 
memories (for a review, see McGaugh, 2004). Noradrenaline is a catecholamine playing 
important hormonal and neurotransmitter functions during the “fight or flight” stress 
response. Rat models of posttraumatic stress have revealed exaggerated NA utilisation levels 
in the locus coeruleus following stress (George et al., 2013), and increased NA levels in the 
rostral pons were related to the presence of trauma reminders (Terzioglu et al., 2013). In 
clinical studies in humans, PTSD has been linked to increased salivary, urinary, blood, and 
cerebrospinal fluid NA levels compared to trauma-exposed and healthy controls (Geracioti 
et al., 2001; Kosten, Mason, Giller, Ostroff, & Harkness, 1987; Nicholson, Bryant, & 
Felmingham, 2014; Pietrzak et al., 2013; Yehuda et al., 1998; Yehuda, Southwick, Giller, 
Ma, & Mason, 1992). A longitudinal study by Videlock et al. (2008) measured NA levels in 
emergency room admissions and again at 10 days, 1-month, and 5-months post-admission. 
Participants who developed PTSD at 5-months had significantly lower plasma NA levels at 
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10 days, 1-month, and 5-months post-trauma, contradicting findings of increased NA levels 
in cross-sectional research. 
An additional method of measuring the impact of NA on PTSD symptoms is via 
pharmacological challenge studies with agents known to impact NA levels. Yohimbine and 
prazosin are two such drugs that have been assessed in PTSD. Yohimbine is an α-2 
adrenergic receptor antagonist that increases NA levels (Southwick, Morgan Iii, Charney, & 
High, 1999), while prazosin is an α-1 adrenergic receptor antagonist that reduces NA levels 
(Fuller, Snoddy, & Perry, 1978). Studies of yohimbine administration have shown an 
increase in PTSD re-experiencing symptoms (Southwick et al., 1999). Prazosin 
administration, however, has been associated with a significant decrease in PTSD-related 
sleep disturbances and nightmares (Raskind et al., 2007; Raskind et al., 2003), a significant 
increase in mean REM duration (Taylor et al., 2008), and a significant reduction of PTSD 
symptom severity and psychological distress (Raskind et al., 2003; Taylor et al., 2006; 
Taylor et al., 2008). Further, propranolol administration (a β-adrenergic receptor antagonist) 
appears to block the effects of stress (Zoladz & Diamond, 2013), and shows promise in the 
treatment of PTSD (Brunet et al., 2011; Pitman, 2011; Pitman et al., 2002; Vaiva et al., 
2003). These findings indicate that hyper-activity of the noradrenergic system, particularly 
NA release, is associated with greater severity of PTSD symptoms, and the blockade of NA 
release may be an effective strategy in PTSD treatment. To our knowledge, research has not 
yet investigated pre-trauma NA levels, and how these may interact with trauma and 
epigenetic processes to increase or reduce risk for PTSD.  
In regards to fear extinction, mice that receive a post-extinction injection of 
epinephrine show an impaired ability to recall extinction learning, unless another injection is 
received immediately prior to extinction recall (Rosa, Myskiw, Furini, Sapiras, & Izquierdo, 
2014). Additionally, increased NA into the amygdala of rats enhanced extinction learning 
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(Berlau & McGaugh, 2006). Thus far, findings appear consistent, with greater NA levels 
influencing greater beta-receptor signaling which, in turn, strengthens memory formation 
(Mueller & Cahill, 2010). Greater activation of noradrenergic receptors during fear 
extinction is associated with better retrieval of extinction (Mueller, Porter, & Quirk, 2008). 
In further support, stimulation of noradrenergic beta-receptors in the amygdala following the 
retrieval of conditioned responses results in a stronger memory trace that is resistant to 
extinction (Debiec, Bush, & LeDoux, 2011). These results posit that whether conditioning or 
extinction is being learned, enhanced noradrenergic receptor signaling results in a stronger 
memory trace. 
A recently expanding body of literature is administering an α2-adrenergic receptor 
antagonist (i.e., yohimbine) and a β-adrenergic receptor antagonist (i.e., propranolol) at 
select intervals during a fear conditioning paradigm to investigate their effects on 
reconsolidation and extinction learning. Thus far, studies are somewhat mixed with some 
studies showing that after fear acquisition, the use of propranolol attenuates fear responses 
when administered in close proximal timing with the conditioned stimuli (Kindt, Soeter, & 
Sevenster, 2014; Soeter & Kindt, 2012) while others note impairments in extinction learning 
(Bos, Beckers, & Kindt, 2012, 2014; Soeter & Kindt, 2011). Further, Soeter and Kindt 
(2012) administered yohimbine immediately prior to fear acquisition, leading to an increase 
in NA release, and a fear conditioning trace that was broadly generalized and resistant to 
extinction. Importantly, the aim of these studies was to target the reconsolidation window 
for the original memory trace to prevent the return of fear (Kindt et al., 2014) rather than the 
formation of a new memory during extinction that is likely in constant competition with the 
original fear memory.  
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Summary. While the evidence suggests that PTSD is associated with hyperactive 
HPA axis activity (via reduced cortisol release, and therefore lower negative feedback of the 
HPA axis stress response), studies are inconsistent regarding the influence of cortisol levels 
(lower versus higher) on fear extinction learning and memory. Cross-sectional research 
suggests that PTSD is linked to increased saliva, urinary, blood, and cerebrospinal fluid 
levels of NA, however a longitudinal study found lower peri-trauma plasma NA levels 
predicted PTSD symptoms 5-months post-trauma. Further, the pharmacological 
enhancement of noradrenergic signaling during extinction learning appears to strengthen 
extinction. While evidence indicates that cortisol and noradrenaline are involved in PTSD 
symptoms, and the regulation of fear responding, this research field appears to be marred by 
certain inconsistencies that require clarity. 
 
2.9.3 Sex hormones: Estrogen and progesterone 
Women are twice as likely to develop PTSD compared to men (Glover, Jovanovic, & 
Norrholm, 2015; Kessler et al., 1995; Shansky, 2015) despite higher rates of trauma 
exposure in men. McLean, Asnaani, Litz, and Hofmann (2011) showed greater lifetime 
PTSD rates in women compared to men in the United States (8.5% vs. 3.4% respectively). 
Due to this increased prevalence in women compared to men, there has been a recent growth 
in research investigating sex differences in PTSD. In their review, Zoladz and Diamond 
(2013) highlight that greater PTSD risk in women is not considered to be due to factors such 
as trauma type, but may be due to biological differences, an idea that has been previously 
discussed by Cahill (2006). A recent prospective study found that women in the luteal phase 
of their menstrual cycle at the time of trauma were significantly more likely to experience 
flashbacks of the trauma compared to other women (Bryant et al., 2011). The luteal phase of 
the menstrual cycle is associated with an increase of estrogen and progesterone levels. In 
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tandem with increasing sex hormones, the luteal phase involves an increase in 
glucocorticoid release (Handa, Burgess, Kerr, & O'Keefe, 1994), which is associated with 
greater emotional memory consolidation (Abercrombie, Kalin, Thurow, Rosenkranz, & 
Davidson, 2003). Bryant et al. (2011) hypothesize that greater consolidation of trauma 
memories may lead to an increase in flashback memories. Indeed, additional research has 
linked increased estrogen and progesterone levels, and the luteal phase with greater intrusive 
memories (Cheung, Chervonsky, Felmingham, & Bryant, 2013; Ferree, Kamat, & Cahill, 
2011; Soni, Curran, & Kamboj, 2013) and greater recall of threatening images (Felmingham, 
Fong, & Bryant, 2012). This evidence has implications for the menstrual cycle and 
associated hormone fluctuations as a key mechanism in the development of PTSD 
symptoms in women, but not men. 
Considerable research examining sex differences in PTSD and disorders 
characterized by excessive fear has stimulated research examining sex differences in fear 
extinction (for a comprehensive review, see Lebron-Milad & Milad, 2012). Milad et al. 
(2010) investigated the effects of estradiol in a two-day fear extinction learning and recall 
paradigm. Healthy men and women underwent fear acquisition and extinction on day one 
and extinction recall on day two. Women with low levels of estradiol had significantly 
poorer extinction recall on day two, compared to women with higher levels of estradiol. Men 
had comparable extinction recall to high-estradiol women, which may speculatively be 
attributed to increased testosterone levels in men (Milad et al., 2010), although more 
research is needed on the relationship between testosterone and fear extinction. Further, 
Wegerer, Kerschbaum, Blechert, and Wilhelm (2014) recently found that healthy women 
with low estradiol demonstrate poorer fear extinction and more intrusive memories than 
women with higher estradiol. These findings support previous research indicating that 
higher estrogen levels result in stronger consolidation of fear extinction learning in rodents 
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(Milad, Igoe, Lebron-Milad, & Novales, 2009) and humans (Glover et al., 2013; Milad et 
al., 2010; Zeidan et al., 2011). Further, Graham and Milad (2013) investigated the effects of 
hormone contraceptives on fear extinction learning in female rats and healthy women. The 
use of contraceptives results in a reduction of estrogen levels and, consistent with previous 
research, was associated with significantly impaired fear extinction recall. Importantly, 
women with PTSD and low estrogen levels show impaired fear extinction learning, 
compared with trauma-exposed controls with low estrogen levels (Glover et al., 2012), 
suggesting that other factors are involved. 
With estrogen levels naturally fluctuating in women, researchers have identified that 
specific phases of the menstrual cycle may confer greater risk for poor consolidation of 
extinction memories. Recently, Glover et al. (2013) measured extinction recall in a sample 
of women currently in the follicular phase (lower estrogen) versus the luteal phase (high 
estrogen). The results indicated that the follicular phase was associated with poorer recall of 
extinction memories. Furthermore, lower estradiol levels in naturally cycling premenopausal 
women have been associated with lower extinction recall (Zeidan et al., 2011). Studies in 
rodents similarly found the proestrus menstrual phase (characterized by high 
estrogen/progesterone) to be associated with greater consolidation of extinction learning 
(Milad, Igoe, et al., 2009). Interestingly, Milad, Goldstein, et al. (2006) found that women in 
the late follicular phase (high estrogen) to show poorer extinction recall than early follicular 
phase women and men. While these findings go against the results of previous studies, the 
authors highlight that this menstrual phase is associated with lower activation of the vmPFC, 
which may account for poorer extinction recall due to the role that this structure plays in the 
consolidation and retrieval of extinction memories (Mueller & Cahill, 2010). 
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2.9.4 Cognitive factors. 
PTSD is reliably associated with deficits in attention and memory function, with 
impairments on these faculties included as diagnostic criteria of the DSM-IV (American 
Psychiatric Association, 2000; Vasterling & Brailey, 2005). Furthermore, PTSD has 
previously been characterized as a disorder of memory (McNally, 2006) due to hallmark re-
experiencing symptoms such as distressing intrusive memories, and deficits in episodic and 
autobiographical memory. Longitudinal studies in combat veterans have identified that 
PTSD diagnosis at post-deployment has been associated with significant pre-deployment 
cognitive deficits in intellectual functioning, attention, learning, and memory (Gale et al., 
2008; Kremen et al., 2007; Marx, Brailey, et al., 2009; Marx, Doron-Lamarca, Proctor, & 
Vasterling, 2009; Thompson & Gottesman, 2008; Vasterling et al., 2012; Vasterling et al., 
2006). Despite overwhelming and consistent evidence of cognitive deficits in PTSD, little 
research has investigated the relationship between cognitive factors and fear extinction. Due 
to this, here we review evidence of specific PTSD-related cognitive functioning in the areas 
of intellectual functioning, attention, and memory, followed by a section discussing the 
currently limited research in fear extinction and cognitive factors. 
 
Intellectual functioning. While the measurement of “intelligence” in PTSD has been 
met with skepticism (Vasterling & Brailey, 2005), a number of studies have implicated a 
role for lower intellectual functioning in the development of PTSD (Breslau, Chen, & Luo, 
2013; Gilbertson, Gurvits, Lasko, Orr, & Pitman, 2001; Macklin et al., 1998; Vasterling, 
Brailey, Constans, Borges, & Sutker, 1997; Vasterling et al., 2002). A study in monozygotic 
twin pairs discordant for combat exposure and PTSD diagnosis indicated that lower 
intelligence was a familial risk factor for greater PTSD symptom severity (Gilbertson et al., 
2006). Specific subscales of intelligence tests have identified verbal intellectual performance 
Chapter 2: Fear extinction, risk factors, and PTSD: A narrative review 49 
 
to be specifically impaired in PTSD (Vasterling & Brailey, 2005). Studies in children have 
revealed that those with PTSD show significantly lower verbal IQ on the WISC-III (Saigh, 
Yasik, Oberfield, Halamandaris, & Bremner, 2006; Samuelson, Krueger, Burnett, & Wilson, 
2010). Further, Saigh et al. (2006) found no significant differences on performance IQ, with 
effects limited to verbal subtests (i.e., vocabulary and comprehension). These results have 
been supported in a study of combat veterans of the Gulf War, with poor performance on the 
WAIS-R being limited to verbal IQ in veterans with PTSD compared to veterans without 
PTSD (Vasterling et al., 1997). Additional research has identified verbal intellectual 
function (including verbal learning and memory) to be a primary cognitive complaint in 
PTSD (Barrett, Green, Morris, Giles, & Croft, 1996; Bremner, Vermetten, Afzal, & 
Vythilingam, 2004; Gilbertson et al., 2006; Grigorovich, Gomez, Leach, & Fish, 2013; 
Jelinek et al., 2006; Marx, Doron-Lamarca, et al., 2009; Parslow & Jorm, 2007; Samuelson 
et al., 2010; Vasterling et al., 2002). 
 
Attention. Studies have identified that PTSD is associated with deficits in attentional 
resources. Recently, Flaks et al. (2014) found differences in processes of selective attention 
and short-term working memory capacity in a sample of urban violence victims with PTSD 
compared to trauma-exposed and non-exposed comparison groups. Patients with PTSD 
show significantly poorer performance than healthy controls on the digit span test, which is 
a measure of sustained attention and short-term memory (Horner, Mintzer, Turner, 
Edmiston, & Brawman-Mintzer, 2013). The findings of these studies are supported by 
numerous studies revealing PTSD-related attentional deficits in children (Beers & De Bellis, 
2002; Samuelson et al., 2010) and veterans (Gilbertson et al., 2006; Marx, Brailey, et al., 
2009; Toomey et al., 2009; Vasterling et al., 2002; Vasterling et al., 2006). However, null 
findings of attentional deficits have been revealed in a community sample (Crowell, Kieffer, 
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Siders, & Vanderploeg, 2002) and well-educated combat veterans with PTSD (Neylan et al., 
2004). 
With hyperarousal to threat being a key diagnostic symptom of PTSD (American 
Psychiatric Association, 2013), studies have investigated attention biases to threatening 
stimuli in PTSD. Prospective studies have identified attentional biases to threat are 
significant predictors of PTSD development in combat veterans (Wald et al., 2013) and 
motor vehicle accident survivors (Naim et al., 2013). Specifically, Wald et al. (2013) 
identified attentional threat biases at military recruitment (pre-trauma) to be a significant 
predictor of post-combat PTSD symptoms. These findings have been supported in cross-
sectional studies indicating that veterans with PTSD show sustained attention to threatening 
stimuli, compared to comparison control groups (Armstrong, Bilsky, Zhao, & Olatunji, 
2013; Olatunji, Armstrong, McHugo, & Zald, 2013). 
 
Memory. Impaired attention in PTSD carries important implications for memory 
processes. As with verbal intelligence being the most consistent deficit in studies of PTSD-
related intellectual functioning, a meta-analysis revealed verbal memory processes to be 
more consistently impaired in PTSD than nonverbal processes (Brewin, Kleiner, Vasterling, 
& Field, 2007). Improvements in verbal learning and memory have been associated with a 
reduction in PTSD symptom severity (Yehuda et al., 2006). Alternatively, a study by Wild 
and Gur (2008) found that poor response to eight sessions of cognitive behavioral therapy in 
PTSD was significantly predicted by poor verbal memory. These results are supported by 
growing research showing verbal learning and memory to be significantly impaired in PTSD 
(Barrett et al., 1996; Bremner et al., 2004; Gilbertson et al., 2006; Grigorovich et al., 2013; 
Jelinek et al., 2006; Marx, Doron-Lamarca, et al., 2009; Parslow & Jorm, 2007; Samuelson 
et al., 2010; Vasterling et al., 2002).  
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In a recent prospective study, Marx, Doron-Lamarca, et al. (2009) assessed 
neurocognitive functioning in a sample of pre-deployed U.S. Army soldiers, and assessed 
PTSD symptom severity at post-deployment. The results showed pre-deployment immediate 
visual recall was negatively correlated with PTSD symptoms at post-deployment (Marx, 
Doron-Lamarca, et al., 2009). Patients with PTSD have also shown poorer performance on 
working memory (Toomey et al., 2009; Vasterling et al., 2002), and visual recall memory 
(Samuelson et al., 2009). Further, veterans with chronic PTSD demonstrate poorer memory 
performance than veterans without PTSD (Yehuda, Golier, et al., 2007), which may be a 
consequence of prolonged secretion of stress hormones (Bomyea et al., 2012).  
 
Fear extinction and cognitive factors. Despite consistent, and accumulating 
evidence of cognitive deficits in PTSD, the relationship between cognitive factors and fear 
extinction is a relatively new field. A recent study found that greater cognitive load during 
fear extinction resulted in impaired fear extinction learning (Raes et al., 2009). That is, 
preliminary evidence indicates that fear extinction learning relies on sufficient cognitive 
resources for efficient consolidation of extinction memories (akin to a dual-processing 
approach). The aforementioned cognitive processes of intelligence, attention, memory, and 
verbal functioning are impaired in PTSD, suggesting that these cognitive resources may be 
involved in fear extinction.  
This notion—that fear extinction learning is a cognitive process relying on the use of 
multiple cognitive faculties—has received little attention, yet some relationships have been 
identified. Fear acquisition shares similarities to an attentional threat bias (Fani et al., 2012; 
Van Damme, Crombez, Hermans, Koster, & Eccleston, 2006), with attentional threat biases 
increasing, decreasing, and returning in parallel with acquisition, extinction, and 
reinstatement phases of a differential fear conditioning paradigm (Van Damme et al., 2006). 
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Additionally, Gazendam and Kindt (2012) found that engaging with a verbal task led to 
impaired fear extinction learning. Together, these early findings provide preliminary support 
for the idea that fear extinction is not an automatic process, but relies on cognitive resources 
for accurate consolidation (Raes et al., 2009). Fear extinction and generalization are 
inherently learning and memory processes, requiring the accurate consolidation and recall 
availability to reduce the likelihood of reinstatement or spontaneous recovery of conditioned 
fear responses (e.g., Milad & Quirk, 2012). Based on the research so far discussed, multiple 
factors affect memory processes required for the storage or generalization of extinction 
memories, however to our knowledge, a link between memory capacity and fear extinction 
learning ability has not yet been examined. 
Summary. Studies in PTSD populations have consistently revealed lower levels of 
intelligence, attention, and memory to be associated with the disorder. Specifically, lower 
verbal intelligence, as well as verbal learning and memory appear to be primary complaints 
of the disorder. While still in its infancy, investigations of fear extinction and cognitive 
factors indicate that fear extinction ability is significantly hindered by increasing cognitive 
load, or by engaging in a verbal cognitive task. Therefore it can be assumed that fear 
extinction learning relies on sufficient cognitive resources for accurate consolidation, and 
the processing of an additional task reduces cognitive resources available for the 
consolidation of extinction. 
 
2.9.5 Sleep disturbances. 
Sleep disturbances are widely considered to be a hallmark symptom of PTSD 
(Germain, 2013; Ross, Ball, Sullivan, & Caroff, 1989), and meet specific DSM-5 criteria 
relating to alterations in arousal and intrusive memories (American Psychiatric Association, 
2013). Sleep is argued to be a central stage involved in emotional memory consolidation 
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(reviewed in Pace-Schott et al., 2015a), and rapid eye movement (REM) sleep has been 
implicated in the consolidation of extinction memories (Spoormaker et al., 2010). Indeed, 
some studies have identified significant differences in REM sleep between clinical PTSD 
samples and comparison groups (Engdahl, Eberly, Hurwitz, Mahowald, & Blake, 2000; 
Mellman, Kumar, Kulickbell, Kumar, & Nolan, 1995; Mellman, Nolan, Hebding, 
KulickBell, & Dominguez, 1997; Ross et al., 1994a, 1994b), while other studies have 
revealed small to no differences (Breslau et al., 2004; Hurwitz, Mahowald, Kuskowski, & 
Engdahl, 1998). Importantly, studies examining specific sleep architecture disturbances in 
PTSD have revealed variable findings in relation to the specific disturbances in sleep stages 
(i.e., differences in REM density, duration and frequency; for a comprehensive review, see 
Pace-Schott, Germain, & Milad, 2015b). 
Prospective studies have found that objective and subjective sleep disturbances 
predict the development of PTSD. An early study tracked PTSD development and sleep 
difficulties of motor vehicle accident survivors over the course of one year (Koren, Arnon, 
Lavie, & Klein, 2002), finding increased excessive daytime sleepiness and insomnia 
symptoms at one month post-trauma significantly predicted PTSD development 11-months 
later. Furthermore, this difference became larger over the following 11-months, with the 
PTSD group reporting significantly poorer sleep quality. Additional studies have also found 
sleep disturbances at the time of the trauma to be a significant predictor of future PTSD 
diagnosis (Bryant et al., 2010; Mellman, Bustamante, Fins, Pigeon, & Nolan, 2002; 
Mellman & Hipolito, 2006; Mellman, Knorr, Pigeon, Leiter, & Akay, 2004; Mellman, 
Pigeon, Nowell, & Nolan, 2007). 
Nightmares are one of the most common symptoms reported in PTSD as a form of 
intrusive memory (Germain, Buysse, & Nofzinger, 2008; Kobayashi, Boarts, & Delahanty, 
2007; Levin & Nielsen, 2007). Pre-deployment nightmares have been found to predict 
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PTSD development in soldiers (van Liempt, van Zuiden, Westenberg, Super, & Vermetten, 
2013), and a therapeutic reduction in nightmares using imagery rehearsal therapy led to an 
improvement in PTSD symptoms (Krakow et al., 2001). Together, these findings indicate 
that sleep disturbances may be an important variable in the maintenance of PTSD 
symptoms, and are an important factor to be considered during treatment. 
There is considerable evidence that sleep quality is important for memory 
consolidation (Stickgold, 2005). The consolidation of fear extinction learning also requires 
sufficient sleep quality, with an emphasis on REM sleep (for a review, see Pace-Schott et al., 
2015a). While only one study has identified impaired extinction learning in REM-deprived 
rats versus controls (Silvestri & Root, 2008), REM deprivation appears to consistently limit 
the consolidation of extinction learning, as evidenced by impaired extinction recall and/or 
generalization (Fu et al., 2007; Pace-Schott, Verga, Bennett, & Spencer, 2012; Spoormaker 
et al., 2012). Participants deprived of sleep show greater SCR to the extinguished stimulus 
(Spoormaker et al., 2010), and poor generalization from an extinguished CS+, to an 
unextinguished CS+ (Pace-Schott et al., 2009). Recently, Spoormaker, Gvozdanovic, 
Samann, and Czisch (2014) found greater left vmPFC activity during fear conditioning to be 
associated with lower physiological expressions of fear during extinction learning the 
following day. Furthermore, greater left vmPFC activity was positively associated with 
REM sleep amount, which was also negatively associated with fear expression during 
extinction. The authors concluded that left vmPFC activity during fear conditioning is 
associated with greater extinction learning, and that this relationship is mediated by REM 
sleep quality (Spoormaker et al., 2014). This idea shows parallels with the finding that 
regions of the prefrontal cortex play specific roles in the consolidation of acquisition, 
extinction learning, and recall of extinguished fear memories (Milad, Wright, et al., 2007). 
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The aforementioned findings have important implications for the simultaneous 
treatment of sleep disturbances and avoidance symptoms in anxiety disorders. That is, there 
is some interplay between extinction learning and sleep quality, with each factor having 
enhancing effects on the other. So, while sleep appears to promote better consolidation of 
extinction memories (Pace-Schott et al., 2009), extinction training also appears to improve 
sleep quality (Sturm, Czisch, & Spoormaker, 2013). These findings are supported by 
research in clinical populations showing that sleep following exposure therapy results in 
significant symptom reductions in spider phobia (Kleim et al., 2014). Furthermore, sleep 
disturbances have been improved with exposure therapy in clinical PTSD samples (Gutner, 
Casement, Stavitsky Gilbert, & Resick, 2013; Long et al., 2011) and cognitive therapy for 
PTSD (Lommen et al., 2016). Despite these findings, however, Lommen et al. (2016) found 
that sleep quality and duration did not predict long-term treatment outcome in PTSD 
patients, and Datta and O'Malley (2013) found that greater sleep quantity is insufficient for 
extinction consolidation. Specifically, extinction learning was only recalled if post-
extinction training REM sleep contained pontine-wave activity in the brainstem. These 
results show important implications for the quality of REM sleep in the consolidation of 
extinction memory, rather than the quantity of REM sleep. Furthermore, these findings 
suggest an important role of the brainstem in extinction memory consolidation (Datta & 
O'Malley, 2013). In summary, the role of sleep plays an integral role in the persistence of 
conditioned fear and consolidation of extinction memory, and should be paid close attention 
in the etiology and treatment of anxiety disorders. 
 
Summary. Prospective studies are consistent that pre- and peri-trauma sleep 
disturbances predict future PTSD symptoms. Evidence is also consistent that sleep 
deprivation leads to poor extinction learning and generalization, with mixed findings for the 
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role of physiological sleep stages, such as REM sleep. Further, clinical studies have shown 
that sleep disturbances and PTSD symptoms are reduced in tandem by exposure therapy and 
CBT for PTSD. 
 
2.10 Summary and Conclusions 
The research presented in this review suggests that risk factors of PTSD may also 
share links with fear extinction. Although we acknowledge some inconsistences in the 
literature, the balance of evidence supports the notion that impaired fear extinction is a 
fundamental factor in PTSD etiology that is involved in, or influenced by, these additional 
risk factors. Substantial evidence shows impaired extinction learning, recall, and the 
generalization of extinction in PTSD populations compared to trauma-exposed and non-
exposed groups, in addition to serving as a pre-trauma risk factor. The over-expression of 
conditioned fear during the early stages of extinction learning (termed fear load) has been 
significantly associated with the presentation of intrusive thoughts of trauma-related fear 
memories, and is argued to present a quantifiable intermediate phenotype underlying the 
etiology of fear-related psychopathologies (Norrholm et al., 2015). The extinction of a 
learned fear association is also the key concept driving exposure therapy, the first line 
treatment approach for PTSD and specific phobia. On this basis, the identification of fear 
extinction as a key variable of PTSD development provides specific clinical relevance, as 
well as theoretical relevance. Further enhancing our understanding of the processes of fear 
extinction can greatly improve our understanding of PTSD risk, and whether extinction 
learning potential can be improved for the purpose of preventing exaggerated fear responses 
that lead to significant health consequences. 
Across a number of research fields, including genetics, hormonal (both stress and sex 
hormones), cognitive, and sleep disturbances, research is revealing important links between 
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PTSD risk factors and fear extinction (see Table 1 for a concise summary of the relationship 
between risk factors and PTSD, and between risk factors and impaired fear 
extinction/response to exposure-based therapies). For example, women with low estrogen 
levels show significantly poorer fear extinction recall compared to women with high 
estrogen levels, and men (Milad et al., 2010), and that menstrual phase at the time of trauma 
is a significant risk factor for PTSD (Bryant et al., 2011). Similarly, verbal intelligence and 
memory are the most consistently impaired cognitive functions in PTSD (Brewin et al., 
2007), and evidence indicates that extinction learning is impaired when individuals are 
required to perform tasks utilizing verbal functioning (Gazendam & Kindt, 2012). Disturbed 
sleep is considered a hallmark symptom of PTSD (Germain, 2013), and growing evidence is 
implicating greater sleep quality to be a key mechanism in healthy extinction learning, 
recall, and generalization (Pace-Schott et al., 2015a). Indeed, recent reviews have 
acknowledged the important interaction between disturbed sleep and impaired fear 
extinction learning in the etiology of anxiety disorder symptoms (Pace-Schott et al., 2015a, 
2015b). The aforementioned factors are just a select few presented in this review to support 
the contribution that impaired fear extinction processes play in PTSD etiology, with 
significant theoretical and clinical implications. 
 
 
Table 1 
Risk Factors of PTSD, and their Relationship with Impaired Fear Extinction/Exposure 
Therapy. 
Risk factor Relation to PTSD Relation to impaired fear 
extinction/exposure therapy 
Genotypes   
   - BDNF Increased BDNF levels soon after 
trauma predict greater PTSD 
Val66met associated with slow 
(impaired) extinction learning. 
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symptoms. Val66met associated with reduced 
response to exposure therapy. 
 
   - COMT Homozygous variants (val/val and 
met/met) interact with trauma to 
predict PTSD. 
Met/met carriers show poorer fear 
extinction learning compared to val 
carriers. 
 
   - 5-HTTLPR s-allele interacts with trauma to 
promote increased PTSD 
symptoms. 
s-allele associated with a stronger 
conditioned fear association that 
may be resistant to extinction. 
 
 
 
 
   - FKBP5 
 
 
 
Shows exclusive interactions with 
early childhood trauma to predict 
PTSD. 
 
 
 
Dexamethasone administration 
enhances extinction learning and 
retention via dynamic FKBP5 
regulation in the HPA axis. 
   - PACAP ADCYAP1R1 SNP (rs2267735) 
interacts with high trauma load to 
predict PTSD. 
PACAP-38 administration results 
in impaired fear extinction recall in 
rodents. 
Hormones   
   - Cortisol Cross-sectional research suggests 
reduced naturally cycling cortisol 
levels in PTSD, and as a marker 
for treatment-resistant PTSD. 
Low peri-trauma cortisol predicts 
increased PTSD symptoms. 
Stress-induced cortisol increases 
associated with reduced fear 
expression in an extinction context 
and an acquisition context. 
Greater cortisol levels tend to be 
associated with more effective fear 
extinction learning. 
Oral cortisol consumption reduced 
spider fear following exposure 
therapy. 
 
 
 
   - Noradrenaline 
 
 
Increased noradrenaline 
associated with greater PTSD 
symptoms and frequency of 
intrusive memories. 
Lower plasma noradrenaline 
levels predict PTSD symptoms 5-
months post-hospitalization. 
 
 
 
Enhanced noradrenergic signaling 
enhances memory formation; not 
limited to the formation of 
conditioning or extinction 
memories. 
 
 
Chapter 2: Fear extinction, risk factors, and PTSD: A narrative review 59 
 
 
 
2.10.1 Theoretical implications. 
The current review highlights the need to establish a timeline or sequence of 
biological and environmental events that lead to the development of PTSD following a 
traumatic stressor. The development of such a timeline allows for the integration of multiple 
   - Estrogen Luteal phase (high estrogen) at 
time of trauma predicts greater 
PTSD symptoms, likely due to 
elevated glucocorticoid signaling 
during this phase of the menstrual 
cycle. 
 
 
 
 
 
 
 
Follicular phase (low estrogen) 
associated with poorer fear 
extinction recall. 
Suggested that high estrogen 
enhances memory consolidation  
Cognitive 
factors 
PTSD associated with significant 
deficits in intellectual functioning, 
attention, learning, and memory. 
In particular, PTSD is most 
commonly associated with 
impairments in verbal learning 
and memory. 
Poorer fear extinction learning 
ability while concurrently 
performing a verbal task, or under 
situations of greater cognitive load. 
Lower verbal learning and memory 
ability predicts poor responding to 
eight sessions of cognitive 
behavioral therapy. 
Sleep 
disturbances 
Sleep disturbances at the time of 
trauma significantly predict 
increased PTSD symptoms. 
Greater daytime sleepiness and 
insomnia post-trauma predicts 
increased PTSD symptoms. 
Greater sleep deprivation 
associated with poorer fear 
extinction learning. 
Extinction learning ability best 
soon after waking, and declines 
throughout the day. 
Improved sleep quality enhances 
fear extinction learning and recall, 
and there is evidence for the 
reverse, that fear extinction 
learning improves sleep quality. 
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theories of PTSD development. For example, certain genotypes affect the regulation of the 
neuroendocrine system, and the negative feedback loop of the HPA axis, in some cases, via 
epigenetic interactions. These processes impair general fear extinction learning and retention 
ability. The occurrence of a traumatic event results in the acquisition of fear that is resistant 
to extinction via dysregulation of the HPA axis and neuroendocrine system, with 
contributions from the vmPFC, hippocampus and amygdala. Additionally, the occurrence of 
a new traumatic event may interact with the psychological consequences of previous trauma 
history to promote severe responding. Following trauma, fear extinction is hindered by the 
development of negative appraisals about the self and the trauma that exacerbate symptoms, 
and nightmares and sleep disturbances further prevent recovery. This is one of many 
possibilities by which a biological profile may confer risk for PTSD, and does not take into 
account the complexities of gene × environment interactions, or the countless influences of 
the environment (i.e., social support). Nevertheless, this review highlights an important need 
to understand the sequential “chain of events” that might lead to increased PTSD 
symptomatology. 
 The present review also carries important implications for well-established and 
empirically tested models of PTSD. One such theory is the cognitive model of PTSD (Ehlers 
& Clark, 2000), which proposed that PTSD symptoms persist as a result of negative 
appraisals of the self and the trauma, and due to fragmented and poorly elaborated 
autobiographical memories of the trauma. The avoidance of trauma reminders further 
exacerbates symptoms and affirms these negative appraisals. Fear extinction may be an 
important mechanism of this theory, with negative appraisals of the trauma and its sequelae 
providing an attentional bias to trauma reminders in the environment. These environmental 
and cognitive triggers result in intrusive and distressing memories of the trauma, which can 
be thought of as conditioned emotional/fear responses. These conditioned responses persist 
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as a result of impaired extinction, and avoidance of these trauma reminders further facilitate 
ongoing fear responding, and hindering extinction. While these two well-respected and well-
supported models (i.e., biological fear extinction, and Ehlers and Clark’s cognitive model) 
are not mutually exclusive, little research has been conducted to examine the convergent 
aspects of these models. 
 
2.10.2 Clinical implications. 
Should the ideas set forth in this review hold true, this model carries significant 
implications for various clinical and applied settings. Specifically, further understanding 
these qualities may allow for interventions to boost extinction learning and consolidation, 
thereby increasing resilience to negative reactions following a trauma. This scenario could 
lead to the redirection of clinical resources to early interventions pre- and post-trauma to 
prevent PTSD onset, thereby reducing negative coping in the aftermath of trauma and 
increasing quality of life.  
A recent review discusses important pharmacological evidence that fear extinction 
can be enhanced via manipulation of key neurochemical imbalances and the promotion of 
synaptic plasticity in neural regions involved in the fear response and associative learning 
(Singewald et al., 2015). Singewald et al. (2015) discuss the effects of manipulating some of 
the factors discussed in the current review, such as BDNF, serotonin, and noradrenaline. For 
example, in section 2.2.2 (noradrenaline) of the current review, we discuss the research that 
enhanced pharmacological activation of noradrenergic signaling resulted in more efficient 
retrieval of extinction learning (e.g., Mueller et al., 2008). Pharmacological agents show 
significant promise in boosting fear extinction learning ability and the retention of extinction 
(for a comprehensive review, see Singewald et al., 2015). Importantly, the combination of 
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pharmacological intervention with exposure-based therapies may enhance fear extinction 
and prevent the return of fear. 
The present review highlights the centrality of fear extinction memory in PTSD, and 
extinction as a possible mechanism linking risk factors to PTSD. At current, exposure-based 
treatments are among the most common treatment options for PTSD, based on the principles 
of extinction training to trauma-relevant stimuli. This review poses additional factors to be 
taken into account during treatment. Research suggests that fear extinction learning and 
memory are malleable constructs, with the potential for change. Time-of-day has revealed 
extinction learning, recall, and the generalization of extinction recall are significantly better 
in the morning compared to the evening in healthy participants (Pace-Schott et al., 2013). 
Similarly, healthy participants instructed with a verbal worrying task showed impaired fear 
extinction learning (as indexed by SCR and US-expectancy) compared to control groups 
(Gazendam & Kindt, 2012). Further, biological research has revealed that healthy women in 
the mid-follicular phase of the menstrual cycle display significantly poorer extinction 
memory compared to early-follicular healthy women and men (Milad, Goldstein, et al., 
2006). To summarise, studies have identified that, in healthy populations, fear extinction 
memory can be altered as a function of time-of-day, cognitive resources devoted to a verbal 
task, and menstrual phase in women. While the target of exposure-based treatments is to 
extinguish the conditioned fear trace of the trauma memory, the above findings suggest that 
when treatment occurs, other factors should be taken into account. Indeed, our lab recently 
identified that extinction learning ability is significantly worse in participants with PTSD as 
they are awake for longer (Zuj et al., 2016), supporting the idea that exposure therapy would 
be more effective earlier in the day, rather than later (Pace-Schott et al., 2013). Further, 
extinction learning in women appears dynamic with menstrual phase (Milad, Goldstein, et 
al., 2006), and exposure therapy may be more effective during the luteal phase, 
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characterized by higher levels of estrogen, which is shown to be involved in enhanced 
memory consolidation. 
 
2.10.3 Directions for future research. 
 Further research is required to explore the key links highlighted within this review. 
Should this conceptual model hold true, these findings carry important implications. In order 
to assess this extinction-based model of PTSD and other fear-related disorders, we suggest a 
number of research directions. First, longitudinal studies in first responder and military 
populations pre-trauma provide unique insights into the interplay between different factors 
(including fear extinction), and the role that each of these might play in the aftermath of 
trauma. In particular, the use of mediation and moderation analyses in such studies would 
allow the identification of causal relationships, as opposed to interactions between two or 
more variables to enhance PTSD risk. The findings of such designs would further our 
understanding of the temporal sequence of events that lead to PTSD development versus 
resilience. Currently, the temporal sequence beginning with trauma exposure and leading to 
increased PTSD symptoms is unknown, and improving our understanding of this sequence 
of events may greatly enhance the development of early interventions post-trauma to prevent 
the onset/persistence of symptoms. 
 Due to the expensive and time-consuming nature of prospective designs, cross-
sectional research in PTSD compared to trauma non-exposed controls presents a unique 
opportunity to determine extinction learning and recall differences between trauma-exposed 
and non-exposed persons. Such designs that also include risk factors and biomarkers 
presented in the current review would increase our current understanding of PTSD risk, 
including the potential to shed light on certain inconsistencies (e.g., lower vs. higher cortisol 
levels conferring risk for PTSD). Third, a lack of genome-wide association studies 
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demonstrates a considerable gap in the literature of genetic and heritable biomarkers for 
PTSD and fear extinction potential. In the current review, we discuss the role of only a small 
selection of candidate genotypes and their role in PTSD and fear extinction. The 
identification of additional genetic risk factors would aid in further understanding the 
genetic makeup that predisposes an individual to severe posttraumatic stress. 
 In addition to the select risk factors presented in the current review, prior trauma 
history may also play a key role. For example, previous evidence indicates that female rape 
victims show significantly lower cortisol levels and greater risk of PTSD if they have 
experience prior assaults (Resnick, Yehuda, Pitman, & Foy, 1995). More recently, Najavits 
and Walsh (2012) found that high dissociation symptoms in PTSD were associated with a 
history of early life trauma (see also Evren et al., 2011; Schafer et al., 2010). With the 
important role that previous trauma can play in responding to a current traumatic event, it is 
likely that trauma history may impair the ability to extinguish fear associated with new 
traumatic events. For example, as a person experiences more traumatic events, their inherent 
ability to extinguish a fearful association is reduced, resulting in greater PTSD risk. To our 
knowledge, however, no studies have examined this. 
In this review, we have highlighted the centrality of fear extinction learning and 
memory, with influences from a number of biological and cognitive factors that also serve as 
risk factors for PTSD. Further, we note that the sequential manner by which fear extinction 
affects, or is affected by these biological and cognitive factors is unknown. Future research 
using moderation and mediation models may prove useful in identifying causal relationships 
and important interactions involving fear extinction and PTSD symptoms. Studies such as 
these carry important implications for treatment, and additional studies using mediation and 
moderation models may identify further variables that could aid or impair treatment outcome 
(e.g., stress and sex hormone levels at the time of treatment). 
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2.10.4 Final comment. 
In the present review, we discuss many of the risk factors for developing PTSD and 
their influence on fear extinction, carrying important implications for the centrality of fear 
extinction in PTSD. This notion has important clinical implications, with these risk factors 
potentially affecting exposure-based treatments of PTSD. However the influence of many of 
these variables on exposure therapy outcome in PTSD is yet to be explored, and may aid in 
improving current treatment models, and in improving treatment itself. In short, research is 
consistent that risk factors of PTSD share an important relationship with fear extinction 
memory, and we suggest that fear extinction may be a central variable linking these risk 
factors to PTSD development and symptom persistence.  
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3.1 Abstract 
Background: Prior research has demonstrated that time-of-day may play an important role in 
the extinction of conditioned fear, with extinction better learned earlier in the day rather than 
later. Impaired fear extinction is widely considered a key mechanism of the fear-related 
features of Posttraumatic stress disorder (PTSD). The relationship between fear extinction 
and PTSD symptoms may be moderated by hours-since-waking.  
Method: In the present experiment, we examined whether hours-since-waking would 
moderate fear extinction learning ability in a clinical PTSD sample (n = 15), compared to 
trauma-exposed (n = 33) and non-exposed controls (n = 22). Participants completed a 
standardized differential fear conditioning and extinction paradigm, providing skin 
conductance response measures to quantify conditioned responding.  
Results: Mixed-model analysis of variance revealed a PTSD-specific impairment in 
extinction learning ability in the late extinction phase. A moderation analysis showed that 
hours-since-waking was a significant moderator of the relationship between impaired late 
extinction and PTSD symptoms. Specifically, we found that participants with higher PTSD 
symptoms demonstrated poorer fear extinction learning ability as they were awake for longer. 
Conclusions: The results of the current study add to a growing literature indicating deficits in 
fear extinction learning in PTSD samples, compared to trauma-exposed and non-exposed 
controls. These results support previous findings that fear extinction is impaired later in the 
day, and extends this to a clinical sample, suggesting that exposure-therapy may be optimized 
by scheduling sessions in the morning. 
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3.2 Introduction 
Posttraumatic stress disorder (PTSD) is characterized by distressing intrusive 
memories of a trauma and avoidance behaviors (American Psychiatric Association, 2013). A 
prominent model posits that impaired fear extinction, the ability to extinguish a conditioned 
fear association, is an important mechanism underlying PTSD (Pitman et al., 2012). 
Extinction is the core principle of exposure therapy, the first-line treatment for PTSD 
(Graham & Milad, 2011), and further investigation is needed to understand the processes that 
aid or impair extinction. Growing research implicates sleep in extinction learning and 
consolidation (Pace-Schott, Germain, & Milad, 2015a). Pace-Schott et al. (2013) revealed 
that sleep prior to extinction learning may enhance extinction, with homeostatic sleep 
demands increasing throughout the day, and reducing extinction potential. Therefore, hours-
since-waking may be an important moderator of extinction learning. 
Fear conditioning is central in explaining the development and persistent of PTSD 
symptoms (Mineka & Oehlberg, 2008). Conditioning and extinction studies reveal PTSD-
associated deficits in extinction learning (Blechert, Michael, Vriends, Margraf, & Wilhelm, 
2007; Norrholm et al., 2011; Orr et al., 2000; Peri, Ben-Shakhar, Orr, & Shalev, 2000) and 
extinction recall the following day (Milad et al., 2008; Milad et al., 2009; Shvil et al., 2014). 
Longitudinal studies assessing pre-trauma extinction reveal impaired extinction learning 
predicts increased PTSD symptoms after trauma (Guthrie & Bryant, 2006; Orr et al., 2012), 
supporting the role of extinction learning in PTSD development. 
Growing evidence suggests an important role of sleep in extinction consolidation 
(Germain, 2013; Pace-Schott, Germain, et al., 2015a; Pace-Schott, Germain, & Milad, 
2015b). The first study to examine such effects found that after extinction learning, a night of 
sleep led to the generalization of an extinguished CS+ to a previously unextinguished CS+, 
compared to a period of wakefulness (Pace-Schott et al., 2009). Additionally, participants 
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who achieved rapid eye movement (REM) sleep during a nap following extinction showed 
significantly smaller skin conductance response (SCR) to the extinguished CS+ after sleep, 
compared to participants who did not achieve REM sleep during the nap (Spoormaker et al., 
2010). Evidence in patients with spider phobia found a reduction in spider fear following 
exposure therapy was significantly greater after a period of sleep than wakefulness (Kleim et 
al., 2014), confirming an earlier study of simulated exposure therapy for spider fear where 
sleep enhanced extinction retention and generalization compared to wakefulness (Pace-
Schott, Verga, Bennett, & Spencer, 2012). 
Sleep disturbances may contribute to issues in managing stressors, enhancing 
vulnerability for developing psychiatric disorders, including PTSD (Bryant, Creamer, 
O'Donnell, Silove, & McFarlane, 2010). Indeed, prospective studies have found pre-, peri-, 
and post-trauma sleep disturbances significantly predict PTSD symptoms (Bryant et al., 
2010; Kobayashi, Sledjeski, Spoonster, Fallon, & Delahanty, 2008; Koren, Arnon, Lavie, & 
Klein, 2002; Mellman, Pigeon, Nowell, & Nolan, 2007; van Liempt, van Zuiden, 
Westenberg, Super, & Vermetten, 2013; Wright et al., 2011). The sleep-wake cycle is 
regulated by the suprachiasmatic nucleus of the hypothalamus (Schwartz & Roth, 2008) and 
structures in the brainstem, hypothalamic and basal forebrain arousal networks (Saper, Fuller, 
Pedersen, Lu, & Scammell, 2010), and hypothalamic and brainstem networks are also 
dysregulated in PTSD (Felmingham et al., 2010). Further, amygdala and prefrontal activation 
impact sleep, and these networks are also dysregulated in PTSD (Germain, Buysse, & 
Nofzinger, 2008), suggesting a neurobiological relationship between these factors. 
Time-of-day has a significant impact on extinction learning, with improved extinction 
and recall in the morning compared to the evening in healthy men (Pace-Schott, Germain, et 
al., 2015a; Pace-Schott et al., 2013). Generalization of an extinguished stimulus to an 
unextinguished stimulus was also better 24-hours later if both learning and recall occurred in 
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the morning when an individual is likely to be well rested. Pace-Schott et al. (2014) 
hypothesized that increased homeostatic sleep pressure may explain greater 
psychophysiological reactivity to conditioned stimuli in the evening, emphasizing the 
influence of the previous nights’ sleep for extinction. During sleep deprivation, adenosine 
levels increase in the basal forebrain to promote sleep, and it is hypothesized that increasing 
adenosine levels may influence sleep homeostasis; that is, the increasing need for restorative 
sleep throughout the day (Porkka-Heiskanen & Kalinchuk, 2011). Pace-Schott, Germain, et 
al. (2015a) suggest strategically timed sleep may promote the consolidation of therapeutic 
extinction learning to maximize treatment benefit. These findings are limited to healthy men 
and yet to be examined in a clinically anxious population characterized by impaired fear 
extinction and impaired sleep, such as PTSD. 
On the basis of accumulating evidence of PTSD-specific extinction impairments, we 
predicted participants with PTSD would have significantly impaired fear extinction learning 
compared to trauma-exposed and trauma-non-exposed controls. Furthermore, based on the 
recent finding of Pace-Schott et al. (2013) we hypothesized that hours-since-waking would be 
a significant moderator between fear extinction learning and PTSD symptoms, with poorer 
fear extinction learning predicting greater PTSD symptom severity, and that this relationship 
would become stronger with increased hours-since-waking. 
 
3.3 Method 
3.3.1 Participants. 
Seventy participants aged 18-63 (M = 24.2 years, SD = 9.3 years; 25 males and 45 
females) were tested between 12-6PM, and comprised three groups: PTSD (n = 15), trauma-
exposed (TC; n = 33), and non-trauma-exposed controls (NTC; n = 22). Participants were 
classified on the basis of exposure to a criterion A stressor which threatened physical 
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integrity (American Psychiatric Association, 2000) using the Traumatic Events Questionnaire 
(TEQ; Vrana and Lauterbach (1994);  war exposure n = 1; accident n = 13; natural disaster n 
= 18; witness n = 29; assaulted or molested n = 21; threatened or held captive n = 15; and 
tortured or terrorist victim n = 1). Mean years since trauma was 7.6 years (SD = 10.7 years). 
Individuals who reported never having experienced a traumatic event were classified as NTC. 
The PTSD Checklist-Civilian version (PCL-C; Weathers, Litz, Huska, & Keane, 1994) was 
used to estimate PTSD caseness, with PTSD participants classified as those presenting with 
at least 1 intrusive symptom, 3 avoidance symptoms, and 2 hyperarousal symptoms (roughly 
equating to a total PCL-C score ≥ 40; Weathers et al., 1994; National Center for 
Posttraumatic Stress Disorder, n.d.) Participants who displayed minimal PTSD symptoms 
were allocated to the TC group. The study was conducted in accordance with the Declaration 
of Helsinki, the design was approved by the University of Tasmania Social Sciences Human 
Research Ethics Committee, and all participants gave full informed consent.  
 
3.3.2 Questionnaires. 
The PCL-C (Weathers et al., 1994) was used for probable PTSD diagnosis according 
to DSM-IV criteria, and to provide a continuous measure of symptom severity. Participants 
also completed the Depression Anxiety Stress Scale 21-item version (DASS; Lovibond & 
Lovibond, 1995), Pittsburgh Sleep Quality Index (PSQI; Buysse, Reynolds, Monk, Berman, 
& Kupfer, 1989) and the Alcohol Use Disorder Identification Test (AUDIT; Babor, Higgins-
Biddle, Saunders, & Monteiro, 2001). Upon arrival to the lab, participants indicated their 
time-of-waking to derive the number of hours-since-waking. 
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3.3.3 Stimuli and experimental protocol. 
We adopted a differential fear conditioning and extinction paradigm used previously 
(Orr et al., 2000). The unconditioned stimulus (US) was a 500ms mild electric shock 
delivered by an electrode to the first interosseous muscle of the dominant hand, set at a level 
considered “highly annoying, but not painful” (Orr et al., 2000). Conditioned stimuli were red 
and blue circles presented individually for 12s on a computer screen. The protocol included 
four experimental phases: habituation, acquisition, early extinction, and late extinction. 
During habituation, participants were exposed to four trials of each coloured circle (8 trials in 
total). During acquisition, one of the coloured circles was followed by the US (CS+) on all 5 
trials (100% reinforcement schedule; Orr et al., 2000) while the other coloured circle was not 
reinforced on any of the five trials (CS-; 10 trials in total). The early extinction phase 
consisted of 5 trials of the CS+ (with no reinforcement) and 5 trials of the CS- (10 trials in 
total) followed by the late extinction phase, which mirrored early extinction. Trial order was 
fixed-random, with no more than two consecutive CS+ or CS- trials. 
 
3.3.4 Skin conductance response. 
Skin conductance level (SCL) was measured through a 22mVrms, 75Hz constant-
voltage coupler (FE116, ADInstruments, Sydney, Australia) with bipolar electrodes placed 
on the intermediate phalange of the first and third finger of the non-dominant hand, sampled 
at 512Hz and stored at 64Hz, and recorded in micro-Siemens (μS). Skin conductance 
response (SCR) to the CS+ and CS- was calculated by subtracting the mean SCL during the 
2s prior to CS onset from the maximum SCR during the 12s CS duration. Scoring was 
conducted by a software macro blind to experimental conditions. SCR values were square-
root transformed, and the absolute value of negative values was transformed and the negative 
sign replaced. Differential conditioned responding (DCR) was calculated by subtracting the 
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SCR of the first CS- from the first CS+, and so on for all trials (as in Menz et al., 2013). DCR 
scores were used to compute an extinction DCR change score for use in the moderation 
analysis, by subtracting the trial 5 DCR from the trial 1 DCR, with greater values indicating a 
greater decline in differential fear responding. 
 
3.3.5 US-expectancy ratings. 
 During the 12s stimulus presentation, participants were asked to rate their threat 
expectancy of the US on a 0-100 visual analogue scale (VAS; 0 “certain no electrical 
stimulus”; 100 “certain electrical stimulus”; as previously used by Lommen et al., 2013).  
 
3.3.6 Statistical analyses. 
To assess fear conditioning and extinction, a 3(group) × 2(CS) × 5(trial) mixed 
analysis of variance (ANOVA) was conducted on SCR data separately for each experimental 
phase (four trials for habituation and acquisition). The first CS+/- trials were removed from 
acquisition analyses as the US had not been encountered, and no learning had occurred. 
Successful fear conditioning was assessed with a significant CS main effect with greater SCR 
to the CS+ compared to the CS- during acquisition. Successful extinction learning was 
assessed with a significant CS × trial interaction, with SCRs decreasing over trials for early 
and late extinction, and with reduced discrimination between the CS+ and CS-. Mixed model 
ANOVAs were identical for SCR data and US-expectancy ratings1, with the exception of the 
first CS+/- trial for SCR data being omitted from analyses. A moderation analysis was 
conducted using the PROCESS macro for SPSS (model 1; Hayes, 2013) with hours-since-
                                                 
1 Five participants were omitted from analyses involving US-expectancy ratings due to 
missing data. The sample size for US-expectancy analyses is N = 65 (PTSD: n = 12; TC: n = 
31; NTC: n = 22). Due to the low sample size of the PTSD group in particular, the results of 
these analyses should be interpreted with caution.  
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waking as the moderator variable, extinction DCR change score as the predictor variable, and 
PCL total as the outcome variable. 
An alpha level of α = .05 was used for all tests of significance (two-tailed). 
Greenhouse-Geisser adjustments were made for within-subjects variables, with epsilon 
values and adjusted-df reported where necessary. Brown-Forsythe F-ratio corrections were 
made when homogeneity of variance was violated. For pairwise comparisons, Bonferroni 
corrections were made, with effect sizes reported as Cohen’s d, following criteria of 0.2, 0.5, 
and 0.8 for small, moderate, and large effects, respectively (Cohen, 1988). For mixed model 
ANOVAs, effect sizes were reported as partial eta-squared (ηp2). 
 
3.4 Results 
3.4.1 Clinical and demographic data. 
Table 1 displays descriptive and inferential statistics for clinical and demographic 
variables. A one-way ANOVA revealed a significant between-group effect of age, F(2, 
18.43) = 7.28, p = .005. As seen in Table 1, participants in the PTSD group were, on average, 
significantly older than participants in the TC and NTC groups (ps < .05), who did not differ 
(p = .375). ANOVA revealed a significant between-group effect for total PCL score, F(2, 
18.30) = 76.44, p < .001, with the PTSD group having a greater PCL total (M = 50.60, 95% 
CI[44.15, 57.05], SD = 11.65) than TCs (M = 25.00 [23.40, 26.60], SD = 4.52), and NTCs (M 
= 19.91 [18.73, 21.09], SD = 2.65), who also showed a significant difference (p < .001). 
Table 1 shows the PTSD group had significantly greater PCL scores for each symptom 
cluster. One-way ANOVA revealed participants in the PTSD group had significantly higher 
scores on the DASS subscales of depression, anxiety and stress than TC and NTC 
participants, who did not significantly differ (ps > .05). Participants in the PTSD group had 
significantly poorer sleep quality compared to TC and NTC participants, who did not 
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significantly differ (p = .187). There were no significant between-group differences in 
alcohol use (p = .124). 
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Table 1 
Mean Scores and SDs of Demographic and Clinical Variables. 
Measures PTSD (n = 15) TC (n = 33) NTC (n = 22) Test Statistic p 
Demographic Data 
   - Age (years) 
   - Sex 
 
32.87 (14.95) 
8F, 7M 
 
22.52 (6.13) 
23F, 10M 
 
20.82 (3.13) 
14F, 8M 
 
F(2, 18.43) = 7.28 
χ2(2) = 1.21 
 
p = .005 
p = .546 
PCL-C 
   - Intrusive 
   - Avoidance 
   - Hyperarousal 
 
3.07 (1.16) 
3.93 (2.15) 
3.40 (0.99) 
 
0.24 (0.61) 
0.70 (0.85) 
0.48 (0.87) 
 
0.00 (0.00) 
0.18 (0.50) 
0.18 (0.50) 
 
F(2, 67) = 109.54 
F(2, 18.44) = 34.12 
F(2, 37.15) = 82.25 
 
p < .001 
p < .001 
p < .001 
DASS 
   - Depression 
   - Anxiety 
   - Stress 
 
7.80 (5.27) 
7.63 (4.54) 
12.23 (5.49) 
 
1.91 (2.10) 
2.18 (1.92) 
4.33 (2.53) 
 
1.14 (1.57) 
1.23 (1.76) 
2.43 (2.13) 
 
F(2, 19.50) = 17.84 
F(2, 21.57) = 20.39 
F(2, 22.32) = 30.89 
 
p < .001 
p < .001 
p < .001 
PSQI Total 8.60 (4.52) 5.31 (2.16) 4.31 (1.91) F(2, 23.49) = 8.25 p = .002 
AUDIT 7.87 (5.82) 5.13 (3.68) 5.23 (4.40) F(2, 65) = 2.15 p = .124 
Note: PCL-C = PTSD Checklist-Civilian version; DASS = Depression Anxiety Stress Scale; PSQI = Pittsburgh Sleep Quality Index; AUDIT = 
Alcohol Use Disorders Identification Test. 
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3.4.2 Hours-since-waking. 
Between-group differences in hours-since-waking showed no indication of group 
biases for hours-since-waking as a moderator: A one-way ANOVA revealed no significant 
between-group differences in hours-since-waking, F(2, 67) = 1.24, p = .296 (PTSD group = 
7:02hrs, SD = 2:30; TC = 6:09, SD = 2:26; and NTC = 5:43, SD = 2:32). Further, a one-way 
ANOVA revealed no significant group differences for time-of-day when testing was 
conducted, F(2, 67) = .34, p = .711 (PTSD group = 14:43PM, SD = 1:42; TC = 15:04PM, SD 
= 2:09; and NTC = 14:40PM, SD = 1:45), indicating that circadian rhythm is unlikely to 
affect analyses involving hours-since-waking. 
 
3.4.3 Fear conditioning and extinction (SCR) 
Habituation. A 3 × 2 × 4 mixed-ANOVA showed no significant main effect of group 
or CS condition or interactions with these variables (Fs < 1.07). There was a significant main 
effect of trial, F(3, 201) = 5.52, p = .001, ηp2 = .076, with SCRs decreasing across trials (see 
Figure 1A). There is likely a reduction in SCRs as participants become used to the task, 
reflecting an initial habituation of responses that is commonly observed. 
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Figure 1. CS × Trial interactions for each experimental phase. Fear acquisition and extinction 
scores pooled across group for the CS+ and CS- across all trials. (A) During the acquisition 
phase, there was a statistically significant CS × trial interaction, with the difference in 
responses to the CS+ and CS- increasing across the acquisition phase, indicating greater 
CS+/- contingency awareness. The first CS+/- trials were removed from the acquisition 
phase, as the US had not been encountered and no learning had occurred. (C) In early 
extinction, there was no significant CS × trial interaction, with means showing that the 
reduction of SCR from trial 1 to trial 5 did not differ between the CS+ and CS-. (D) During 
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the late extinction phase, there was a trend for a CS × trial interaction, F(3.74, 250.75) = 
2.42, p = .053, ηp2 = .035, ε = .936, with a greater reduction in SCR from trial 1 to trial 2 for 
the CS- compared to the CS+. Error bars depict 95% confidence intervals of the mean. μS1/2, 
SCR square-root transformed in micro-siemens. 
 
 
Acquisition. The successful acquisition of a conditioned response to the CS+ is 
evidenced by a significant main effect of CS, F(1, 67) = 69.29, p < .001, d = 0.84. Mixed-
model ANOVA revealed the CS+ elicited a significantly larger SCR (M = 0.89 [0.76, 1.02], 
SD = 0.55) than the CS- (M = 0.37 [0.25, 0.48], SD = 0.49). There was a significant main 
effect of trial, F(2.68, 179.41) = 3.81, p = .014, ηp2 = .054, ε = .893. Additionally, ANOVA 
revealed a significant group main effect, F(2, 67) = 4.09, p = .021, ηp2 = .109, with the TC 
group showing larger SCR (M = 0.81 [0.66, 0.96], SD = 0.43) compared to PTSD and NTC 
groups (M = 0.59 [0.37, 0.81], SD = 0.43; and M = 0.49 [0.31, 0.67], SD = 0.43, 
respectively). However, there were no significant group × CS, or group × trial interactions, 
indicating that responses to the CS+ and CS- did not differ between groups. 
 
Early extinction. Mixed ANOVA revealed a significant main effect of CS, with the 
CS+ eliciting a larger SCR (M = 0.54 [0.44, 0.65], SD = 0.44) than the CS- (M = 0.42 [0.33, 
0.51], SD = 0.39), F(1, 67) = 7.57, p = .008, d = 0.29. There was no significant group × CS 
interaction (p = .243), indicating all groups were still displaying conditioned responding 
during the early extinction phase. ANOVA also revealed a significant main effect of trial, 
with a decline in SCR across the experimental phase, F(3.29, 220.44) = 27.99, p < .001, ηp2 = 
.295, ε = .823, indicating an overall reduction in SCRs across trials (see Figure 1C). Further, 
there was no significant CS × trial interaction, F(3.78, 253.37) = 0.37, p = .819, ηp2 = .006, ε 
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= .945, with no change in SCR to the CS+ and CS-, providing additional support that all 
groups were still displaying conditioned responses to the CS+ in early extinction (see Figure 
1C). No further main effects or interactions were significant (Fs < 1). 
 
Late extinction. There was a significant trial main effect, with SCRs decreasing 
across trials, F(3.11, 208.53) = 16.82, p < .001, ηp2 = .201, ε = .778. There was no significant 
main effect of CS, F(1, 67) = 1.16, p = .295, d = 0.08, and a trend for a CS × trial interaction, 
F(3.74, 250.75) = 2.43, p = .053, ηp2 = .035, ε = .936, suggesting a reduction in conditioned 
responding for all groups by the end of late extinction. There was a trend for a CS × trial 
interaction, F(3.74, 250.75) = 2.42, p = .053, ηp2 = .035, ε = .936, with a greater reduction in 
SCR from trial 1 to trial 2 for the CS- compared to the CS+.  Importantly, the mixed ANOVA 
revealed a significant group × CS × trial interaction, F(7.49, 250.75) = 2.43, p = .018, ηp2 = 
.068, ε = .936. Tests of simple interaction effects revealed a significant CS × trial interaction 
for the PTSD group only, F(2.44, 34.16) = 4.26, p = .017, ηp2 = .233, ε = .610. As seen in 
Figure 2A, the PTSD group displayed a temporary increase in SCR to the CS+, followed by 
an increase in responding to the CS-. Notably, this interaction was only identified in the 
PTSD group, with no effects found for TCs and NTCs (p = .184 and p = .585, respectively), 
indicating a PTSD-specific impairment in extinguishing conditioned responses.  
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Figure 2. Group × CS × Trial interaction in late extinction. Late extinction SCR scores for the CS+ and CS- by trial for each: (A) PTSD; (B) TC; 
and (C) NTC groups. The PTSD group showed reduced extinction learning, with the CS+ eliciting a temporary increase in SCR, followed by an 
SCR increase to the CS-. CS × trial interactions for the TC and NTC groups were not significant (p = .184 and p = .585, respectively). Error bars 
depict 95% confidence intervals of the mean. μS1/2, SCR square-root transformed in micro-siemens. 
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3.4.4 Threat expectancy. 
 Habituation. No significant main effects or interactions were identified during the 
habituation phase. 
 
 Acquisition. Mixed ANOVA revealed a significant CS main effect, F(1, 62) = 
459.27, p < .001, d = 4.43, and trial main effect, F(3.25, 201.24) = 5.19, p = .001, ηp2 = .077, 
ε = .811. Further, there was a significant CS × trial interaction, F(3.07, 190.20) = 103.01, p < 
.001, ηp2 = .624, ε = .767, with increased differential responding between the CS+ and CS- 
over the course of the acquisition phase. No further main effects or interactions were 
significant. 
 
Early extinction. ANOVA revealed a significant CS main effect, F(1, 62) = 42.51, p 
< .001, d = 0.87, and a significant main effect of trial, F(2.58, 160.01) = 66.44, p < .001, ηp2 
= .517, ε = .645. There was also a significant CS × trial interaction, F(3.30, 204.41) = 6.60, p 
< .001, ηp2 = .096, ε = .824, US-expectancies to the CS+ and CS- decreasing over the early 
extinction phase. 
 
Late extinction. Mixed-model ANOVA revealed a significant main effect of CS, F(1, 
62) = 9.48, p = .003, d = 0.60, with greater US-expectancy to the CS+ (M = 28.30 [22.31, 
34.29], SD = 24.19) compared to the CS- (M = 19.94 [14.47, 25.41], SD = 22.09). Further, 
there was a significant trial main effect, F(1.87, 116.15) = 47.29, p < .001, ηp2 = .433, ε = 
.468, with US-expectancies reducing from trial 1 (M = 43.89 [37.66, 50.11], SD = 25.10) to 
trial 5 (M = 14.72 [9.34, 20.10], SD = 21.69). 
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3.4.5 Hours-since-waking moderation. 
As a significant group effect was only found during late extinction, the DCR change 
score from this phase was calculated and entered into the moderation model as the predictor 
variable, with PCL total as the outcome variable, and hours-awake as the moderator (Table 2, 
Model 1). The model predicted a significant amount of variance in PCL scores, R2 = .18, F(3, 
66) = 4.93, p = .004. Table 2 shows late extinction DCR change was a significant predictor of 
PCL scores, with a trend for the role of hours-awake, and a significant hours-awake × late 
extinction DCR change interaction. Age, depression, anxiety and stress were individually 
included in the model as covariates with little change to inferential statistics, and no change 
to the pattern of effects (see Supporting Information; Appendix C). 
 
Table 2 
 Linear Models of Predictors of PCL Total. 
 b SE b t p 
Model 1     
   - Constant 28.88 
[25.97, 31.80] 
1.46 19.79 < .001 
   - Hours-awake 1.14 
[-0.05, 2.32] 
0.59 1.91 .060 
   - Late extinction DCR change -2.37 
[-4.68, -0.06] 
1.16 -2.05 .045 
   - Hours-awake × late extinction -1.18 
[-2.07, -0.29] 
0.45 -2.63 .011 
Model 2     
   - Constant 28.62 
[25.67, 31.57] 
1.48 19.38 < .001 
   - Hours-awake 1.22 
[-0.11, 2.54] 
0.66 1.84 .071 
   - CS+ SCR change -2.47 
[-5.63, 0.69] 
1.58 -1.56 .124 
   - Hours-awake × CS+ change -1.80 
[-3.29, -0.30] 
0.75 -2.40 .019 
Note: SE = standard error. Square brackets show 95% confidence intervals of b. 
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As shown in Figure 3, for participants with higher PTSD symptom severity, increased 
hours-awake was significantly associated with poorer extinction learning (as indexed by a 
smaller decline in DCR change over the late extinction phase), and this effect becomes 
stronger with increasing hours-awake. To ensure that increased responding to the CS- in trial 
1 for the PTSD group did not drive this effect, a change score was calculated for the CS+ in 
late extinction (trial 5 SCR subtracted from trial 1 SCR) and included as the predictor 
variable. Table 2 (Model 2) shows a significant moderation interaction, with b-values 
revealing a consistent pattern with Model 1. 
 
 
Figure 3. Hours-awake moderation. The relationship between hours-awake, late extinction 
DCR change and PCL total was significant at higher levels (+1 SD) of hours-awake (8.70 
hours, b = -5.31 [-8.75, -1.87], t = -3.08, p = .003), and mean levels (6.21 hours, b = -2.37 [-
4.68, -0.06], t = -2.05, p = .045), with no significant effects at lower levels (-1 SD) of hours-
awake (3.71 hours, b = 0.57 [-2.39, 3.54], t = 0.39, p = .700). These findings indicate a linear 
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relationship between late extinction DCR change and PCL total, at increasing levels of hours-
since-waking, whereby participants with higher PCL scores demonstrate lower change in 
differential fear responding in the late extinction phase, and this relationship becomes 
stronger as participants are awake for longer. * p < .05, ** p < .01. 
 
 
3.5 Discussion 
This study found hours-since-waking moderates the relationship between fear 
extinction and PTSD symptoms. Participants with higher PCL scores show significantly 
poorer extinction learning with increasing hours-awake. These findings support research 
identifying poorer extinction learning in the evening in healthy controls (Pace-Schott et al., 
2013), and extends them to a clinical sample with PTSD compared to TC and NTC. 
Together, these results have important clinical implications for scheduling exposure therapy 
to optimize treatment benefit. 
The findings of the present study are consistent with previous research that fear 
extinction learning is significantly impaired in PTSD compared with nonclinical controls 
(Blechert et al., 2007; Norrholm et al., 2011; Orr et al., 2000; Peri et al., 2000). The results 
highlight an interesting pattern, with extinction learning impairments limited to the late 
extinction phase, with no between-group differences during early extinction. This pattern of 
findings is novel and may reflect early consolidation processes. Further investigations with 
varying extinction learning and recall periods (e.g., 2-day paradigms; Milad et al., 2008; 
Milad et al., 2009; Shvil et al., 2014) may provide some insight into the consolidation of 
extinction recall. Further, it should be noted that the PCL estimates probable PTSD diagnosis, 
and future research would benefit from using a Clinician Administered PTSD Scale. 
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Alternatively, participants in the PTSD group may develop increased state anxiety in 
anticipation of the US, despite clear learning of the CS+/- contingency during acquisition. 
During late extinction, participants in the PTSD group temporarily show larger SCR to the 
CS- compared to the CS+, suggesting fear generalization from the CS+ to the CS-. However, 
this effect dissipates quickly, which may be a result of the 100% reinforcement schedule 
during acquisition. The use of a partial reinforcement schedule (e.g., 60%; Milad et al., 2007; 
Pace-Schott et al., 2013) may shed light on the mechanisms of fear generalization.  
Pace-Schott et al. (2013) found extinction learning was more effective in the morning 
compared to the evening in healthy males. The current results show higher PCL scores are 
negatively associated with extinction learning as participants are awake for longer, extending 
previous findings to a clinical sample of males and females. This supports the notion that 
extinction is better learned soon after sleep compared to later in the day, with greater 
physiological reactivity to stimuli partially attributed to increased sleep demands (Pace-
Schott et al., 2014). This idea is supported by research showing enhanced extinction learning 
and greater generalization of recall memories soon after sleep (Pace-Schott et al., 2009; Pace-
Schott et al., 2013; Pace-Schott et al., 2014; Pace-Schott et al., 2012), particularly REM sleep 
(Spoormaker, Gvozdanovic, Samann, & Czisch, 2014; Spoormaker et al., 2010). 
In the current study, we found hours-since-waking moderates the relationship between 
fear extinction and PTSD symptoms. Previous research revealed elevated circadian levels of 
cortisol and testosterone in the morning, which may explain significantly enhanced extinction 
learning and recall in the morning (Pace-Schott et al., 2013). PTSD is often characterized by 
hypocortisolism (Yehuda & Seckl, 2011), and increased cortisol levels enhance extinction 
learning (Bentz et al., 2013; Merz, Hamacher-Dang, & Wolf, 2014). Cortisol experiences 
circadian effects (van Zuiden et al., 2011), suggesting the cortisol acrophase in the morning 
may be one mechanism by which hours-awake impacts extinction in PTSD. Further, the 
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PTSD group was, on average, significantly older than the TC and NTC groups. There was a 
weak negative correlation between age and late extinction DCR change, and including age as 
a covariate in the moderation analysis did not alter the findings (see Supporting Information; 
Appendix C). This implies that age does not significantly influence the effects in the current 
study, however should be controlled in future research. 
While the absence of physiological measures of sleep and waking are a limitation of 
the current study, our findings highlight the role that sleep plays in fear extinction ability. 
Self-report measures of sleep using the PSQI revealed the PTSD group reported significantly 
poorer sleep quality compared to control groups. Poorer sleep quality in the PTSD group may 
reduce the restorative benefits of sleep, thereby increasing homeostatic sleep demands and 
producing a smaller window early in the day for maximum extinction potential. Further, 
recent evidence found extinction is learned faster and better generalized in the morning in 
participants who achieve sleep earlier and report higher-morningness (Pace-Schott, Rubin, et 
al., 2015), suggesting chronotype may influence the present study’s findings. Currently, the 
relationship between REM sleep and PTSD diagnosis is somewhat inconclusive (Germain, 
2013), however further polysomnographic sleep studies examining REM sleep as a 
moderator between fear extinction and PTSD symptoms may clarify this relationship. 
Further, although there were no significant between-group differences in testing time, 
circadian rhythm was not directly examined in the current study and should be included in 
future investigations into the effects of hours-awake. 
 
3.5.1 Clinical implications. 
Pace-Schott et al. (2012) suggested the effectiveness of exposure therapy could be 
improved by scheduling treatment soon after sleep. The implications of the present study are 
in accordance with previous recommendations that a period of sleep shortly before or after 
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exposure therapy may aid in therapeutic extinction learning (Kleim et al., 2014; Pace-Schott 
et al., 2012). This notion is supported by a wealth of research proposing that sleep aids in 
memory consolidation (e.g., Diekelmann, 2014; Diekelmann & Born, 2010). 
 
3.6 Conclusion 
The present study confirms impaired fear extinction learning associated with PTSD, 
and extends previous findings to reveal that this relationship is moderated by hours-since-
waking, with PTSD-related extinction impairments increasing with time-awake. These 
findings suggest important implications for scheduling exposure-based treatments for PTSD, 
indicating that extinction learning potential, and thus benefit from exposure therapy, may 
decrease throughout the day. Future research would benefit from physiological measures of 
sleep to determine a role that REM sleep plays in enhancing this window of opportunity for 
optimized treatment benefit.  
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3.8 Online Supporting Information 
S1 – Habituation 
S2 – Acquisition 
S3 – Early extinction 
S4 – Late extinction 
S5 – Age Correlations with DCR Change Scores 
 
Differential Conditioned Response (DCR) scores were created by subtracting the CS- trial 1 
SCR from the CS+ trial 1 SCR, and so on for every trial. Group × trial analyses were 
conducted for each phase.  
 
S1. Habituation. 
A 3 (group) × 4 (trial) mixed-model ANOVA revealed no significant group or trial main 
effects, and no significant group × trial interaction (Fs < 1, ps > .569). 
 
S2. Acquisition. 
The DCR score from trial 1 was omitted from analyses of acquisition as the unconditioned 
stimulus (US) had not yet been encountered, and thus no learning had occurred on these 
trials. A 3 (group) × 4 (trial) mixed-model ANOVA revealed no significant group or trial 
main effects, and no significant group × trial interaction (Fs < 1.14, ps > .340). 
 
S3. Early extinction. 
A 3 (group) × 5 (trial) mixed-model ANOVA revealed no significant group or trial main 
effects, and no significant group × trial interaction (Fs < 1.45, ps > .243). 
 
Chapter 3: Hours-awake moderates fear extinction in PTSD 117 
 
S4. Late extinction. 
A 3 (group) × 5 (trial) mixed-model ANOVA revealed no significant main effect of group, 
F(2, 67) = 0.44, p = .647, ηp2 = .013. ANOVA revealed a trend for a trial main effect, F(3.74, 
250.75) = 2.42, p = .053, ηp2 = .035, ε = .936, and a significant group × trial interaction, 
F(7.49, 250.75) = 2.43, p = .018, ηp2 = .068, ε = .936. Test of simple main effects revealed a 
significant main effect of trial for the PTSD group, F(2.44, 34.16) = 4.26, p = .017, ηp2 = 
.233, ε = .610, with no significant main effects for the TC and NTC groups (p = .184 and p = 
.585, respectively). Inspection of the means revealed that the PTSD group experienced an 
increase in DCR from trial 1 to trial 2 (M = -.48, to M = .641, respectively), followed by a 
decrease to trial 4 (M = -.388), and a further increase to trial 5 (M = .06). 
 
S5. Age correlations with DCR change scores 
Pearson’s correlations were conducted between age and the DCR change scores for the 
acquisition, early extinction and late extinction phases. During acquisition and early 
extinction there were no significant correlations, Pearson’s r(N = 70) = -.02, p = .856, and 
r(N = 70) = .02, p = .856, respectively. There was a trend for a weak negative correlation 
between age and late extinction DCR scores, r(N = 70) = -.21, p = .078, indicating a pattern 
whereby increasing age is associated with a reduction in differential extinction learning 
during this phase. However this is a weak correlation, and including age as a covariate in 
moderation analyses did not change the results, or alter the pattern of findings. 
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Table S1 
Linear Model of Predictors of PCL Total (Age Covariate). 
 
 
Note: With age included as a covariate, the model predicted a significant amount of variance 
in PCL scores, R2 = .28, F(4, 65) = 6.23, p < .001. Further inspection of the interaction 
revealed that as hours-awake increased, the relationship between PCL scores and extinction 
learning became stronger. Specifically, the relationship between hours-awake, late extinction 
DCR and PCL total was only significant at higher levels (+1 SD) of hours-awake (b = -3.66 
[-7.12, -0.21], t = -2.12, p = .038), compared to mean levels (b = -1.53 [-3.79, 0.74], t = -1.35, 
p = .183) and lower levels (-1 SD; b = 0.61 [-2.20, 3.42], t = 0.43, p = .666). 
SE = standard error. Square brackets show 95% confidence intervals of b. 
  
 b SE b t p 
Constant 13.10 
[2.65, 23.56] 
5.23 2.50 .015 
Hours-awake 0.66 
[-0.52, 1.84] 
0.59 1.11 .270 
Late Extinction DCR 3.79 
[-1.66, 9.24] 
2.73 1.39 .170 
Hours-awake × Late Extinction -0.86 
[-1.73, 0.02] 
0.44 -1.95 .055 
Age (covariate) 0.47 
[0.15, 0.79] 
0.16 2.91 .005 
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Table S2 
Linear Model of Predictors of PCL Total (Depression Covariate). 
 
Note: With depression included as a covariate, the model predicted a significant amount of 
variance in PCL scores, R2 = .60, F(4, 65) = 24.45, p < .001. Further inspection of the 
interaction revealed that as hours-awake increased, the relationship between PCL scores and 
extinction learning became stronger. Specifically, the relationship between hours-awake, late 
extinction DCR and PCL total was significant at higher levels (+1 SD) of hours-awake (b = -
3.46 [-5.93, -1.00], t = -2.81, p = .007), and mean levels (b = -1.78 [-3.41, -0.15], t = -2.18, p 
= .033), but was not significant at lower levels (-1 SD; b = -0.09 [-2.19, 2.00], t = -0.09, p = 
.930). 
SE = standard error. Square brackets show 95% confidence intervals of b. 
  
 b SE b t p 
Constant 18.50 
[15.59, 24.41] 
2.96 6.25 < .001 
Hours-awake 0.52 
[-0.35, 1.40] 
0.44 1.19 .237 
Late Extinction DCR 2.42 
[-1.64, 6.47] 
2.03 1.19 .238 
Hours-awake × Late Extinction -0.68 
[-1.32, -0.03] 
-2.10 -2.10 .039 
Depression (covariate) 2.26 
[1.72, 2.81] 
8.25 8.25 < .001 
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Table S3 
Linear Model of Predictors of PCL Total (Anxiety Covariate). 
 
Note: With anxiety included as a covariate, the model predicted a significant amount of 
variance in PCL scores, R2 = .71, F(4, 65) = 39.01, p < .001. Further inspection of the 
interaction revealed that as hours-awake increased, the relationship between PCL scores and 
extinction learning became stronger. Specifically, the relationship between hours-awake, late 
extinction DCR and PCL total was significant at higher levels (+1 SD) of hours-awake (b = -
2.78 [-4.91, -0.65], t = -2.60, p = .011), compared to mean levels (b = -1.41 [-2.81, 0.002], t = 
-1.99, p = .050), and lower levels (-1 SD; b = -0.03 [-1.82, 1.77], t = -0.03, p = .975). 
SE = standard error. Square brackets show 95% confidence intervals of b. 
  
 b SE b t p 
Constant 16.25 
[11.11, 21.39] 
2.57 6.31 < .001 
Hours-awake 0.62 
[-0.14, 1.37] 
0.38 1.64 .106 
Late Extinction DCR 2.02 
[-1.46, 5.50] 
1.74 1.16 .251 
Hours-awake × Late Extinction -0.55 
[-1.10, 0.001] 
0.28 -1.99 .051 
Anxiety (covariate) 2.76 
[2.25, 3.27] 
0.75 10.75 < .001 
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Table S4 
Linear Model of Predictors of PCL Total (Stress Covariate). 
 
Note: With stress included as a covariate, the model predicted a significant amount of 
variance in PCL scores, R2 = .76, F(4, 65) = 43.92, p < .001. Further inspection of the 
interaction revealed that as hours-awake increased, the relationship between PCL scores and 
extinction learning became stronger. However, differences were not significant at higher 
levels (+1 SD) of hours-awake (b = -1.07 [-3.05, 0.92], t = -1.08, p = .286), mean levels (b = -
0.54 [-1.82, 0.75], t = -0.83, p = .409), or lower levels (-1 SD; b = -0.002 [-1.61, 1.61], t = -
0.002, p = .998). 
SE = standard error. Square brackets show 95% confidence intervals of b. 
  
 b SE b t p 
Constant 12.43 
[7.65, 17.21] 
2.40 5.19 < .001 
Hours-awake 0.70 
[0.02, 1.37] 
0.38 2.07 .043 
Late Extinction DCR 0.79 
[-2.36, 3.95] 
1.58 0.50 .618 
Hours-awake × Late Extinction -0.21 
[-0.72, 0.29] 
0.25 -0.84 .404 
Stress (covariate) 2.21 
[1.86, 2.55] 
0.17 12.61 < .001 
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Table S5 
Linear Model of Predictors of PCL Total (Baseline Cortisol Covariate). 
 
Note: With baseline cortisol included as a covariate, the model predicted a significant amount 
of variance in PCL scores, R2 = .19, F(4, 64) = 3.67, p = .009. Further inspection of the 
interaction revealed that as hours-awake increased, the relationship between PCL scores and 
extinction learning became stronger. Specifically, the relationship between hours-awake, late 
extinction DCR and PCL total was significant at higher levels (+1 SD) of hours-awake (b = -
5.39 [-8.88, -1.89], t = -3.08, p = .003), and mean levels (b = -2.41 [-4.75, -0.07], t = -2.06, p 
= .044), but was not significant at lower levels (-1 SD; b = 0.56 [-2.42, 3.55], t = 0.38, p = 
.708). 
SE = standard error. Square brackets show 95% confidence intervals of b. 
 
 
  
 b SE b t p 
Constant 29.59 
[26.20, 32.98] 
1.70 17.45 < .001 
Hours-awake 1.15 
[-0.07, 2.37] 
0.61 1.89 .064 
Late Extinction DCR 1.17 
[-4.75, -0.07] 
1.17 -2.06 .044 
Hours-awake × Late Extinction -1.19 
[-2.09, -0.29] 
0.45 -2.63 .011 
Baseline Cortisol (covariate) -3.06 
[-11.95, 5.83] 
4.45 -0.69 .494 
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Table S6 
Linear Model of Predictors of PCL Total (Post-Acquisition Cortisol Covariate). 
 
Note: With post-acquisition cortisol included as a covariate, the model predicted a significant 
amount of variance in PCL scores, R2 = .18, F(4, 64) = 3.54, p = .011. Further inspection of 
the interaction revealed that as hours-awake increased, the relationship between PCL scores 
and extinction learning became stronger. Specifically, the relationship between hours-awake, 
late extinction DCR and PCL total was significant at higher levels (+1 SD) of hours-awake (b 
= -5.39 [-8.90, -1.88], t = -3.07, p = .003), and mean levels (b = -2.47 [-4.82, -0.12], t = -2.10, 
p = .040), but was not significant at lower levels (-1 SD; b = 0.45 [-2.55, 3.45], t = 0.30, p = 
.765). 
SE = standard error. Square brackets show 95% confidence intervals of b. 
 
  
 b SE b t p 
Constant 28.72 
[24.77, 32.68] 
1.98 14.50 < .001 
Hours-awake 1.07 
[-0.14, 2.28] 
0.61 1.76 .083 
Late Extinction DCR -2.47 
[-4.82, -0.12] 
1.18 -2.10 .040 
Hours-awake × Late Extinction -1.17 
[-2.07, -0.26] 
0.45 -2.58 .012 
Post-acquisition cortisol 
(covariate) 
1.70 
[-13.33, 16.73] 
7.52 0.23 .822 
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Table S7 
Linear Model of Predictors of PCL Total (Cortisol Reactivity Covariate). 
 
Note: With cortisol reactivity included as a covariate, the model predicted a significant 
amount of variance in PCL scores, R2 = .21, F(4, 64) = 4.33, p = .004. Further inspection of 
the interaction revealed that as hours-awake increased, the relationship between PCL scores 
and extinction learning became stronger. Specifically, the relationship between hours-awake, 
late extinction DCR and PCL total was significant at higher levels (+1 SD) of hours-awake (b 
= -5.53 [-8.98, -2.09], t = -3.21, p = .002), and mean levels (b = -2.46 [-4.76, -0.17], t = -2.14, 
p = .036), but was not significant at lower levels (-1 SD; b = 0.60 [-2.33, 3.54], t = 0.41, p = 
.682). 
SE = standard error. Square brackets show 95% confidence intervals of b. 
 
 
 
 
 b SE b t p 
Constant 29.18 
[26.26, 32.09] 
1.46 19.97 < .001 
Hours-awake 1.28 
[0.08, 2.49] 
0.61 2.12 .038 
Late Extinction DCR -2.46 
[-4.76, -0.17] 
1.15 -2.14 .036 
Hours-awake × Late Extinction -1.23 
[-2.12, -0.34] 
0.45 -2.76 .008 
Cortisol Reactivity (Covariate) 13.80 
[-3.18, 30.78] 
8.50 1.62 .109 
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4.1 Abstract 
Background: Considerable research has revealed impaired fear extinction to be a significant 
predictor of PTSD. Fear extinction is also considered the primary mechanism of exposure 
therapy, and a critical factor in PTSD recovery. The cognitive theory of PTSD proposes that 
symptoms persist due to excessive negative appraisals about the trauma and its sequelae. 
Research has not yet examined the relationship between fear extinction and negative 
appraisals in PTSD. 
Methods: A cross-sectional sample of PTSD (n = 21), trauma-exposed (n = 33), and non-
exposed participants (n = 26) underwent a standardized differential fear conditioning and 
extinction paradigm, with skin conductance response (SCR) serving as the index of 
conditioned responses. The Posttraumatic Cognitions Inventory (PTCI) was used to index 
catastrophic negative appraisals. 
Results: Participants with PTSD demonstrated significantly slower extinction learning and 
greater negative appraisals compared to control groups. A moderation analysis revealed that 
both negative trauma-relevant appraisals and fear extinction learning were independently 
associated with PTSD symptoms, but there was no moderation interaction. 
Limitations: The current study was limited by a modest sample size, leading to the inclusion 
of participants with subclinical PTSD symptoms. Further, the current study only assessed fear 
extinction learning, and including a second day extinction recall task may show alternative 
effects. 
Conclusions: These findings indicate that negative appraisals and fear extinction did not 
interact in PTSD, but had independent effects. Here we show for the first time in an 
experimental framework that negative appraisals and fear extinction play separate roles in 
PTSD symptoms. 
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4.2 Introduction 
 Posttraumatic stress disorder (PTSD) is characterized by persistent fear, intrusive 
memories, and negative appraisals about oneself and a traumatic event (Dunmore, Clark, & 
Ehlers, 1999). Symptoms naturally subside in many trauma survivors, but persist as PTSD in 
approximately 2-10% of people (Atwoli, Stein, Koenen, & McLaughlin, 2015; Ramchand et 
al., 2010). The cognitive theory of PTSD (Ehlers & Clark, 2000) proposes that two key 
mechanisms underlie the persistence of PTSD: negative appraisals relating to the trauma and 
its sequelae, and poorly elaborated autobiographical memories and conditioned fear 
responses which readily prime intrusive memories that are triggered by trauma reminders 
(Ehlers & Clark, 2000). 
 A considerable body of research supports the idea that PTSD develops and is 
maintained by negative cognitions about a significant traumatic event (Dunmore et al., 1999; 
Dunmore, Clark, & Ehlers, 2001; Ehlers, Mayou, & Bryant, 1998, 2003). That is, traumatic 
experiences lead to negative appraisals about the trauma and its sequelae, causing feelings of 
current threat, persistent avoidance, and generalization of fear (Ehlers & Clark, 2000). 
Numerous studies have shown acute post-trauma negative appraisals significantly predict 
increased PTSD symptoms in adults and children following a range of traumatic events (e.g., 
Dunmore et al., 2001; Ehlers et al., 1998, 2003; Ehring, Ehlers, & Glucksman, 2008). 
Moreover, the tendency to engage in negative appraisals prior to a traumatic event predicts 
PTSD symptoms several years after exposure (Bryant & Guthrie, 2007). 
A second influential model proposes that PTSD develops from impaired fear 
extinction learning and recall (Pitman et al., 2012). In this model, fear conditioning occurs 
during trauma, and re-exposure to trauma reminders and subsequent avoidance of reminders 
facilitate conditioned fear and fear generalization. Extinction typically occurs when the 
conditioned stimuli are presented in the absence of any aversive consequence, and in the 
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context of trauma this typically involves experience of benign trauma reminders. In this 
sense, the minority of trauma survivors who experience persistent symptoms can be regarded 
as suffering impaired extinction (Davis & Myers, 2002). Considerable evidence demonstrates 
that individuals presenting with PTSD show impairments in fear extinction and extinction 
recall (e.g., Milad et al., 2008; Norrholm et al., 2011; Shvil et al., 2014; Zuj et al., 2016). 
Recent studies have also found pre-trauma extinction learning significantly predicts increased 
post-traumatic stress (Guthrie & Bryant, 2006; Lommen, Engelhard, Sijbrandij, van den 
Hout, & Hermans, 2013; Orr et al., 2012). 
These models are not mutually exclusive, given that Ehlers and Clark (2000) also 
suggest that intrusive memories and conditioned fear responses triggered by trauma 
reminders are thought to reinforce negative appraisals, which act to maintain anxiety and 
sense of current threat. Further, longitudinal evidence has found that PTSD symptoms can be 
predicted by pre-trauma fear extinction learning (Guthrie & Bryant, 2006), and maladaptive 
pre-trauma negative appraisals (Bryant & Guthrie, 2007). Therefore, impaired extinction 
capacity pre-trauma and heightened negative appraisals may interact to potentiate fear 
responses following trauma. In an experimental framework, negative appraisals may 
moderate the relationship between fear extinction and PTSD symptoms. To our knowledge, 
no previous studies have examined fear extinction and negative appraisals in tandem, in 
relation to PTSD. 
On the basis of Ehlers and Clark’s (2000) model, we predicted first that excessively 
negative appraisals (indexed by the Posttraumatic Cognitions Inventory (PTCI)) would be 
associated with increased PTSD symptom severity. Second, on the basis of considerable 
cross-sectional and longitudinal evidence we hypothesized that impaired fear extinction 
learning would be associated with PTSD symptoms. As yet, studies have not considered these 
two prevailing models in tandem, thus moderation analyses were conducted testing for a 
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possible interaction between fear extinction learning and negative appraisals in influencing 
PTSD symptom severity. 
 
4.3 Method 
4.3.1 Participants. 
 Eighty participants aged 18-63 years (M = 27.8 years, SD = 12.8 years; 33 males and 
47 females) comprised three groups: PTSD (n = 21), trauma-exposed without PTSD (TC; n = 
33), and non-trauma exposed controls (NTC; n = 26). The PTSD and TC groups were 
classified on the basis of experiencing a criterion A stressor, whereby physical integrity was 
threatened (American Psychiatric Association, 2000) using the Traumatic Events 
Questionnaire (TEQ; Vrana & Lauterbach, 1994). Traumatic events included war-related 
combat (n = 5), life-threatening accident (n = 21), natural disaster (n = 26), witnessing a 
traumatic event (n = 34), assaulted or molested (n = 21), threatened or held captive (n = 13), 
and tortured or terrorist victim (n = 2). Mean years since trauma for the PTSD group was 10.1 
years (SD = 12.8 years) and 10.5 years (SD = 11 years) for the TC group. Trauma-exposed 
individuals were classified into either the PTSD or TC group using the PTSD Checklist 
(PCL-C) for DSM-IV (Weathers, Litz, Huska, & Keane, 1994). The PCL-C for DSM-IV was 
used as recruitment occurred prior to diagnostic instruments for the DSM-V being available. 
The University of Tasmania Social Sciences ethics committee approved the study protocol. 
Informed consent of the participants was obtained after the nature of the procedures had been 
fully explained. 
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4.3.2 Measures. 
PTSD Checklist-Civilian version. The PCL-C (Weathers et al., 1994) is a 17-item 
self-report measure that provides diagnostic information according to PTSD criteria on the 
DSM-IV (American Psychiatric Association, 2000). Responses are made on a 5-point Likert 
scale in regards to how often participants were distressed by each symptom in the past month, 
ranging from 1 (“Not at all”) to 5 (“Extremely”). Participants who presented with at least 1 
intrusive symptom, 3 avoidance symptoms, and 2 hyperarousal symptoms were classified as 
PTSD (Weathers et al., 1994). The PCL-C for DSM-IV shows strong psychometric properties 
(Wilkins, Lang, & Norman, 2011). The PCL total also provides an ordinal measure of 
symptom severity with a recommended clinical PTSD cut-off of 50, and subclinical PTSD of 
40 (National Center for Posttraumatic Stress Disorder, n.d.). 
 
 Posttraumatic Cognitions Inventory. The PTCI (Foa, Ehlers, Clark, Tolin, & Orsillo, 
1999) is a 33-item self-report measure of negative posttraumatic appraisals regarding the self, 
world, and self-blame. Responses are made on a 7-point Likert scale from 1 (“totally 
disagree”) to 7 (“totally agree”). The PTCI has demonstrated good psychometric properties 
(Foa et al., 1999). 
 
4.3.3 Fear conditioning and extinction paradigm. 
 The present study employed a standardized differential fear conditioning and 
extinction paradigm used previously (Orr et al., 2000; Zuj et al., 2016). Findings from a 
subset of the participants in the current study have been reported elsewhere examining the 
impact of hours-since-waking on fear extinction learning in PTSD (Zuj et al., 2016). The 
unconditioned stimulus (US) was a 500ms mild electric shock delivered to the first 
interosseous muscle of the dominant hand, set to a level considered “highly annoying, but not 
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painful” by each participant prior to the task (Orr et al., 2000). Conditioned stimuli were red 
and blue circles presented individually for 12s on a computer screen. The testing protocol 
included four experimental phases: habituation, acquisition, early extinction, and late 
extinction. During habituation, participants were exposed to four trials of each colored circle 
(eight trials in total). During acquisition, one of the colored circles (CS+) was followed by 
the US (mild electric shock) on all five trials (100% reinforcement schedule; Orr et al., 2000) 
while the other colored circle was not reinforced on any of the five trials (CS-; ten trials in 
total). The early extinction phase consisted of five trials of the CS+ (with no reinforcement) 
and five trials of the CS- (ten trials in total), followed by a short break of approximately one 
minute before participants completed the late extinction phase, which mirrored early 
extinction. Trial order was pseudo-random, with no more than two consecutive CS+ or CS- 
trials, and inter-trial intervals ranged from 12-21 seconds. 
 
4.3.4 Skin conductance response. 
 Skin conductance level was measured through a 22mVrms, 75Hz constant-voltage 
coupler (FE116, ADI Instruments) with bipolar electrodes on the intermediate phalange of 
the first and third fingers of the non-dominant hand, sampled at 512Hz and stored at 64Hz, 
and recorded in micro-siemens (μS). Skin conductance response (SCR) to the CS+ and CS- 
was calculated by subtracting the mean SCL during the 2s prior to stimulus onset from the 
maximum SCL during the 12s stimulus duration. SCR values were square-root transformed, 
and the absolute value of negative scores was transformed and the negative sign replaced. 
Differential conditioned responding (DCR) was calculated by subtracting the SCR of the first 
CS- from the first CS+, for all trials (Menz et al., 2013; Zuj et al., 2016). For use in 
moderation analyses, DCR change scores were calculated for the extinction phases by 
subtracting the trial 5 DCR from the trial 1 DCR, with higher values representing a greater 
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change in differential fear responding across the experimental phase (i.e., better fear 
extinction performance). 
 
4.3.5 US-expectancy ratings. 
 During the 12s stimulus presentation, participants were asked to rate their threat 
expectancy of the US on a 0-100 visual analogue scale (VAS; 0 “certain no electrical 
stimulus”; 100 “certain electrical stimulus”; as previously used by Lommen et al., 2013).  
 
4.3.6 Statistical analyses. 
Three (Group) × 2 (CS) × 5 (trial) mixed model analyses of variance (ANOVA) were 
conducted for each phase (with four trials for habituation and acquisition) to examine fear 
conditioning and extinction across groups. The first CS+/- trials were removed from 
acquisition analyses as the US had not been encountered, and no learning had occurred. 
Analyses were identical for both SCR and US-expectancy data, however the latter was used 
as a measure of contingency awareness. Greenhouse-Geisser corrections were made for 
within-subjects variables where necessary. Brown-Forsythe F-ratio corrections were made 
where homogeneity of variance was violated. Pairwise comparisons were conducted with 
Bonferroni corrections or Games-Howell tests where appropriate. Moderation analyses were 
conducted using the PROCESS macro for SPSS (Model 1; Hayes, 2013). An alpha level of α 
= .05 was used for all tests of statistical significance. Effect sizes are reported as Cohen’s d 
following the criteria of 0.2, 0.5, and 0.8 as small, moderate and large effects, respectively 
(Cohen, 1988). Partial-eta squared (ηp2) are reported as effect sizes for mixed-model 
ANOVAs. 
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4.4 Results 
4.4.1 Descriptive and clinical data. 
 One-way ANOVA showed there was a significant between-group difference in PTSD 
total symptom severity, F(2, 25.99) = 135.20, p < .001, with the PTSD group displaying 
significantly elevated PTSD symptoms compared to TC and NTC groups. Further, the PTSD 
group displayed significantly higher levels of negative appraisals, and symptoms of 
depression, anxiety, and stress (see Table 1 for demographic and inferential data). 
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Table 1 
Mean Scores and SDs of Demographic and Clinical Measures. 
Measures PTSD (n = 21) TC (n = 33) NTC (n = 26) Test statistic p 
Demographic data      
   - Age (years) 32.67 (14.62) 27.45 (10.05) 24.31 (9.82) F(2, 52.27) = 2.90 .064 
   - Sex 13F, 8M 15F, 18M 19F, 7M χ2(2) = 4.70 .096 
PCL-C      
   - Total 52.52 (11.38) 23.39 (3.98) 19.85 (2.57) F(2, 25.99) = 135.20 < .001 
   - Intrusive 3.00 (1.22) 0.27 (0.52) 0.00 (0.00) F(2, 77) = 126.51 < .001 
   - Avoidance 4.24 (1.81) 0.42 (0.71) 0.19 (0.49) F(2, 27.90) = 82.61 < .001 
   - Hyperarousal 3.52 (1.03) 0.39 (0.66) 0.15 (0.46) F(2, 41.75) = 137.73 < .001 
PTCI      
   - Total 113.32 (36.91) 73.33 (28.90) 61.81 (23.60) F(2, 75) = 17.91 < .001 
   - Self 2.92 (1.21) 1.83 (0.83) 1.58 (0.63) F(2, 41.12) = 12.31 < .001 
   - World 4.59 (1.33) 3.02 (1.23) 2.15 (0.82) F(2, 75) = 25.43 < .001 
   - Self-blame 3.23 (1.48) 2.16 (1.09) 2.15 (1.24) F(2, 75) = 5.39 .006 
DASS      
   - Depression 9.43 (5.76) 2.21 (2.38) 1.27 (1.76) F(2, 29.33) = 30.64 < .001 
   - Anxiety 8.14 (4.26) 1.97 (1.91) 1.00 (1.60) F(2, 32.32) = 39.92 < .001 
   - Stress 13.62 (6.34) 4.88 (3.17) 2.38 (2.23) F(2, 33.26) = 40.83 < .001 
AUDIT 6.86 (5.46) 6.12 (3.92) 6.00 (4.14) F(2, 77) = 0.25 .779 
Note: PCL-C = PTSD Checklist-Civilian version; PCTI= Posttraumatic Cognitions Inventory; DASS = Depression Anxiety Stress Scale; 
AUDIT = Alcohol Use Disorders Identification Test. 
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4.4.2 SCR amplitude data. 
 Habituation. During the habituation phase, mixed-model ANOVA showed a 
significant main effect of trial, F(2.87, 220.71) = 2.75, p = .046, ηp2 = .034, ε = .955, as SCRs 
reduced over the course of the phase as participants became habituated to the task (see Figure 
1A). 
 
 Acquisition. During the acquisition phase, mixed-model ANOVA showed a 
significant main effect of CS, F(1, 77) = 81.88, p < .001, d = 0.88, with significantly greater 
SCRs to the CS+ (M = 0.86, 95% CI[0.73, 0.99], SD = 0.58) than the CS- (M = 0.39 [0.28, 
0.49], SD = 0.49) reflecting acquisition of fear conditioning to the CS+. There was also a 
significant main effect of trial, F(2.85, 219.27) = 4.66, p = .004, ηp2 = .057, ε = .949, with 
SCRs decreasing on average across the acquisition phase (see Figure 1B). No further main 
effects or interactions were significant. 
 
 Early extinction. Mixed-model ANOVA revealed a significant main effect of CS, 
F(1, 77) = 10.78, p = .002, d = 0.31, showing that, pooled across group and trial, the CS+ 
continued to elicit a greater SCR (M = 0.60 [0.51, 0.69], SD = 0.41) than the CS- (M = 0.47 
[0.38, 0.56], SD = 0.40). Further, there was a significant main effect of trial, F(3.51, 269.88) 
= 33.65, p < .001, ηp2 = .304, ε = .876, and a significant group × trial interaction, F(7.01, 
269.88) = 2.16, p = .038, ηp2 = .053, ε = .876. Test of simple main effects show that the TC 
and NTC groups demonstrate a significant reduction in SCRs from trial 1 to trial 2 (p < .001, 
and p = .020, respectively), however the PTSD group displayed no significant reduction in 
SCR from trial 1 to trial 2 (p = .140), however there was a significant reduction from trial 2 to 
trial 3 (p = .021). These findings suggest that the PTSD group displayed slower extinction 
learning than the TC and NTC groups (see Figure 2). 
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 Late extinction. Mixed-model ANOVA revealed that there was still a significant, 
albeit small effect between the CS+ (M = 0.50 [0.39, 0.60], SD = 0.47) and the CS- (M = 0.42 
[0.33, 0.51], SD = 0.40), F(1, 77) = 4.42, p = .039, d = 0.19. Further, there was a significant 
main effect of trial, F(3.35, 258.09) = 17.59, p < .001, ηp2 = .186, ε = .838, with SCRs 
decreasing across trials (see Figure 1D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. CS × Trial interaction for each experimental phase. Panel (A) shows square-root 
transformed SC responses during the habituation phase. Panel (B) shows that despite a 
gradual decline in SC responding, CS+/- stimulus discrimination increases across the phase. 
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The first CS+/- trials were removed from analyses of the acquisition phase, as the US had not 
been encountered, and no learning had occurred. Panels (C) and (D) show that SCRs to the 
CS+ and CS- decreased across the early and late extinction phases, respectively. 
 
 
 
Figure 2. Group × Trial interaction during early extinction. During the early extinction phase, 
there was a significant group × trial interaction, showing that the PTSD group displayed a 
slower rate of extinction and safety signal learning across the first 3 to four trials, compared 
to the TC and NTC groups, who showed a rapid reduction in responding from trial 1 to trial 
2. Error bars depict 95% confidence intervals of the mean. Vertical axis displays square-root 
transformed SCR values (μS1/2). 
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4.4.3 Threat expectancy. 
 Habituation. During the habituation phase, 3 (group) × 2 (CS) × 4 (trial) mixed-
model ANOVA revealed a significant main effect of trial, F(2.02, 145.57) = 2.04, p = .001, 
ηp2 = .092, ε = .674, indicating a reduction in US-expectancy ratings over the experimental 
phase, pooled across CS and group.  
 
Acquisition. During acquisition, there was a significant CS × trial interaction, F(3.42, 
242.98) = 108.76, p < .001, ηp2 = .605, ε = .830, with differential responding between the 
CS+ and CS- increasing over trials, indicating greater threat expectancy developing to the 
CS+ and reduced threat expectancy to the CS-. 
 
Early extinction. There was also a significant CS × trial interaction in the early 
extinction phase, F(3.93, 244.27) = 10.29, p < .001, ηp2 = .125, ε = .619, with differential 
responding decreasing over the phase. Specifically, by the end of the early extinction phase, 
participants are showing reduced differential threat expectancy between the CS+ and the CS-, 
as the CS+ ceases to predict the US (mild electric shock).  
 
Late extinction. Further, there was also a significant CS × trial interaction in the late 
extinction phase and differential threat expectancy to the CS+ and CS- continued to decline, 
F(3.56, 256) = 3.59, p = .010, ηp2 = .048, ε = .558. 
 
4.4.4 Fear extinction and negative appraisals. 
 To examine the relationship between fear extinction learning and negative appraisals 
in PTSD, a moderation analysis was conducted (Model 1; Hayes, 2013). PCL total was 
included as the outcome variable, and PTCI total was included as the moderator. As primary 
Chapter 4: Negative appraisals and fear extinction are independently related to PTSD 139 
 
group effects in fear extinction learning were found during early extinction, an early 
extinction DCR change score was calculated and entered into the model as the predictor 
variable. The total model predicted a significant amount of variance in PTSD symptoms, R2 = 
.450, F(3, 74) = 20.18, p < .001. As seen in Table 2, both negative appraisals and early 
extinction DCR change showed significant relationship with PTSD symptoms, however there 
was no significant interaction between negative appraisals and extinction. That is, negative 
appraisals did not moderate the relationship between fear extinction learning and PTSD 
symptom severity. Analyses were repeated with the self, world, and self-blame subscales of 
the PTCI as moderator variables, which yielded similar, albeit weaker patterns of effects (see 
supplementary materials). 
 
 
Table 2 
Linear model of predictors of PCL total. 
 b  SE b t p 
Constant 29.34 [26.82, 31.86] 1.26 23.22 < .001 
Negative appraisals 0.28 [0.21, 0.36] 0.04 7.74 < .001 
Early extinction DCR change -2.62 [-5.15, -0.09] 1.27 -2.06 .043 
Negative appraisals × early extinction -0.03 [-0.11, 0.04] 0.04 -0.92 .359 
Note: SE = Standard Error; Square brackets show 95% confidence intervals of b. 
 
 
4.5 Discussion 
 The results of the present study reveal that both negative appraisals of the trauma and 
its sequelae, as well as impaired fear extinction learning are associated with elevated PTSD 
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symptoms. This study was the first to our knowledge to examine whether negative appraisals 
and fear extinction learning interact to influence PTSD symptoms. Moderation analyses 
revealed that negative appraisals did not moderate the relationship between fear extinction 
and PTSD symptoms, suggesting that fear extinction and negative appraisals do not interact 
in PTSD. This provides novel evidence that negative appraisals and fear extinction play 
independent roles in PTSD symptoms. 
 Ehlers and Clark (2000) proposed that a key mechanisms underlying the development 
of PTSD is excessive negative appraisals of the trauma and its sequelae (also see Ehlers et al., 
2003). Using the PTCI as an index of trauma-related negative appraisals, our results confirm 
this prediction by finding that the PTCI total has a significant positive relationship with 
PTSD symptoms. This supports a wealth of prior studies indicating the importance of 
excessively negative appraisals in PTSD (e.g., Dunmore et al., 1999, 2001; Ehlers et al., 
1998). Analyses with the PTCI self, world, and self-blame subscales showed similar patterns 
with the PTCI total score (see Supplementary Materials). Participants in the current study 
experienced a range of interpersonal and disaster-related traumas, with many participants 
experiencing both. Future studies examining specific trauma populations may shed light on 
the contributions of individual trauma-types on negative appraisals and PTSD symptoms. 
 There is considerable evidence of PTSD-related impairments in fear extinction 
learning (Norrholm et al., 2011; Orr et al., 2000; Peri, Ben-Shakhar, Orr, & Shalev, 2000; Zuj 
et al., 2016), and the findings of the current study support this notion. Specifically, we found 
that the PTSD group displayed a slower reduction in conditioned responding during the early 
extinction phase, which is concordant with the idea of fear load (Norrholm et al., 2015). That 
is, PTSD is associated with greater expression of fear during the early stages of extinction 
learning, relative to comparison groups. Further, rapid fear extinction may be due in part to 
the 100% reinforcement schedule used during fear acquisition, which may also explain the 
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trial main effect found during acquisition, where SCRs gradually declined across the 
experimental phase as participants habituated to the task. Studies failing to find group 
differences in extinction learning have found PTSD to be associated with impaired recall of 
fear extinction learning 24h later, compared to controls (e.g., Milad et al., 2008; Milad et al., 
2009). Future research should employ 2-day extinction learning and recall designs to assess 
the interactive effects of negative appraisals and fear extinction on the recall of extinction 
learning. 
 The findings of the present study have important potential implications for treatment 
strategies. Previous research has found comparable treatment gains between exposure therapy 
alone, cognitive restructuring alone, or a combination of the two (Marks, Lovell, Noshirvani, 
Livanou, & Thrasher, 1998; Tarrier, Sommerfield, Pilgrim, & Humphreys, 1999). Bryant, 
Moulds, Guthrie, Dang, and Nixon (2003), however, found that participants who underwent 
imaginal exposure combined with cognitive restructuring showed a greater reduction of 
PTSD symptoms than imaginal exposure alone. The findings of the current study suggest that 
both cognitive therapy for negative appraisals and exposure therapy for fear extinction are 
important elements to be included in treatment, as both have independent effects on PTSD 
symptoms (e.g., Marks et al., 1998). 
 The cognitive model further hypothesizes that persistent PTSD is caused by 
fragmented and poorly contextualized trauma memories, and dysfunctional behavioral and 
cognitive strategies aimed at reducing feelings of threat, yet further exaggerating the problem 
(Ehlers et al., 2003). A limitation of the current study is that we were unable to examine these 
aspects of the model, and future research would benefit from investigating the role of 
extinction in the elaboration of trauma memories, and the nature of intrusive memories in 
PTSD. Specifically, extinction networks show an important role of the basolateral amygdala 
in the expression or inhibition of fear (Milad & Quirk, 2012), and this neural substrate is also 
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involved in emotional memory consolidation (e.g., Roozendaal et al., 2009; Roozendaal, 
Schelling, & McGaugh, 2008). This suggests a neurobiological basis for impaired extinction 
memory as a mechanism in the intrusive re-experiencing symptoms of PTSD. As fear 
extinction recall impairments are a robust finding in PTSD (e.g., Milad et al., 2008; Milad et 
al., 2009), specifically assessing the memory for fear extinction may show stronger 
convergences between extinction and cognitive models of PTSD. 
 The present study had some limitations, including a relatively modest clinical sample, 
the use of a cross-sectional design, and the lack of investigation of fear extinction recall 
measures, which have been one of the most robust findings in terms of potential mechanisms 
in PTSD. To further delineate the role of these potential mechanisms, future research is 
needed that employs longitudinal prospective designs to test the independent and interactive 
effects of negative appraisals and fear extinction learning (and recall of fear extinction 
learning) on PTSD symptom development over time. Employing a partial reinforcement 
schedule may test whether these relationships stand under conditions of less predictable 
threat, which may reduce the speed of extinction learning and enhance sensitivity of this 
measure. 
 In conclusion, as far as we are aware this is the first study to examine the interactive 
effects of negative, trauma-related appraisals and impaired fear extinction learning on PTSD 
symptomatology.  We found evidence for an independent effect of both negative appraisals 
and fear extinction learning on PTSD symptoms. This supports the two key proposed 
mechanisms in a prevailing cognitive model of PTSD (Ehlers and Clark, 2000), but we did 
not find an interaction between cognitions and fear extinction learning. This highlights there 
are both cognitive and biological processes involved in PTSD, and both require addressing in 
treatment. In an experimental setting, we show that negative appraisals and fear extinction 
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function independently in PTSD, and treatment may be optimized by targeting both of these 
factors. 
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4.7 Supplementary Material 
 
Table S1. Moderation analysis with PTCI self subscale as the moderator 
Table S2. Moderation analysis with PTCI world subscale as the moderator 
Table S3. Moderation analysis with PTCI self-blame subscale as the moderator 
 
Table S1 
Moderation Analysis with PTCI Self Subscale as the Moderator. 
 b  SE b t p 
Constant 29.46 [26.90, 32.02] 1.29 22.93 < .001 
Negative appraisals (self) 9.80 [7.15, 12.46] 1.33 7.36 < .001 
Early extinction DCR change -2.23 [-4.81, 0.36] 1.30 -1.72 .090 
Negative appraisals × early extinction -2.03 [-4.60, 0.54] 1.29 -1.58 .537 
Note: SE = standard error. Square brackets show 95% confidence intervals of b. 
 
Table S2  
Moderation Analysis with PTCI World Subscale as the Moderator. 
 b  SE b t p 
Constant 29.12 [26.46, 31.79] 1.34 21.78 < .001 
Negative appraisals (world) 6.16 [4.32, 8.01] 0.92 6.67 < .001 
Early extinction DCR change -2.25 [-4.95, 0.45] 1.36 -1.66 .101 
Negative appraisals × early extinction -0.03 [-1.97, 1.92] 0.98 -0.03 .980 
Note: SE = standard error. Square brackets show 95% confidence intervals of b. 
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Table S3 
Moderation Analysis with PTCI Self-blame Subscale as the Moderator. 
 b  SE b t p 
Constant 29.09 [26.09, 32.08] 1.50 19.33 < .001 
Negative appraisals (self-blame) 4.15 [1.81, 6.49] 1.18 3.53 < .001 
Early extinction DCR change -0.91 [-3.93, 2.12] 1.52 -0.60 .552 
Negative appraisals × early extinction -2.09 [-4.93, 0.76] 1.43 -1.46 .148 
Note: SE = standard error. Square brackets show 95% confidence intervals of b. 
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5.1 Abstract 
Background: Posttraumatic stress disorder (PTSD) is associated with hyperactive 
noradrenergic signaling, and learning and memory performance is enhanced with increased 
noradrenaline (NA) activity. Learning to extinguish emotional fear reactions to trauma-
related triggers is the goal of exposure-based therapies, and is likely to involve key 
noradrenergic processes, however the relationship between endogenous NA activity and fear 
extinction learning ability in PTSD is largely unknown.  
Method: Here, a sample of participants with PTSD (n = 21), trauma exposure without PTSD 
(n = 36), and non-trauma-exposed controls (n = 27) completed a standardized differential fear 
conditioning and extinction paradigm, and provided saliva samples for salivary alpha-
amylase (as an index of NA levels). Skin conductance response (SCR) served as the index of 
conditioned responding, and the unconditioned stimulus (US) was a 500ms mild electric 
shock.  
Results: There were no significant between-group differences on baseline or post-acquisition 
NA levels. There was a PTSD-specific impairment in fear extinction learning during the early 
extinction phase where the PTSD group displayed a slower reduction of SC responses 
compared to the TC and NTC groups. A moderation analysis revealed that NA did not 
moderate the relationship between early extinction learning and PTSD symptoms.  
Conclusions: These findings suggest that the relationship between fear extinction learning 
ability and PTSD symptoms does not change as a function of salivary NA levels. As elevated 
NA levels are thought to facilitate both learning and memory processes, future research 
should replicate the current study with a 2-day fear extinction recall paradigm to investigate 
the role of NA in the memory for fear extinction. 
 
  
Chapter 5: Noradrenaline does not moderate fear extinction in PTSD 151 
 
5.2 Introduction 
 Hyperactive noradrenergic signaling is considered a hallmark correlate of 
posttraumatic stress disorder (Zoladz & Diamond, 2013), a chronic psychiatric condition that 
can develop following a severe traumatic event (American Psychiatric Association, 2013). 
Elevated noradrenergic signaling of stress hormones such as noradrenaline (NA) is associated 
with enhanced emotional memory formation (Mueller & Cahill, 2010). The aim of exposure-
based therapies for PTSD is to facilitate the extinction of conditioned fear memories 
associated with triggers for the trauma memory. Behavioral research in healthy controls 
suggest that strategically increasing NA release at key points of a fear conditioning and 
extinction paradigm can strengthen conditioned fear (Antov, Wolk, & Stockhorst, 2013), or 
enhance the consolidation of extinction memories (Antov, Melicherová, & Stockhorst, 2015). 
These findings indicate that NA levels may interact with fear extinction learning performance 
in PTSD, with important implications for exposure-based therapies. 
 During situations of heightened arousal such as trauma and stress, the sympathetic 
nervous system (SNS) signals fast NA release (among other catecholamines and 
neurotransmitters; Southwick et al., 1999). Consistent evidence shows that clinical patients 
and combat veterans with PTSD display elevated baseline NA levels (Geracioti et al., 2001; 
Glover & Poland, 2002; Lemieux & Coe, 1995; Yehuda et al., 1998; Young & Breslau, 
2004). Elevated baseline NA in PTSD is aligned with the hypothesis of the SNS contributing 
to increased situational arousal and re-experiencing symptoms of PTSD (Griffin, Resick, & 
Galovski, 2012; Liberzon, Abelson, Flagel, Raz, & Young, 1999). Furthermore, greater NA 
levels in combat veterans within two months of deployment predicted increased PTSD 
symptom severity three months later (Highland et al., 2015), suggesting that heightened 
noradrenergic signaling strengthened conditioned fear associations. An additional 
longitudinal study, however, found that peripheral NA levels shortly post-trauma were a poor 
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risk factor for PTSD in civilian trauma victims (Videlock et al., 2008), suggesting that other 
factors may be involved in the relationship between hyperactive noradrenergic signaling and 
PTSD symptoms. 
 Enhanced NA activity is implicated in stronger emotional memory formation 
(Mueller & Cahill, 2010), and a prevailing model of PTSD posits that benign stimuli present 
at the time of the trauma act as triggers for conditioned emotional fear memories (e.g., 
Mineka & Oehlberg, 2008; Pitman et al., 2012). Ample evidence demonstrates that 
individuals with PTSD show impaired extinction of these conditioned fear associations 
(Blechert, Michael, Vriends, Margraf, & Wilhelm, 2007; Norrholm et al., 2011; Orr et al., 
2000; Peri, Ben-Shakhar, Orr, & Shalev, 2000; Zuj et al., 2016). Indeed, successful fear 
extinction is the aim of exposure-based therapies for PTSD and other fear-related disorders, 
and therefore greater understanding of the relationship between NA activity and fear 
extinction carries important implications for improving current treatment methods. Recently, 
Soeter and Kindt (2012) administered yohimbine (leading to increased NA release) to healthy 
individuals immediately prior to fear acquisition, resulting in a conditioned memory trace that 
was broadly generalized and resistant to extinction learning. Similarly, a study using a cold 
pressor test in healthy males to induce a noradrenergic stress reaction found that the cold 
pressor test immediately prior to fear acquisition resulted in a conditioned fear memory trace 
that was resistant to extinction (Antov et al., 2013). Alternatively, the cold pressor test used 
immediately before extinction learning resulted in enhanced extinction learning (Antov et al., 
2015). These findings suggest that noradrenergic signaling may shape fear conditioning and 
extinction learning, however this has not been tested in patients with PTSD. 
 The current study used a standardized differential fear conditioning and extinction 
paradigm to investigate the role of endogenous salivary NA activity in fear extinction 
learning and PTSD, compared to trauma-exposed and non-exposed control groups without 
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PTSD. Based on previous research using behavioral tasks to manipulate NA levels in healthy 
participants (e.g., Antov et al., 2015; Antov et al., 2013), we predicted that endogenous NA 
levels would moderate the relationship between fear extinction learning ability and PTSD 
symptoms. Specifically, PTSD is consistently associated with impaired fear extinction 
learning (e.g., Norrholm et al., 2011; Zuj et al., 2016), however this relationship may become 
stronger with lower NA activity. 
 
5.3 Method 
5.3.1 Participants. 
 Eighty-four participants aged 18-63 years (M = 27.6 years, SD = 11.4) and comprising 
37 males and 47 females were involved in the study. Participants were allocated to groups on 
the basis of exposure to a criterion A stressor (American Psychiatric Association, 2013) using 
the Traumatic Events Questionnaire (TEQ; Vrana & Lauterbach, 1994). The PTSD 
Checklist-Civilian version (PCL-C; Weathers, Litz, Huska, & Keane, 1994) was used to 
estimate PTSD symptom severity – participants who displayed at least 1 intrusive symptom, 
3 avoidance symptoms, and 2 hyperarousal symptoms were classified as PTSD (Weathers et 
al., 1994). Participants who displayed relatively low PCL scores were classified as trauma-
exposed controls (TC). Participants who reported no experience of a traumatic event were 
classified as non-trauma exposed controls (NTC). These criteria resulted in three groups: 
PTSD (n = 21), TC (n = 36), and NTC (n = 27). Participants in the PTSD and TC groups 
were exposed to a variety of environmental and interpersonal traumas, including war 
exposure (n = 5), accident (n = 21), natural disaster (n = 27), witness to serious injury or 
death (n = 36), assaulted or molested (n = 22), threatened or held captive (n = 12), and 
tortured or the victim of terrorism (n = 2). Mean years since trauma for the PTSD group was 
10.1 years (SD = 12.8 years), and 10.1 years (SD = 10.9 years) for the TC group. Participants 
Chapter 5: Noradrenaline does not moderate fear extinction in PTSD 154 
 
also completed the Depression Anxiety Stress Scale – 21 item version (DASS; Lovibond & 
Lovibond, 1995). This study was approved by the University of Tasmania Social Science 
Human Research Ethics Committee, and all participants gave full informed consent. 
 
5.3.2 Fear conditioning and extinction paradigm. 
 The present study employed a differential fear conditioning and extinction paradigm 
used previously (Orr et al., 2000; Zuj et al., 2016). Findings from a subset of participants in 
the current study have been reported elsewhere (Zuj et al., 2016). The unconditioned stimulus 
(US) was a 500ms mild electric shock delivered to the first interroseous muscle of the 
dominant hand, and set to a level considered “highly annoying, but not painful” by each 
participant prior to the task (Orr et al., 2000; Zuj et al., 2016). Red and blue circles were used 
as conditioned stimuli (CS), and were presented individuals for 12 seconds on a computer 
screen. The testing protocol included four experimental phases: habituation, acquisition, 
early extinction, and late extinction. During habituation, participants were exposed to four 
trials of each coloured circle (eight trials in total). During acquisition, one of the coloured 
circles (CS+) was followed by the US on all five trials (100% reinforcement schedule) while 
the other coloured circle was not reinforced on any of the five trials (CS-; ten trials in total). 
The early extinction phase consisted of five trials of the CS+ (with no reinforcement) and five 
trials of the CS- (ten trials in total). Following a short rest period of approximately one 
minute (Milad, Orr, Pitman, & Rauch, 2005), participants completed the late extinction 
phase, also with no presentation of the US. Trial order was pseudo-random, with no more 
than two consecutive CS+ or CS- trials. 
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5.3.3 Skin conductance response. 
 Skin conductance level was measured through a 22mVrms, 75Hz constant-voltage 
coupler (FE116, ADInstruments) with bipolar electrodes on the intermediate phalange of the 
first and third fingers of the non-dominant hand, sampled at 512Hz and stored at 64Hz, and 
recorded in micro-Siemens (μS). Skin conductance response (SCR) to the CS+ and CS- was 
calculated by subtracting the mean SCL during the 2s prior to stimulus onset from the 
maximum SCL during the 12s stimulus duration. SCR values were square-root transformed, 
and the absolute value of negative scores was transformed and the negative sign replaced. 
Differential conditioned responding (DCR) was calculated by subtracting the SCR of the first 
CS- from the first CS+, for all trials (Menz et al., 2013). For use in moderation analyses, 
DCR change scores were calculated for the extinction phases by subtracting the trial 5 DCR 
from the trial 1 DCR, with higher values representing a greater change in differential fear 
responding across the experimental phase (i.e., better fear extinction performance). 
 
5.3.4 US-expectancy ratings. 
During the 12s stimulus presentation, participants were asked to rate their threat 
expectancy of the US on a 0-100 visual analogue scale (VAS; 0 “certain no electrical 
stimulus”; 100 “certain electrical stimulus”; as previously used by Lommen, Engelhard, 
Sijbrandij, van den Hout, & Hermans, 2013). 
 
5.3.5 Salivary alpha-amylase. 
 All participants provided saliva samples at the beginning of testing, and immediately 
post-fear acquisition. Endogenous noradrenergic activity was indexed via salivary alpha-
amylase (sAA), which has received support from human and animal research as a valid 
biomarker of noradrenergic activity (Nater & Rohleder, 2009). Samples were collected 
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immediately post-fear acquisition as NA has an immediate peak latency response post-threat 
(Nater & Rohleder, 2009). As sAA is an enzyme found in saliva, participants were requested 
to refrain from exposure to cigarettes, food, or liquids (other than water) for one hour prior to 
the study (Rohleder & Nater, 2009). Samples were analyzed using a commercially available 
ELISA assay (Salimetrics, USA) according to the manufacturers instructions, with intra- and 
inter-assay variability of 5.6% and 6.3%, respectively. Baseline and post-acquisition sAA 
were square-root transformed to normalize distributions. sAA reactivity scores were 
calculated by subtracting baseline sAA levels from the post-acquisition sAA level. 
 
5.3.6 Statistical analyses. 
 Three participants were excluded from all analyses due to not learning the CS-US 
contingency by the end of acquisition. Separate 3 (group) × 2 (CS) × 5 (trial) mixed-model 
ANOVAs were conducted separately for each phase (with four trials for habituation and 
acquisition). The first CS+/- trials were removed from acquisition analyses as the US had not 
been encountered, and no learning had occurred. Greenhouse-Geisser corrections were made 
for within-subjects variables where necessary. Brown-Forsythe F-ratio adjustments were 
made where necessary, and pairwise comparisons were conducted with Bonferroni 
corrections or Games-Howell tests where appropriate. Moderation analyses were conducted 
using the PROCESS macro for SPSS (Model 1; Hayes, 2013). An alpha level of α = .05 was 
used for all tests of statistical significance. Effect sizes are reported as Cohen’s d following 
the criteria of 0.2, 0.5, and 0.8 as small, moderate and large effects, respectively (Cohen, 
1988). Partial-eta squared (ηp2) are reported for mixed-model ANOVAs. 
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5.4 Results 
5.4.1 Descriptive and clinical data. 
 Descriptive statistics and additional inferential data are displayed in Table 1. One-way 
ANOVA revealed no significant between-group difference on age, F(2, 50.76) = 2.93, p = 
.062. As expected, there were significant between group differences in PCL total scores, F(2, 
25.55) = 135.50, p < .001, with the PTSD group having significantly higher mean PTSD 
symptom severity than the TC and NTC groups (ps < .001), who also significantly differed (p 
< .001). 
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Table 1 
Mean Scores and SDs of Demographic, Clinical and Salivary Measures. 
Measures PTSD (n = 21) TC (n = 36) NTC (n = 27) Test statistic p 
Demographic data      
   - Age (years) 32.67 (14.62) 26.97 (9.76) 24.48 (9.67) F(2, 50.76) = 2.93 .062 
   - Sex 13F, 8M 15F, 21M 19F, 8M χ2(2) = 5.56 .062 
PCL-C      
   - Total 52.52 (11.38) 23.47 (3.87) 19.93 (2.56) F(2, 25.55) = 135.50 < .001 
   - Intrusive 3.00 (1.22) 0.28 (0.51) 0.00 (0.00) F(2, 81) = 132.52 < .001 
   - Avoidance 4.24 (1.81) 0.39 (0.69) 0.19 (0.48) F(2, 27.28) = 84.48 < .001 
   - Hyperarousal 3.52 (1.03) 0.44 (0.77) 0.15 (0.46) F(2, 45.66) = 127.70 < .001 
DASS      
   - Depression 9.43 (5.76) 2.28 (2.37) 1.52 (2.15) F(2, 30.88) = 28.47 < .001 
   - Anxiety 8.14 (4.26) 1.94 (1.87) 1.11 (1.67) F(2, 32.19) = 39.33 < .001 
   - Stress 13.62 (6.34) 4.89 (3.07) 2.56 (2.36) F(2, 32.98) = 40.04 < .001 
AUDIT 6.86 (5.46) 6.22 (3.83) 6.11 (4.10) F(2, 55.50) = 0.18 .837 
Note: PTSD = Posttraumatic Stress Disorder; TC = Trauma-exposed control group; NTC = Non-trauma exposed control group; PCL-C = PTSD 
Checklist-Civilian version; DASS = Depression Anxiety Stress Scale; AUDIT = Alcohol Use Disorders Identification Test. 
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5.4.2 Salivary alpha-amylase. 
 A one-way ANOVA revealed no significant between-group differences on baseline 
sAA levels, F(2, 81) = 0.05, p = .955, or post-acquisition levels, F(2, 81) = 1.04, p = .359. A 
repeated measures ANOVA revealed there was a significant increase in sAA from baseline to 
post-acquisition, F(1, 81) = 4.64, p = .034, ηp2 = .054, however there was no group × time 
interaction, F(2, 81) = 2.18, p = .120, ηp2 = .051. Figure 1 displays mean sAA levels during 
baseline and post-acquisition. 
 
 
 
Figure 1. Group and total levels of baseline and post-acquisition salivary Alpha Amylase 
(sAA). On average, all groups showed an increase in sAA levels from baseline to post-
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acquisition, however these levels did not differ significantly between groups. Figure shows 
raw sAA values. Error bars represent 95% CIs. 
 
 
5.4.3 SCR amplitude data. 
 Habituation. Mixed-model ANOVA revealed a significant main effect of trial, 
F(2.89, 233.80) = 3.08, p = .030, ηp2 = .037, ε = .962, with SCRs decreasing over the four 
trials, pooled across groups (see Figure 2A). No further main effects of interactions were 
significant. 
 
 Acquisition. There was a significant CS main effect, F(1, 81) = 84.10, p < .001, d = 
0.88, with the CS+ eliciting, on average, a significantly larger SCR (M = 0.86, 95% CI[0.73, 
0.91], SD = 0.58) than the CS- (M = 0.39 [0.29, 0.50], SD = 0.49). Further, there was a 
significant main effect of trial, F(2.85, 230.74) = 4.58, p = .005, ηp2 = .054, ε = .950. 
Importantly, there was a significant group × CS interaction, F(2, 81) = 3.37, p = .039, ηp2 = 
.077. Tests of simple effects revealed no between-group simple main effect for the CS+, F(2, 
81) = 0.15, p = .863, ηp2 = .004, however there was a marginally significant between-group 
effect in responding to the CS-, F(2, 81) = 3.08, p = .051, ηp2 = .071. This effect shows that 
there were no significant differences between the PTSD and TC groups in responses to the 
CS- (p = .734), however both the PTSD and TC group displayed significantly greater 
responding to the CS- than the NTC group (p = .032, and p = .037, respectively). 
 
 Early extinction. There was a significant CS main effect, F(1, 81) = 8.38, p = .005, d 
= 0.27, with the CS+ eliciting, on average, a significantly larger SCR (M = 0.60 [0.51, 0.69], 
SD = 0.41) than the CS- (M = 0.49 [0.40, 0.58], SD = 0.42). Further, there was a significant 
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main effect of trial, F(3.63, 293.71) = 31.98, p < .001, ηp2 = .283, ε = .907, and a significant 
group × trial interaction, F(7.25, 293.71) = 2.19, p = .033, ηp2 = .051, ε = .907. Tests of 
simple effects show the TC and NTC groups demonstrate significant reduction in SCRs from 
trial 1 to trial 2 (p < .001, and p = .003, respectively) and all further between-trial changes 
were non-significant. The PTSD group, however, showed a significant reduction in SCRs 
from trial 1 to trial 2 (p = .021) and from trial 2 to trial 3 (p = .002), with no significant 
between-trial changes after trial 3. These findings suggest that extinction learning is slower 
for the PTSD group, compared to TC and NTC groups (see Figure 3). 
 
 Late extinction. ANOVA revealed a significant main effect of CS, F(1, 81) = 4.77, p 
= .032, d = 0.19, with the CS+ still eliciting greater SCRs (M = 0.51 [0.40, 0.61], SD = 0.48) 
than the CS- (M = 0.42 [0.34, 0.51], SD = 0.40). Further, there was a significant main effect 
of trial, F(3.34, 270.51) = 17.21, p < .001, ηp2 = .175, ε = .835, with SCRs reducing across the 
phase, pooled across group and CS (see Figure 2D). No main effects or interactions involving 
group were significant during the late extinction phase. 
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Figure 2. CS × Trial interaction for each experimental phase. Panel (A) shows square-root 
transformed SC responses during the habituation phase. Panel (B) shows that despite a 
gradual decline in SC responding, CS+/- stimulus discrimination increases across the phase. 
The first CS+/- trials were removed from analyses of the acquisition phase, as the US had not 
been encountered, and no learning had occurred. Panels (C) and (D) show that SCRs to the 
CS+ and CS- decreased across the early and late extinction phases, respectively. 
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Figure 3. Group × Trial interaction during early extinction. This interaction shows that the 
PTSD group displayed a slower rate of extinction and safety signal learning across the first 3 
to four trials, compared to the TC and NTC groups, who showed a rapid reduction in 
responding from trial 1 to trial 2. Error bars represent 95% confidence intervals of the mean. 
Vertical axis displays square-root transformed SCR values (μS1/2). 
 
 
5.4.4 Threat expectancy. 
 Habituation. No significant main effects or interactions were revealed during the 
habituation phase.  
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Acquisition. Mixed-model ANOVA revealed a significant CS × trial interaction 
during the acquisition phase F(3.40, 254.88) = 103.38, p < .001, ηp2 = .580, ε = .850, with 
differential responding increasing across trials, pooled across groups.  
 
Early extinction. During early extinction, there was also a significant CS × trial 
interaction, F(3.46, 262.58) = 10.29, p < .001, ηp2 = .119, ε = .864, with differential 
responding decreasing over early extinction.  
 
Late extinction. During late extinction there was still a significant CS × trial 
interaction as differential responding continued to decrease, F(3.63, 275.49) = 3.84, p = .006, 
ηp2 = .048, ε = .906. Furthermore, ANOVA revealed a significant group main effect during 
late extinction, with the PTSD group reporting higher average US-expectancy ratings than the 
TC and NTC groups, pooled across CS and trials, F(2, 76) = 4.76, p = .011, ηp2 = .111. 
 
5.4.5 Fear extinction and sAA moderation. 
 To investigate interactions between fear extinction and sAA in PTSD, we conducted a 
moderation analysis (Model 1; Hayes, 2013) with the PCL total score as the outcome variable 
and an early extinction DCR change score served as the predictor variable. sAA levels 
collected immediately post-acquisition were included in the model as the moderator variable 
(see Table 2, Model 1). To control for baseline sAA levels, the analysis was repeated with a 
sAA reactivity score as the moderator (see Table 2, Model 2). As shown in Table 2, the total 
model did not predict a significant amount of variance in PCL total, R = 0.12, R2 = .015, F(3, 
80) = 0.42, p = .741, with no significant main effects of early extinction DCR change or post-
acquisition sAA, and no significant moderation interaction. Further, no significant model was 
found using sAA reactivity as a moderator, R = 0.12, R2 = .016, F(3, 80) = 0.42, p = .739. 
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Table 2 
Linear Model of Predictors of PCL Total. 
 b  SE b t p 
Model 1     
   - Constant 29.50 [26.24, 32.77] 1.64 17.98 < .001 
   - Post-acquisition sAA -0.32 [-1.23, 0.59] 0.46 -0.70 .485 
   - Early extinction DCR change -1.01 [-4.20, 2.17] 1.60 -0.63 .528 
   - sAA × early extinction 0.24 [-0.62, 1.10] 0.43 0.55 .586 
Model 2     
   - Constant 29.60 [26.35, 32.86] 1.63 18.12 < .001 
   - sAA reactivity -0.47 [-1.69, 0.75] 0.61 -0.77 .445 
   - Early extinction DCR change -1.10 [-4.27, 2.08] 1.60 -0.69 .494 
   - sAA reactivity × early extinction -0.10 [-1.23, 1.03] 0.57 -0.18 .857 
Note: SE = Standard Error; Square brackets show 95% confidence intervals of b. 
 
 
5.5 Discussion 
 The aim of the current study was to investigate the relationship between endogenous 
NA activity and fear extinction learning in PTSD, compared to trauma-exposed and non-
exposed control groups. First, we found there were no significant between-group differences 
in baseline salivary NA levels. While there was a significant increase in NA following the 
acquisition phase and US presentation, this difference did not change as a factor of group. 
Second, the PTSD group showed significantly slower fear extinction learning during the early 
extinction phase, compared to the TC and NTC groups. Third, moderation analyses revealed 
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that NA levels did not moderate the relationship between fear extinction learning and PTSD 
symptoms. 
 Increased noradrenergic signaling is known to enhance emotional learning and 
memory processes (Mueller & Cahill, 2010). Previous research has used behavioral (e.g., 
Antov et al., 2015; Antov et al., 2013) and pharmacological tasks (e.g., Soeter & Kindt, 2012) 
designed to activate the stress response and subsequent catecholamine release. The current 
study, however, measured endogenous NA levels (indexed by sAA) prior to, and immediately 
following fear acquisition. While the US (in this case, a mild electric shock) appeared to 
increase NA release, these levels showed no interaction with group or fear extinction learning 
ability. One possible explanation for this effect is that more sensitive 
behavioral/pharmacological manipulations may be necessary to increase NA to sufficient 
levels for measurable effects on fear extinction learning performance. That is, previous 
research showing relationships between NA and fear conditioning and extinction have either 
used a specific stress induction task (e.g., cold pressor test; Antov et al., 2015) or 
pharmacological challenge (e.g., yohimbine and propranolol; Soeter & Kindt, 2012), leading 
to marked increases or decreases in NA and the sensitivity to observe effects on extinction 
learning. 
 The findings of the present study show specific PTSD-related impairments in early 
extinction learning. Specifically, extinction learning appeared to be slower in the PTSD 
group, compared to TC and NTC groups. These findings support a wealth of evidence of 
extinction learning deficits in PTSD (Blechert et al., 2007; Norrholm et al., 2011; Orr et al., 
2000; Peri et al., 2000; Zuj et al., 2016). Furthermore, we also found a significant group × CS 
interaction during fear acquisition, showing that the PTSD and TC groups demonstrated 
elevated fear responding to the CS- compared to the NTC group. This finding indicates that 
elevated fear expression to a safety signal may be a consequence of trauma exposure, rather 
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than a PTSD-specific trait. Alternatively, this effect may be the result of enhanced fear 
generalization as a result of trauma exposure. Previous evidence has suggested that impaired 
safety signal learning is specific to PTSD (Jovanovic, Kazama, Bachevalier, & Davis, 2012), 
however the findings of the current study indicate that further research is needed to separate 
the effects of trauma exposure versus PTSD symptom development. 
 A limitation of the current study is that we did not include a second day fear 
extinction recall test, and therefore cannot test the effect that NA release immediately prior to 
extinction learning had on memory consolidation processes. Previous research used a cold 
pressor test prior to fear extinction learning to activate the stress response and increase NA 
release, resulting in a stronger extinction memory trace that was recalled the next day (Antov 
et al., 2015). Further, evidence has identified a relationship between NA activity and 
emotional memory consolidation (Nicholson, Bryant, & Felmingham, 2014; Segal & Cahill, 
2009). These findings suggest that noradrenergic signaling may be integral in the 
consolidation of emotionally salient memories (such as conditioned fear memories), rather 
than the acquisition of fear memories. Future research would benefit from examining the 
impact of endogenous NA activity in a follow-up extinction recall task (for example, see 
Shvil et al., 2014). A further limitation is that sAA is an indicator of sympathetic arousal 
(Bali & Jaggi, 2015; Nater & Rohleder, 2009), and not a direct measure of central NA levels. 
Although sAA response to physical and psychological stressors corresponds with 
sympathetic nervous system response patterns (Nater & Rohleder, 2009), a more direct 
measure of NA activity would strengthen future research in this area. An additional limitation 
of the current study is the use of participants with subclinical PTSD symptoms. Future 
research would benefit from a sample consisting exclusively of clinically severe PTSD 
symptoms for greater sensitivity to find PTSD-specific effects. 
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  In conclusion, the current study found that PTSD is associated with increased fear 
load, as indicated by significantly slower extinction learning ability during the early trials of 
fear extinction. Further, while there was an overall increase in NA levels post-fear 
acquisition, reactive NA levels did not differ as a function of group, and did not interact with 
fear extinction learning ability. Previous research suggest that behavioral or pharmacological 
tasks are required for stress-induced NA release that has a significant impact on fear 
extinction learning, however we cannot conclude on the memory effects of NA release during 
a standardized differential fear conditioning and extinction paradigm, and we recommend 
replication of the current methodology with a 2-day fear extinction learning and recall 
paradigm. 
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6.1 Abstract 
Background: Posttraumatic stress symptoms (PTSS) are commonly associated with 
impairments in extinguishing fear to signals previously associated with danger, and also with 
inhibiting fear to safety signals. Previous studies indicate that PTSS are associated with low 
cortisol activity, and cortisol is shown to facilitate fear extinction. Few studies have examined 
the influence of cortisol reactivity on fear extinction in PTSS.   
Method: We used a standardized fear conditioning and extinction paradigm to investigate the 
relationship between fear extinction and endogenous salivary cortisol activity in participants 
with high PTSS (n = 18), trauma-exposed controls (n = 33), and non-trauma-exposed controls 
(n = 27). Skin conductance response (SCR) was used as an index of conditioned responding. 
Saliva samples were collected at baseline, and 20 minutes post-fear acquisition for basal and 
reactive cortisol levels, respectively.  
Results: PTSS participants demonstrated a slower rate of extinction learning during the early 
extinction phase. A moderation analysis revealed that cortisol reactivity was a significant 
moderator between fear inhibition to the safety signal (CS-) during early extinction and 
PTSS, but not to the threat signal (CS+). Specifically, this interaction was significant in two 
ways: (1) participants with elevated cortisol reactivity showed lower PTSS as fear inhibition 
improved; and (2) participants with low cortisol reactivity showed higher PTSS as fear 
inhibition improved.  
Conclusion: The findings of the present study show that the relationship between fear 
inhibition and cortisol reactivity is complex, and suggest that cortisol reactivity shapes safety 
signal learning in PTSS. 
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6.2 Introduction 
 Posttraumatic stress disorder (PTSD) develops following a traumatic event that 
threatens physical integrity (American Psychiatric Association, 2013). Symptoms of PTSD 
include distressing intrusive memories, avoidance of trauma reminders, negative cognitions 
and mood, and hyperarousal. A prevailing model posits that persistent PTSD symptoms 
develop, in part, because of an impaired ability to extinguish a conditioned fear trace (e.g., 
Mineka & Oehlberg, 2008; Pitman et al., 2012). Stimuli present during the trauma become 
associated with fear and heightened arousal responses experienced during the event. After the 
event, benign stimuli act as triggers (conditioned stimuli; CS) for the fear response. PTSD-
related impairments in fear extinction learning are well established (Blechert, Michael, 
Vriends, Margraf, & Wilhelm, 2007; Norrholm et al., 2011; Orr et al., 2000; Peri, Ben-
Shakhar, Orr, & Shalev, 2000; Zuj, Palmer, Hsu, et al., 2016), and impaired fear extinction 
has been proposed as a central construct that links pre-trauma biological and cognitive 
vulnerability factors to PTSD (Zuj, Palmer, Lommen, & Felmingham, 2016). This is 
supported by evidence that impaired extinction learning prior to trauma exposure predicts 
subsequent PTSD following trauma (Guthrie & Bryant, 2006; Lommen, Engelhard, 
Sijbrandij, van den Hout, & Hermans, 2013; Orr et al., 2012). Further, exposure-based 
therapies for PTSD act on the principle of extinguishing conditioned fear to trauma-related 
memory triggers (Milad, Rauch, Pitman, & Quirk, 2006). 
 Dysregulations in cortisol activity are commonly observed in patients with PTSD 
(Yehuda, 1997, 2009). The hypothalamic-pituitary-adrenal (HPA) axis is the premier 
neuroendocrine center involved in the neurochemical release of hormones and neuropeptides 
to combat stress. The end product of this neurochemical release, cortisol, binds to 
glucocorticoid receptors (GRs) in a negative feedback loop to inhibit the sympathetic nervous 
system and ongoing arousal (Yehuda, 1997), thus returning these neural systems to 
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homeostasis. Alterations in the negative feedback system of the HPA axis have long been 
hypothesized in PTSD (e.g., Yehuda, Giller, Southwick, Lowy, & Mason, 1991; Yehuda et 
al., 1993). After controlling for methodological differences (e.g., time-of-day, measurement 
type), a recent meta-analysis found that PTSD (and PTSD comorbid with major depressive 
disorder) was associated with lower daily cortisol output relative to non-trauma-exposed 
controls, and enhanced HPA feedback appears to be associated with general trauma exposure 
(Morris, Compas, & Garber, 2012). The authors conclude that lower daily cortisol output 
may be a risk factor for the development of PTSD, rather than an effect of trauma exposure. 
Nevertheless, an earlier meta-analysis by Miller, Chen, and Zhou (2007) noted that the 
relationship between cortisol activity and PTSD is complex, and further research in this area 
is required. 
 The effect of cortisol release (via pharmacological augmentation or acute stress tasks) 
on fear extinction learning has received little attention. Studies that have been conducted vary 
in their methodological design, for example the timing of cortisol administration (or stress 
induction) during conditioning and extinction paradigms (Merz, Hermann, Stark, & Wolf, 
2014). A recent study in healthy participants found that a stress-induction task impaired the 
retrieval of fear extinction memories, despite no deficit in fear acquisition or extinction 24 
hours earlier (Raio, Brignoni-Perez, Goldman, & Phelps, 2014). Studies in rodents have 
found that glucocorticoid receptor agonists enhance the uptake of cortisol and facilitate fear 
extinction learning (Yang, Chao, & Lu, 2006). These effects are partly due to actions on 
glutamate N-methyl-D-aspartate (NMDA) receptors in the amygdala (Yang, Chao, Ro, Wo, & 
Lu, 2007), and many studies have shown glucocorticoid administration facilitates extinction 
(Barrett & Gonzalez-Lima, 2004; Cai, Blundell, Han, Greene, & Powell, 2006; de Quervain, 
Aerni, Schelling, & Roozendaal, 2009). 
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 Successful fear extinction is the underlying construct and goal of exposure therapy 
(Graham & Milad, 2011; Rothbaum & Davis, 2003), and convergent evidence in clinical 
settings suggest that glucocorticoid administration improves response to exposure treatment 
for fear-related disorders. For example, clinical patients suffering from spider phobia who 
were administered hydrocortisone demonstrated significantly reduced fear after undergoing 
exposure therapy compared with placebo-controls (Soravia et al., 2006; Soravia et al., 2014). 
Further, Yehuda et al. (2015) have shown that exposure therapy induces current, situational 
fear during treatment, which in turn increases patient drop out rates and that this can be 
countered with hydrocortisone administration in conjunction with prolonged exposure 
therapy. This reduces situational fear expression during the treatment session and thereby 
reduces drop out rates and enhances treatment benefit (Yehuda et al., 2015). In support, a 
recent study in patients with panic disorder and agoraphobia demonstrated that elevated 
endogenous cortisol significantly moderates greater symptom improvement to exposure 
therapy (Meuret et al., 2015). Together, these findings implicate that elevated cortisol levels 
facilitate the experimental and therapeutic extinction of fear.   
Few studies have examined the influence of cortisol reactivity on fear extinction 
learning in the context of PTSD. Therefore, the current study used a discrimination fear 
conditioning and extinction paradigm to investigate the relationship between fear extinction 
and endogenous salivary cortisol reactivity in a sample with posttraumatic stress disorder 
symptoms (PTSS) and compared this to trauma-exposed, and non-exposed control groups 
without PTSS. Based on previous evidence, we considered two ways in which this 
relationship could manifest. First, greater cortisol reactivity may simply be associated with 
better fear extinction performance and lower PTSS. The second possibility is that cortisol 
reactivity may moderate the relationship between fear extinction learning and PTSS. That is, 
PTSS may be associated with significantly poorer fear extinction learning (e.g., Blechert et 
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al., 2007; Norrholm et al., 2011), but this relationship may be stronger for participants with 
lower cortisol reactivity.  
 
6.3 Method 
6.3.1 Participants. 
 Seventy-eight participants aged 18-63 years (M = 28.1 years, SD = 11.8 years; 35 
males and 43 females) comprised three groups: PTSS (n = 18), trauma-exposed controls (TC; 
n = 33), and non-trauma-exposed controls (NTC; n = 27). Participants were classified on the 
basis of exposure to a criterion A stressor that threatened physical integrity (American 
Psychiatric Association, 2013) using the Traumatic Events Questionnaire (TEQ; Vrana & 
Lauterbach, 1994). Participants were exposed to a variety of environmental and interpersonal 
traumas: war exposure (n = 4), life-threatening accident (n = 19), natural disaster (n = 24), 
witness to serious injury or death (n = 33), assaulted or molested (n = 22), threatened or held 
captive (n = 12), and tortured or terrorist victim (n = 1). Mean years since trauma for the 
PTSS group was 10.5 years (SD = 13.7 years), and 9.8 years (SD = 11.1 years) for the TC 
group. The PTSD Checklist-Civilian version (PCL-C; Weathers, Litz, Huska, & Keane, 
1994) was used to estimate PTSS severity – participants who presented with at least 1 
intrusive memory symptom, 3 avoidance symptoms, and 2 hyperarousal symptoms (defined 
as a score ≥ 3 on respective PCL-C items; National Center for Posttraumatic Stress Disorder, 
n.d.) were classified as showing clinical PTSS according to diagnostic criteria of the DSM-
IV. Following these criteria, all PTSS participants had a PCL-C total greater than 40, and 
61% (n = 11) of the PTSS group showed a PCL-C total greater than 50. The PCL-C for 
DSM-IV was used as testing began prior to the release of diagnostic instruments for the 
DSM-5. Participants were regarded as TC if they reported experience of a criterion A 
stressor, but did not reach the minimum possible cutoff of 30 for PTSD in general population 
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samples (National Center for Posttraumatic Stress Disorder, n.d.). All participants in the TC 
group showed a PCL-C total score ≤ 29. Participants who reported no lifetime experience of 
a criterion A stressor were classified as NTC. Participants also completed the Depression 
Anxiety Stress Scale-21 item version (DASS; Lovibond & Lovibond, 1995). The Tasmanian 
Health and Medical Research Ethics Committee and the University of Tasmania Social 
Science Human Research Ethics Committee approved this study, and all participants gave 
full informed consent. 
 
6.3.2 Fear conditioning and extinction paradigm. 
 The present study employed a differential fear conditioning and extinction paradigm 
used previously (Orr et al., 2000; Zuj, Palmer, Hsu, et al., 2016). Findings from a subset of 
the participants in the current study have been published elsewhere, which examined the 
impact of time-since-waking on fear extinction learning (Zuj, Palmer, Hsu, et al., 2016). The 
unconditioned stimulus (US) was a 500ms mild electric shock delivered to the first 
interosseous muscle of the dominant hand, and set to a level considered “highly annoying, 
but not painful” by each participant prior to the task (Orr et al., 2000; Zuj, Palmer, Hsu, et al., 
2016). Conditioned stimuli (CS) were red and blue circles presented individually for 12s on a 
computer screen. The testing protocol included four experimental phases: habituation, 
acquisition, early extinction, and late extinction. During habituation, participants were 
exposed to four trials of each colored circle (eight trials in total). After a short pause, 
participants were prompted to begin the acquisition phase when ready. During this phase, one 
of the colored circles (CS+) was followed by the US on all five trials (100% reinforcement 
schedule) while the other colored circle was not reinforced on any of the five trials (CS-; ten 
trials in total). There was a short interval of approximately 2-3 minutes post-acquisition, 
before participants completed the early and late extinction phases. The early extinction phase 
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consisted of five trials of the CS+ (with no reinforcement) and five trials of the CS- (ten trials 
in total), followed by the late extinction phase, which mirrored early extinction. There was an 
approximately 1 minute rest period between early and late extinction (Milad, Orr, Pitman, & 
Rauch, 2005). Trial order was pseudo-random, with no more than two consecutive CS+ or 
CS- trials, and a variable inter-trial interval was used, ranging from 12-21 seconds (M = 16 
seconds). All phases were completed in a single testing session. To ensure contingency 
awareness, participants were asked at the end of testing which colored circle was associated 
with the US. All participants reported accurate contingency awareness. 
 
6.3.3 Skin conductance. 
 Skin conductance level (SCL) was measured through a 22mVrms, 75Hz constant-
voltage coupler (FE116, ADInstruments) with bipolar electrodes on the intermediate 
phalange of the first and third fingers of the non-dominant hand, sampled at 512Hz and 
stored at 64Hz, and recorded in micro-siemens (μS). Skin conductance response (SCR) to the 
CS+ and CS- was calculated by subtracting the mean SCL during the 2s prior to stimulus 
onset from the maximum SCL during the 12s stimulus duration. SCR values were square-root 
transformed to normalize distributions (for negative SCR values, the absolute value was 
square-root transformed and the negative sign replaced).  
 
6.3.4 US-expectancy ratings. 
 During each 12s stimulus presentation, participants were asked to rate their 
expectancy of the US on a 0-100 visual analogue scale (0 "certain no electrical stimulus"; 100 
"certain electrical stimulus"; as used previously by Lommen et al., 2013). 
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6.3.5 Salivary cortisol. 
 Saliva for cortisol was collected twice during testing. The first sample was collected 
upon arrival to the lab, and the second sample was collected approximately 20 minutes after 
the fear acquisition phase. Samples were immediately transferred to a freezer. Prior to assay, 
the saliva was thawed and centrifuged, and cortisol was measured using a commercially 
available ELISA assay (Salimetrics, USA) according to the manufacturers instructions. 
Salivary cortisol showed an assay sensitivity of 0.003 μg/dL. Intra-assay variability was 
4.1%, and inter-assay variability was 4.6%. Cortisol data were square-root transformed to 
normalize distributions. A cortisol reactivity score was calculated by subtracting baseline 
levels from post-acquisition levels. To control for circadian variation in cortisol, testing was 
conducted between 12-6PM. Time-of-testing and hours-since-waking did not differ 
significantly between groups (p = .114, and p = .610, respectively). 
 
6.3.6 Statistical analyses. 
 Separate 3 (group) × 2 (CS) × 5 (trial) mixed-model analyses of variance (ANOVA) 
were conducted for each phase (with four trials for habituation and acquisition) to examine 
fear conditioning and extinction across groups. The first CS+/- trials during the acquisition 
phase were removed from analyses as the US had not been encountered at this stage, and no 
fear learning would have occurred (Zuj, Palmer, Hsu, et al., 2016) Analyses were identical 
for both the SCR and US-expectancy data. Greenhouse-Geisser corrections were made for 
within-subjects variables where necessary. Brown-Forsythe F-ratio adjustments were made 
where necessary, and pairwise comparisons were conducted with Bonferroni corrections or 
Games-Howell tests where appropriate. Moderation analyses were conducted using the 
PROCESS macro for SPSS (Model 1; Hayes, 2013). An alpha level of α = .05 was used for 
all tests of statistical significance. Effect sizes are reported as Cohen’s d following the criteria 
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of 0.2, 0.5, and 0.8 as small, moderate, and large effects, respectively (Cohen, 1988). Partial-
eta squared (ηp2) are reported as effect sizes for mixed-model ANOVAs. 
 
6.4 Results 
6.4.1 Descriptive and clinical data. 
 Descriptive statistics, and additional inferential data are displayed in Table 1. One-
way ANOVA revealed a significant between-group difference on age, F(2, 42.51) = 4.15, p = 
.023. While there was no significant age difference between the PTSS and TC groups (p = 
.16), and between the TC and NTC groups (p = .47), the PTSS group was, on average, 
significantly older than NTC participants (p = .037). As expected, there were significant 
between-group differences in PCL total scores, F(2, 21.17) = 122.98, p < .001. The PTSS 
group showed a significantly higher mean PCL total than the TC and NTC groups (ps < 
.001), who also significantly differed (p < .001). One-way ANOVA revealed significant 
between-group differences on the depression, anxiety and stress subscales of the DASS (see 
Table 1 for descriptive and inferential statistics). Games-Howell post-hoc tests revealed that 
the PTSS group displayed significantly higher levels of depression, anxiety and stress than 
the TC and NTC groups (all ps < .001). The TC group also had significantly higher levels of 
stress than the NTC group (p = .003), with no significant differences on depression or anxiety 
between these two groups. 
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Table 1  
Mean Scores and SDs for Demographic and Clinical Variables. 
Measures PTSD (n = 18) TC (n = 33) NTC (n = 27) Test statistic P-value 
Demographic data      
   - Age (years) 34.9 (15.0) 27.5 (10.1) 24.4 (9.7) F(2, 42.51) = 4.15 .023 
   - Sex 11F, 7M 14F, 19M 18F, 9M χ2(2) = 3.87 .145 
PCL-C      
   - Total 54.33 (11.81) 23.45 (3.85) 19.96 (2.52) F(2, 21.17) = 122.98 < .001 
   - Intrusive 3.38 (1.26) 0.19 (0.40) 0.00 (0.00) F(2, 58) = 132.30 < .001 
   - Avoidance 4.15 (1.82) 0.39 (0.67) 0.29 (0.59) F(2, 16.55) = 48.12 < .001 
   - Hyperarousal 3.77 (1.17) 0.48 (0.81) 0.18 (0.53) F(2, 25.09) = 74.56 < .001 
DASS      
   - Depression 9.78 (6.16) 2.27 (2.35) 1.63 (2.15) F(2, 24.67) = 23.94 < .001 
   - Anxiety 8.28 (4.10) 1.88 (1.85) 1.19 (1.66) F(2, 27.72) = 37.75 < .001 
   - Stress 13.11 (5.62) 5.00 (3.08) 2.59 (2.37) F(2, 30.92) = 37.51 < .001 
AUDIT 7.06 (5.61) 6.27 (3.80) 6.22 (4.32) F(2, 45.78) = 0.21 .813 
Note: PCL-C, PTSD Checklist; DASS, Depression Anxiety Stress Scale; AUDIT, Alcohol Use Disorders Identification Test. 
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6.4.2 Salivary cortisol. 
 Three (group) × 2 (time) repeated measures ANOVA revealed no significant change 
in cortisol levels from baseline to post-acquisition, F(1, 73) = 0.06, p = .81. Further, there 
was no significant group × time interaction, F(2, 73) = 0.10, p = .91. Raw baseline and post-
acquisition cortisol levels are displayed in Figure 1. 
 
 
 
Figure 1. Group and total levels of baseline and post-acquisition cortisol. On average, groups 
did not significantly differ, and there were no significant changes from baseline to post-
acquisition. Figure shows raw salivary cortisol values. Error bars represent 95% confidence 
intervals. 
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6.4.3 SCR amplitude data. 
 Habituation. Mixed-model ANOVA showed a trend-level main effect of trial during 
the habituation phase, F(2.85, 213.85) = 2.52, p = .06, ηp2 = .032, with SCR levels reducing 
across all trials. All further main effects and interactions were nonsignificant (ps > .05). 
 
Acquisition. Mixed-model ANOVA showed a significant main effect of CS, F(1, 75) 
= 67.01, p < .001, d = 0.83, with significantly greater responding to the CS+ (M = 0.84, 95% 
CI[0.70, 0.97], SD =0.60) compared to the CS- (M = 0.38 [0.27, 0.50], SD = 0.49) suggesting 
the acquisition of a conditioned fear response. There was also a significant main effect of 
trial, with SCRs declining across the acquisition phase, F(2.85, 213.55) = 3.55, p = .017, ηp2 
= .045. There were no further significant interactions, and no significant F-tests involving 
group. 
 
  Early extinction. During early extinction there was a significant main effect of CS, 
F(1, 75) = 6.47, p = .013, d = 0.24, indicating that participants continued displaying 
significantly greater SCRs in early extinction to the CS+ (M = 0.59 [0.50, 0.69], SD = 0.42) 
compared to the CS- (M = 0.49 [0.39, 0.59], SD = 0.43). Figure 2 shows that, on average, 
there was a reduction in SCR to the CS+/- from trial 1 to trial 5, as reflected in a significant 
main effect of trial, F(3.58, 268.14) = 27.76, p < .001, ηp2 = .270. Further, there was a 
significant group × trial interaction, F(7.15, 268.14) = 2.63, p = .012, ηp2 = .065. Tests of 
simple main effects revealed that the TC and NTC groups showed a significant reduction in 
SCRs from trial 1 to trial 2 (ps < .001), with no significant change in responding thereafter. 
The PTSS group, however, displayed a trend-level reduction in SCRs from trial 1 to trial 2 (p 
= .051), and a significant reduction from trial 2 to trial 3 (p = .006), suggestive of a slower 
rate of extinction learning that continued to decline from trial 2 to trial 3. 
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 Late extinction. Mixed-model ANOVA revealed that the CS main effect was no 
longer significant, F(1, 75) = 2.79, p = .10, d = 0.15. A significant main effect of trial 
remained, F(3.26, 244.66) = 13.93, p < .001, ηp2 = .157, where responding to both the CS+ 
and CS- declined across the five trials (see Figure 2). No further main effects or interactions 
were significant. 
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Figure 2. Panel (A) displays SCRs to the CS+ and CS- during the fear conditioning and 
extinction paradigm for the PTSS group. Panel (B) displays SCRs for the TC group, and 
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panel (C) displays SCRs for the NTC group. The first CS+/- trial of acquisition was omitted 
from all statistical analyses as the US had not yet been encountered, and no fear learning had 
occurred. The first trial of acquisition has been included in the figure for general information 
on the fear learning processes between PTSD, TC, and NTC groups. The NTC group 
displayed greater SCR to the CS+ compared to the CS- on trial 1 of acquisition, which was 
not anticipated. There was a significant group × trial interaction during the early extinction 
phase, with participants in the PTSD group showing a trend-level reduction from trial 1 to 
trial 2, and a significant reduction from trial 2 to trial 3, compared to the TC and NTC groups, 
who showed a significant reduction of SCRs from trial 1 to trial 2. Error bars display 95% 
confidence intervals of the mean. μS1/2, SCR square-root transformed in micro-siemens. ** p 
< .01. 
 
 
6.4.4 Threat expectancy ratings. 
Habituation. A 3 × 2 × 4 mixed-model ANOVA revealed a significant main effect of 
trial during habituation, F(2, 139.14) = 5.38, p = .006, ηp2 = .071, with US-expectancy ratings 
gradually declining as participants habituated to the task.  
 
Acquisition. During acquisition, there were significant main effects of CS, F(1, 69) = 
235.42, p < .001, d = 3.04, and trial, F(3.50, 241.23) = 3.29, p = .016, ηp2 = .046, ε = .874. 
The successful acquisition of fear was evidenced by a significant CS × trial interaction, 
F(3.50, 241.66) = 82.67, p < .001, ηp2 = .545, with differential responding to the CS+/- 
increasing throughout acquisition. That is, threat expectancy to the CS+ increased while 
responding to the CS- decreased, as shown in Figure 3. 
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Early extinction. During early extinction, ANOVA revealed significant main effects 
of CS, F(1, 70) = 46.96, p < .001, d = 0.97, and trial, F(2.53, 176.87) = 65.27, p < .001, ηp2 = 
.483, ε = .632. These main effects were superseded by a significant CS × trial interaction, 
F(3.39, 236.96) = 7.16, p < .001, ηp2 = .093, ε = .846, with differential responding reducing 
across the early extinction phase (see Figure 3). 
 
Late extinction. Similar to early extinction, the late extinction phase showed a 
significant main effect of CS, F(1, 70) = 18.10, p < .001, d = 0.47. There was a significant  
trial main effect, F(2.18, 152.72) = 39.40, p < .001, ηp2 = .360, ε = .545. ANOVA also 
revealed a significant CS × trial interaction, F(3.43, 239.95) = 3.95, p = .006, ηp2 = .053, 
showing that the differential threat expectancy declined from trial 1 to trial 5 during the late 
extinction phase. Further, during late extinction there was a significant group main effect, 
F(2, 70) = 8.98, p < .001, ηp2 = .204, with the PTSS group displaying higher mean US-
expectancy (M = 47.24 [37.40, 57.07], SD = 20.33) than TC and NTC groups (M = 23.07 
[15.78, 30.35], SD = 20.33, and M = 23.80 [15.69, 31.91], SD = 20.33, respectively). 
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Figure 3. Threat expectancy ratings for the CS+ and CS- across the differential conditioning 
and extinction paradigm are displayed separately for the PTSS group (A), TC group (B), and 
NTC group (C). The acquisition panels show clear understanding of the CS+/US 
contingency, with scores greater than 50 representing increased threat expectancy, and scores 
lower than 50 representing reduced threat expectancy. The early and late extinction panels 
show that threat expectancy of the US attenuated for all three groups. Error bars display 95% 
confidence intervals of the mean. 
 
 
6.4.5 Moderation analyses. 
 As a significant group × trial interaction effect on SCR was only found during early 
extinction, and the three groups were all displaying similar levels of extinction learning by 
trial 3, the difference between trial 1 and trial 2 was calculated separately for the CS+ and the 
CS-, and entered into separate moderation analyses as the predictor variables (see Table 2, 
Models 1 and 2, respectively). Cortisol reactivity was entered as the moderator, with PCL 
total as the outcome variable, and age and depression were included as covariates. Using the 
predictor derived from the CS+ change score, there was a significant total model, R2 = .660, 
F(5, 70) = 27.18, p < .001. However, as seen in Table 2, model 1, there was no significant 
effect of cortisol reactivity or CS+ change, and there was no significant moderation 
interaction between these variables. The main effects and moderation interaction remained 
nonsignificant after including age and depression as covariates. 
 
 
 
Chapter 6: Cortisol reactivity moderates fear inhibition to safety signals in PTSD  191 
 
 
Table 2 
Linear Model of Predictors of PCL Total. 
 b SE b t p 
Model 1     
   - Constant 11.63 [6.02, 17.25] 2.82 4.13 < .001 
   - Cortisol reactivity 3.99 [-20.48, 28.45] 12.27 0.33 .746 
   - CS+ change T1-T2 -1.94 [-5.12, 1.24] 1.60 -1.21 .229 
   - CS+ change × Cortisol reactivity 6.34 [-33.19, 45.88] 19.82 0.75 .750 
Model 2     
   - Constant 11.65 [6.32, 16.99] 2.67 4.36 < .001 
   - Cortisol reactivity -0.81 [-23.79, 22.16] 11.52 -0.07 .944 
   - CS- change T1-T2 0.53 [-2.06, 3.12] 1.30 0.41 .685 
   - CS- change × Cortisol reactivity -46.44 [-78.17, -14.71] 15.91 -2.92 .005 
Note: SE = standard error; Square brackets show 95% confidence intervals of b; * interaction 
is significant after age and depression were included in the model as covariates. 
 
 
 Using the early extinction CS- change from trial 1 to trial 2 as the predictor, the model 
predicted a significant amount of variance in PCL total, R2 = .690, F(5, 70) = 31.08, p < .001. 
There were no significant main effects of cortisol reactivity or CS- change. Critically, 
however, cortisol reactivity was a significant moderator of the relationship between CS- 
change and PCL total (see Table 2, model 2), with age and depression included as covariates. 
As shown in Figure 4, participants with greater cortisol reactivity showed a negative 
relationship between fear extinction learning and PTSS. That is, for participants with lower 
PTSS severity, high cortisol reactivity was associated with facilitated fear extinction learning 
to the CS-. This relationship was not evident at lower levels of cortisol reactivity: For 
participants with moderate levels of cortisol reactivity, fear extinction learning was not 
significantly related to PTSD symptoms. And, interestingly, for participants with low cortisol 
Chapter 6: Cortisol reactivity moderates fear inhibition to safety signals in PTSD  192 
 
 
reactivity, the inverse relationship was found, with higher PTSD symptoms associated with 
better fear extinction. 
 
 
 
Figure 4. The relationship between early extinction CS- change and PTSS was significant at 
lower levels (-1.5 SD) and higher levels (+1.5 SD) of cortisol reactivity. At moderate (mean) 
levels of cortisol reactivity, there was no significant relationship between fear extinction 
learning and PTSS. These findings suggest a positive relationship between PTSS and 
extinction learning when cortisol reactivity is low. Further, there is a negative relationship 
between PTSS and extinction learning when cortisol reactivity is high. * p < .05. ** p < .01. 
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6.5 Discussion 
 The aim of the current study was to investigate the relationship between fear 
extinction learning and endogenous cortisol reactivity in PTSS. We found that cortisol 
reactivity was a significant moderator of the relationship between fear extinction (specifically 
to the safety signal) and PTSS. This effect was demonstrated in two ways. (1) High cortisol 
reactivity was associated with lower PTSS severity as fear extinction learning to the safety 
signal improved; and (2) low cortisol reactivity was associated with higher PTSS severity as 
fear extinction learning to the safety signal improved. Interestingly, this effect was only 
found with fear responding to the CS-, rather than the CS+. 
 In the present study, cortisol reactivity was a significant moderator between fear 
extinction to the CS- (but not the CS+) and PTSS. During the extinction phase(s) of a simple 
discrimination paradigm as employed in the current study, appropriate responding to the CS+ 
and CS- reflect extinction learning and fear inhibition, respectively (Jovanovic & Norrholm, 
2011). Therefore, we speculate that the moderation analysis of the current study revealed 
cortisol reactivity to specifically interact with processes of fear inhibition in PTSS severity. 
Recent research implicates impaired fear inhibition to safety signals to be a key biomarker in 
PTSD (Jovanovic, Kazama, Bachevalier, & Davis, 2012; Jovanovic & Norrholm, 2011). 
Previous research has shown patients with PTSD tend to show generalized conditioned fear 
responding from a reinforced CS+ to a non-reinforced CS- (Grillon & Morgan, 1999). This 
effect has previously been hypothesized to be attributable to either difficulty in learning the 
CS/US contingency, or an error in appropriately inhibiting fear despite accurate contingency 
awareness (Jovanovic et al., 2009). The findings of the present study support the latter, as all 
participants reported awareness of the CS/US contingency, a fact that is further supported by 
the self-reported threat expectancy ratings during the acquisition and early extinction phases 
(see Figure 3). Further, we previously demonstrated that PTSD is associated with impaired 
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fear extinction learning, which becomes worse with greater hours-since-waking (Zuj, Palmer, 
Hsu, et al., 2016), and increased endogenous cortisol activity has recently been shown to 
mediate better treatment response in the morning in a sample of patients with panic disorder 
and agoraphobia (Meuret et al., 2016). In the current study, however, participants in the PTSS 
group showed a general impairment in fear responding to both CS+/- during early extinction, 
with no specific extinction deficit to either CS. Rather, the findings of the current study 
showed that cortisol reactivity interacts with fear inhibition to the CS- (but not extinction to 
the CS+) in a model of PTSS severity. 
Regarding the influence of cortisol, the findings of the current study are supported by 
recent work showing that endogenous cortisol levels significantly moderate (Meuret et al., 
2015) and mediate (Meuret et al., 2016) exposure-therapy success in patients with panic 
disorder and agoraphobia. Pharmacological studies have also demonstrated that 
dexamethasone suppression of HPA axis function significantly reduces exaggerated fear-
potentiated startle in patients with PTSD, compared to traumatized controls without PTSD 
(Jovanovic et al., 2011). Interestingly, this finding was only revealed for fear-potentiated 
startle to the CS+ and not the CS-, suggesting a role for endogenous cortisol reactivity in fear 
inhibition. The findings of the current study, that endogenous cortisol reactivity is a 
moderator of fear inhibition, but not fear extinction learning, is a novel result, and requires 
further investigation. Additionally, glucocorticoid administration (significantly increasing 
cortisol output) in conjunction with exposure therapy for specific phobia significantly 
reduced symptom severity compared to the placebo control group in keeping with earlier 
research (de Quervain et al., 2009). Together, these findings suggest that cortisol 
augmentation and enhancing safety signal learning during the therapy process may improve 
treatment response. Although salivary cortisol has recently been used in similar research 
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(Meuret et al., 2016; Meuret et al., 2015), the collection of 24h blood samples would provide 
a more accurate indication of the role of cortisol in fear extinction or inhibition. 
 The standardized differential fear conditioning and extinction paradigm used in the 
current study produced reliable fear conditioning and extinction learning. These findings are 
in line with previous studies showing PTSD-related impairments in extinction learning 
(Blechert et al., 2007; Norrholm et al., 2011; Orr et al., 2000; Peri et al., 2000), although 
some studies have failed to find specific extinction learning deficits in PTSD (Milad et al., 
2008; Milad et al., 2009). The findings of the present study are consistent with the idea of 
“fear load”, that PTSD is associated with significantly increased fear expression during the 
early trials of extinction learning (Norrholm et al., 2015; Norrholm et al., 2011). However, 
extinction learning in the current study occurred rapidly, with the PTSS group extinguishing 
conditioned fear responses by trial 3 of early extinction, and by trial 2 for the control groups 
with relatively small effect sizes. We speculate that this rapid extinction learning may be due 
to the use of a 100% reinforcement schedule during fear acquisition. While full reinforcement 
schedules are commonly used (e.g., Jovanovic et al., 2014; Orr et al., 2012; Orr et al., 2000), 
replicating the current study using less predictable US-exposure (e.g., 60% reinforcement 
schedule, as used by Milad et al., 2007; Pace-Schott et al., 2013) may slow extinction 
learning and increase the sensitivity to reveal effects. 
 The current finding that better fear extinction performance is associated with lower 
PTSS in the context of higher cortisol reactivity is consistent with the findings of a study that 
found glucocorticoid administration enhanced exposure therapy outcome in specific phobia 
(de Quervain et al., 2011). Exposure therapy is one of the most recommended treatments for 
PTSD (Foa, Keane, Friedman, & Cohen, 2009) and acts by extinguishing conditioned fear 
memories associated with the trauma (Graham & Milad, 2011; Yehuda et al., 2015). 
Recently, Yehuda et al. (2015) found that hydrocortisone augmentation of exposure therapy 
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resulted in significantly greater PTSD symptom reduction and patient retention compared to 
placebo. Due to increased PTSD symptom expression during initial exposure therapy 
sessions, patient drop-out rates are a serious issue (e.g., Jeffreys et al., 2014; Yehuda et al., 
2015), and the results of the current study suggest that hydrocortisone augmentation of 
exposure therapy may have been effective in part due to the interaction between altered 
cortisol levels and correcting impaired fear inhibition processes. 
While the primary finding of the moderation analysis is in line with previous research 
(e.g., Meuret et al., 2015), the moderation also revealed that for participants with low cortisol 
reactivity, greater PTSS was associated with better fear inhibition. This effect was not 
expected, and we speculate that low cortisol reactivity may act as a moderator of poor 
response to exposure therapy in clinical settings. That is, approximately 15-45% of patients 
still show diagnostic criteria for PTSD after prolonged exposure therapy (e.g., Mørkved et al., 
2014; Powers, Halpern, Ferenschak, Gillihan, & Foa, 2010). We suggest that prolonged 
exposure therapy may target key fear-related symptoms of PTSD, but may be ineffective in 
the treatment of other symptoms when HPA function is hypoactive, leading to ongoing need 
for treatment. Glucocorticoid administration may be beneficial in such situations. 
Alternatively, previous research in the glucocorticoid receptors of the rat nucleus of the 
solitary tract revealed a dose-response relationship with memory consolidation, whereby 
intermediate doses enhanced consolidation with no effects at low or high doses (Roozendaal, 
Williams, & McGaugh, 1999). The moderation effect of low cortisol reactivity on the 
relationship between fear inhibition and PTSD symptoms was not anticipated, and 
preliminary animal evidence suggest that glucocorticoid receptors, and possibly cortisol 
activity, follow a U-curve dose-response relationship with learning and memory processes.  
These effects notwithstanding, some limitations were present in the current study. 
First, we only examined the relationship between cortisol reactivity and fear extinction 
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learning, and a previous pilot study suggests that a one-month course of low-dose cortisol 
administration in patients with PTSD resulted in reduced traumatic memory symptoms 
compared to placebo (de Quervain, 2008). Future research using a multi-day extinction 
learning and recall paradigm (e.g., Milad et al., 2008; Milad et al., 2009) may reveal 
important insights into this issue. Second, the PTSS group used in the current study also 
included participants with subclinical symptoms, and a sample of greater clinical severity are 
necessary to make robust implications for the interaction between cortisol and fear extinction 
in a clinical treatment setting. Finally, the use of self-report diagnostic instruments (and 
diagnostic tools for the DSM-IV) is a limitation of the current study, and future research 
would benefit from clinical diagnostic tools, such as the Clinician Administered PTSD Scale 
(CAPS) for the DSM-5. 
 In conclusion, we observed that endogenous cortisol reactivity is a significant 
moderator between the inhibition of fear responses to the CS- (but not the CS+) and PTSS. 
Our findings provide evidence that elevated cortisol influences the relationship between 
PTSS and fear inhibition, such that greater fear inhibition to a safety signal is associated with 
lower PTSS, and this relationship only occurs in participants experiencing greater cortisol 
reactivity. This finding provides a novel insight into the processes of fear inhibition, 
suggesting that endogenous cortisol reactivity moderates the relationship between fear 
inhibition to safety signals and PTSS. 
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7.1 Overview of Thesis Aims and Outcomes 
 Impaired fear extinction learning and memory are considered primary influences of 
PTSD development and symptom persistence. The aim of the current thesis was to 
investigate key variables that may moderate the relationship between fear extinction and 
PTSD symptom severity. Chapter two presents a comprehensive narrative review of the 
central role that fear extinction appears to play in PTSD symptoms, as evidenced by shared 
relationships with risk factors for PTSD. Importantly, PTSD and fear extinction share the 
same neural networks of the amygdala, prefrontal cortex, and hippocampus, suggesting that 
biological and cognitive processes that rely on these networks are also involved. On balance, 
the literature consistently shows that impaired fear extinction is associated with, (1) the same 
polymorphisms of candidate genotypes involved in PTSD; (2) neuroendocrine and 
noradrenergic abnormalities associated with PTSD symptom expression; (3) similar effects of 
sex hormones estrogen and progesterone, potentially explaining sex differences in PTSD; (4) 
significant impacts of verbal functioning, which is considered primary complaint of PTSD; 
and (5) sleep disturbances and the negative impact of poor sleep quality. As fear extinction is 
considered to be a key component in the development of fear-related features of PTSD, and 
fear extinction has been shown to be associated with these risk factors, the aim of the current 
thesis was to explore some of these risk factors as potential moderators between fear 
extinction learning and PTSD symptoms. That is, the literature is currently unclear on 
whether fear extinction interacts with these risk factors in a model of PTSD symptoms. Due 
to sample size limitations, some of these risk factors (such as candidate genotypes and sex 
hormones) could not be included in the current thesis, and future research would benefit from 
investigating these relationships. This thesis presents a novel investigation of time-of-day, 
negative cognitive appraisals, noradrenaline, and cortisol as moderators of the relationship 
between fear extinction learning and PTSD symptoms. 
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The four empirical studies included in the current thesis (spanning chapters 3 – 6) 
present investigations of key variables (specifically, hours-since-waking, negative appraisals, 
noradrenaline, and cortisol, respectively) as moderators between fear extinction learning and 
PTSD symptoms. These studies used a cross-sectional clinical sample of participants with 
PTSD, trauma-exposure without PTSD, and non-trauma-exposed healthy controls. Skin 
conductance served as the primary index of fear conditioned responses, and stress hormone 
levels were assessed via saliva assays for cortisol and salivary alpha-amylase (as a proxy for 
noradrenergic functioning). Figure 1 presents a graphical representation of the primary 
empirical findings from the current thesis. Subsequent sections summarize the key findings 
and implications of each chapter, followed by theoretical implications, methodological 
limitations, and directions for future research. 
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Figure 1. Significant direct effects and moderation interactions from Chapters 3, 4, and 6. This figure displays a conceptual diagram of the 
interactions between predictors and moderators on PTSD symptom severity, and is not a statistical representation of relationships (Hayes, 2013).
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b = -2.37, p = .045 
b = 0.28, p < .001 
b = -46.44, p = .005 
b = 0.53, p = .685 
b = -2.62, p = .043 
Early Extinction 
DCR Change Score 
Chapter 4 
Chapter 4 
Chapter 3 Chapter 6 
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7.2 Key Empirical Findings and Implications of the Thesis 
7.2.1 The role of sleep in fear extinction (Chapter 3). 
Sleep disturbances are widely considered a hallmark symptom of PTSD (Germain, 
2013; Ross, Ball, Sullivan, & Caroff, 1989), and poor sleep can adversely impact cognitive 
and emotional functioning. Further, sleep plays a key role in the consolidation of emotional 
memories (Pace-Schott, Germain, & Milad, 2015), including fear extinction memories 
(Spoormaker et al., 2010). Time-of-day has recently been found to be an important factor in 
fear extinction memories, with significantly better extinction learning and memory reported 
in the morning compared to the evening in healthy participants (Pace-Schott et al., 2013). 
Chapter three examined whether the relationship between fear extinction learning and PTSD 
symptoms changes as a factor of hours-since-waking. Moderation analyses revealed a 
significant interaction between fear extinction learning and hours-since-waking in predicting 
PTSD symptom severity. Specifically, participants with higher PTSD symptoms showed 
significantly poorer fear extinction learning, and this linear relationship became stronger as 
participants were awake for longer.  
A limitation of the study presented in Chapter three is the absence of a 
polysomnographic-recording of sleep wave architecture. For example, as reviewed in Chapter 
two, previous research in rodents and humans has shown deprivations in rapid eye movement 
(REM) sleep to significantly impair fear extinction learning (Silvestri & Root, 2008) and 
memory (Fu et al., 2007; Pace-Schott, Verga, Bennett, & Spencer, 2012; Spoormaker et al., 
2012). Rather, Chapter three used hours-since-waking as a measure of homeostatic sleep 
pressure, which refers to the notion that cognitive and emotional performance are at their best 
soon after waking, and slowly become worse throughout the day as an individual’s need for 
sleep increases. It was recently argued that extinction learning deficits later in the day can be 
attributed to homeostatic sleep pressures (Pace-Schott et al., 2014), whereby increasing 
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adenosine activity in the basal forebrain correlate with sleep deprivation to promote a greater 
need for sleep (Porkka-Heiskanen & Kalinchuk, 2011). In other words, we argue that 
extinction capacity is enhanced due to the restorative benefits of sleep. Should this 
interpretation hold true, these findings carry important implications for the implementation of 
treatment, suggesting that exposure therapy may be most beneficial when scheduled soon 
after waking, rather than later (Pace-Schott et al., 2013; Pace-Schott et al., 2014; Zuj, Palmer, 
Hsu, et al., 2016). 
Previous research shows alterations in cortisol output with circadian rhythm 
(Kalsbeek et al., 2012). Further, Pace-Schott et al. (2013) found that higher 
testosterone/cortisol ratio was associated with better fear extinction learning in the morning. 
To examine whether cortisol had any effect on hours-since-waking as a moderator between 
fear extinction and PTSD symptoms, basal cortisol, post-acquisition cortisol, and cortisol 
reactivity were individually tested as covariates of this relationship (see section 3.8 of the 
current thesis). Moderation analyses revealed that cortisol was not a significant covariate, and 
all main effects and interactions remained the same. Nevertheless, increased cortisol has 
previously been shown to enhance therapeutic extinction (Soravia et al., 2006; Soravia et al., 
2014), and should be taken into consideration in future studies of time-of-day effects on 
extinction and PTSD symptoms. 
 
7.2.2 The role of cognition in fear extinction (Chapter 4). 
 The cognitive theory of PTSD (Ehlers & Clark, 2000) proposes that PTSD symptoms 
persist due to excessive negative appraisals about the trauma and its sequelae. Evidence 
suggests that the cognitive theory of PTSD and the fear extinction account are not mutually 
exclusive, as conditioned fear responses triggered by trauma reminders are thought to 
reinforce negative appraisals (Ehlers & Clark, 2000). To our knowledge, however, no 
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previous studies have examined fear extinction and negative appraisals in tandem, in relation 
to PTSD. Chapter four investigated negative appraisals as a moderator of the relationship 
between fear extinction learning and PTSD symptoms. The moderation analysis revealed 
excessively negative appraisals and poor fear extinction learning ability were significantly 
associated with greater PTSD symptom severity. Despite this, however, there was no 
significant moderation between negative appraisals and fear extinction, suggesting that these 
two factors may function independently in relation to PTSD. While this study was conducted 
in an experimental framework, the findings presented in Chapter four highlight that there are 
both cognitive and biological processes in PTSD which may benefit from targeted treatment 
approaches. That is, should this notion hold true, these findings suggest the need for exposure 
therapy to promote fear extinction, as well as cognitive therapy targeting catastrophic 
negative appraisals. 
 Previous research has demonstrated that imaginal exposure therapy combined with 
cognitive restructuring (aimed at correcting negative appraisals of the trauma) resulted in 
significantly enhanced treatment outcome compared to imaginal exposure alone (Bryant, 
Moulds, Guthrie, Dang, & Nixon, 2003). This finding is in contrast to conclusions that 
prolonged exposure therapy combined with cognitive restructuring has no additive benefits 
over prolonged exposure therapy alone (Foa et al., 2005; Marks, Lovell, Noshirvani, 
Livanou, & Thrasher, 1998). While the research presented in Chapter four was not conducted 
in a clinical treatment setting, the results suggest that fear extinction learning and catastrophic 
negative appraisals do not interact, and show independent relationships with PTSD 
symptoms, perhaps requiring specific attention during treatment. 
 Regarding cognition and PTSD more generally, consistent research has found 
cognitive performance deficits in PTSD, particularly in verbal learning and memory (e.g., 
Barrett, Green, Morris, Giles, & Croft, 1996; Bremner, Vermetten, Afzal, & Vythilingam, 
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2004; Gilbertson et al., 2006; Grigorovich, Gomez, Leach, & Fish, 2013). The effects of 
verbal functioning on fear extinction learning ability, however, have received little attention. 
Of the few studies conducted to assess this, one study found that engaging with a verbal 
worrying task led to poorer fear extinction learning (Gazendam & Kindt, 2012), providing 
preliminary evidence that fear extinction is not an automatic process, but relies on cognitive 
resources (Raes, De Raedt, Verschuere, & De Houwer, 2009). Indeed, greater cognitive 
demand results in weaker fear conditioning (Carter, Hofstotter, Tsuchiya, & Koch, 2003), 
however the effects on extinction are unclear. 
 As opposed to research in rodents, human fear extinction learning appears to be 
modulated by cognitive processes (Hermans, Craske, Mineka, & Lovibond, 2006; P. F. 
Lovibond, 2004). That is, any disparities found between research in animals and humans is 
argued to be due to higher-order cognitive processing in humans, resulting in the ability to 
verbally and symbolically understand US contingencies (Hermans et al., 2006). This higher-
order understanding of conditioning is reflected in a study showing similar changes in SC 
responding and US-expectancy ratings to CS and safety signals, suggesting the convergence 
of conditioned SCR and cognitive threat expectancy (P. F. Lovibond, 2004; P. F. Lovibond, 
Davis, & O'Flaherty, 2000). In summary, fear extinction in humans appears to be driven by 
key cognitive processes (P. F. Lovibond, 2004), and the absence of available cognitive 
resources can have significant consequences for extinction performance (Raes et al., 2009).  
 
7.2.3 The role of stress hormones in fear extinction (Chapters 5 and 6). 
 The stress response involves two waves of neurochemical release (Joëls & Baram, 
2009). The first wave of the stress response involves the rapid release of adrenaline and 
noradrenaline in sympathetic arousal structures to respond to an immediate stressor. The 
second wave of the stress response involves the hypothalamic-pituitary-adrenal (HPA) axis, 
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and its end product, cortisol, to shut down the stress response. The key finding of Chapter 
five suggests that noradrenaline is not a significant moderator between fear extinction and 
PTSD, while Chapter six shows cortisol reactivity to be a significant moderator between fear 
inhibition to safety signals and PTSD symptoms. 
Evidence suggests that a cortisol deficit may be involved in the etiology of PTSD 
(Pitman et al., 2012), with cortisol administration to cardiac surgery patients reducing 
posttraumatic stress symptoms (Schelling et al., 2004). Recent evidence suggests that 
reducing current situational fear expression of patients receiving exposure therapy may be an 
effective means of reducing patient drop-out rates, leading to greater treatment outcomes 
(Yehuda et al., 2015). Indeed, the findings of Chapter six show that enhanced fear extinction 
learning ability is associated with lower PTSD symptoms, and this relationship becomes 
stronger with elevated cortisol reactivity. Further, this finding was only in relation to the CS-, 
and not the CS+, potentially reflecting cortisol influences on the processes of fear inhibition, 
which is gaining attention as a key biomarker of PTSD symptoms (Jovanovic et al., 2012; 
Jovanovic & Norrholm, 2011). Essentially, fear expression in safe contexts or to stimuli 
signaling safety may be due, in part, to cortisol reactivity. Enhancing cortisol release may 
facilitate corrective fear expression to safe contexts, and these findings are in line with recent 
clinical evidence that elevating cortisol leads to greater exposure therapy response in PTSD 
(Yehuda et al., 2015). 
Cortisol output is also modulated by the menstrual cycle, as increased estrogen 
attenuates stress-related activity in the HPA axis and noradrenergic system (Charney, 2004). 
There has been a growing research interest in the effect of sex hormones on fear extinction 
learning and PTSD symptoms. Consistent research in healthy controls shows that lower 
estrogen is associated with impaired fear extinction learning (Wegerer, Kerschbaum, 
Blechert, & Wilhelm, 2014) and recall (Milad et al., 2010; Zeidan et al., 2011). Participants 
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with PTSD have shown convergent evidence, with low estradiol associated with impaired 
fear extinction (Glover et al., 2012) and inhibition (Glover et al., 2013). In contrast, a recent 
study demonstrated that women with PTSD showed poorer fear extinction retention in the 
midluteal phase of the menstrual cycle, which was attributed to elevated progesterone levels 
(Pineles et al., 2016). These findings suggest that estrogen and progesterone may also be 
important moderators of the relationship between fear extinction and PTSD symptoms, and 
future research using moderation (or mediation) may reveal direct and/or indirect effects 
between these variables. 
 
7.3 Theoretical Implications 
 A deeper understanding of the behavioral and biological factors that shape the role of 
fear extinction in PTSD would allow for more targeted treatment methods (Holmes & 
Singewald, 2013). As noted by Mineka and Oehlberg (2008), the classical conditioning and 
extinction approach to PTSD has previously been criticized for being too simplistic in 
explaining the development and maintenance of symptoms for such disorders as PTSD. As 
reviewed in Chapter two, a number of PTSD-related risk factors have been identified that 
also share relationships with fear extinction learning (Zuj, Palmer, Lommen, & Felmingham, 
2016). This narrative review, and the increasing evidence of key moderators of fear 
extinction learning, suggests that current fear extinction models need to incorporate broader 
domains of biological and cognitive influences (Myers & Davis, 2007; Orsini & Maren, 
2012). Further research should also examine the temporal relationships between these 
variables. That is, are some of these variables pre-trauma vulnerability factors? It is important 
to understand when and how stress hormones, sleep disturbances, and cognitions impact the 
trajectory from trauma to PTSD symptoms. Prospective longitudinal studies are required to 
answer these questions. 
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 The study presented in Chapter four investigated the relationship between fear 
extinction learning and negative appraisals, a key aspect of the cognitive theory of PTSD 
(Ehlers & Clark, 2000). In particular, we confirmed predictions that both fear extinction 
learning and negative appraisals influence PTSD, but we did not support the hypothesis of an 
interaction between these two variables. A limitation of this study, however, is that this 
model was assessed in a lab-based setting, with non-trauma-relevant conditioned stimuli. 
Using a conditioning paradigm with trauma-relevant stimuli (e.g., see Wegerer et al., 2014) 
may produce stronger conditioned emotional responses, which could demonstrate a 
relationship with trauma-related negative appraisals. The cognitive model further 
hypothesizes that persistent PTSD is caused by fragmented and poorly contextualized trauma 
memories, and dysfunctional behavioral and cognitive strategies aimed at reducing feelings 
of threat, yet further exaggerating symptoms (Ehlers, Mayou, & Bryant, 2003). In relation to 
this, a limitation of Chapter four is that we were unable to examine these aspects of the 
model, and future research would benefit from investigating the role of extinction in the 
elaboration of autobiographical trauma memories, and the nature of intrusive memories in 
PTSD. A conditioned-intrusion paradigm, as used by Wegerer et al. (2014), may be useful 
here. 
 The findings of Chapter four show significant associations between negative 
appraisals and PTSD, and between impaired fear extinction learning and PTSD, but no 
moderation interaction was found. This finding suggests that these two theories each present 
important variables involved in PTSD symptoms, however these constructs are in parallel 
with each other, showing no interactions in relation to PTSD. This has important implications 
for the potential integration of theories of PTSD symptom development and maintenance. 
Specifically, there has been little convergence of theory and empirical literature, and more 
research is needed to examine potential links between cognitive and biological influences. 
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While the findings of Chapter four did not demonstrate clear links between the fear extinction 
account and the cognitive model of PTSD (Ehlers & Clark, 2000), future research should 
explore trauma-relevant stimuli in the context of fear conditioning and extinction paradigms 
with increased unpredictability of aversive stimuli, and record of instructive memories. 
Examining these effects on fear extinction recall as well as extinction learning may identify 
previously unexplored convergences of theory. 
 The notion that PTSD is associated with increased fear expression to safety signals is 
receiving increased interest. Impaired fear inhibition to safety signals is argued to be an 
intermediate phenotype between the neurocircuitry and clinical symptoms of PTSD 
(Jovanovic & Norrholm, 2011). Further, it has been argued that issues in differentiating threat 
versus safety signals is a reflection of impaired contextual processing in PTSD (for a review, 
see Liberzon & Abelson, 2016). The study findings presented in Chapter six showed that 
cortisol reactivity was a moderator between fear inhibition to a safety signal (but not the 
previously reinforced CS+) and PTSD symptoms. These findings provide support for the 
notion that PTSD is associated with heightened fear expression to a safety signal, and that 
this relationship appears to be shaped by cortisol reactivity. 
 
7.4 Methodological Limitations 
7.4.1 Cross-sectional study design. 
 The first and foremost limitation of the research in this thesis is that it was cross-
sectional, rather than longitudinal. That is, causal interpretations are constrained and it 
remains unclear whether the variables being observed aided in the development of PTSD 
symptoms. For example, the findings presented in Chapter six suggest that cortisol reactivity 
shapes the role of fear extinction learning (in particular, fear to a safety signal) in PTSD. 
While this evidence presents some interesting and novel insights into the role of cortisol in 
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fear extinction in PTSD, it remains unclear whether this interaction plays a role in the 
development of conditioned fear responses that are resistant to extinction. For example, a 
prospective study by McFarlane, Barton, Yehuda, and Wittert (2011) assessed cortisol in the 
acute aftermath of a trauma, and found a negative correlation between morning cortisol and 
PTSD symptoms six-months later. Thus, longitudinal studies would allow for robust 
conclusions to be drawn on the specific role of fear extinction learning and memory in PTSD. 
As highlighted in Chapter two, there is considerable prospective evidence for a role of the 
variables presented in the current thesis (that is, sleep, cognitions, noradrenaline, and 
cortisol), however the temporal timeframe of these variables is unclear. Specifically, future 
research investigating the role that these variables (and impaired fear extinction) play in the 
trajectory of trauma to PTSD symptom development may reveal important insights for early 
detection and intervention. 
 
7.4.2 Indices of conditioned fear responding. 
 The studies presented in the current thesis used SCR as the primary index of 
conditioned responding, and self-reported expectancy ratings of the unconditioned stimulus 
(US-expectancy) as a measure of threat expectancy. While SCR is a commonly used 
psychophysiological measure of conditioned responding (e.g., Blechert, Michael, Vriends, 
Margraf, & Wilhelm, 2007; Milad, Orr, Pitman, & Rauch, 2005; Orr et al., 2000; Pace-Schott 
et al., 2013), it suffers from limitations such as substantial artefact and individual variability, 
with upwards of 37% attrition rates reported due to participants classed as SCR non-
responders (e.g., Inslicht et al., 2013; Pineles et al., 2016; Spring et al., 2015). Although SCR 
is considered a measure of sympathetic arousal (Boucsein, 1992), there is some evidence that 
SCR actually reflects cognitive threat expectancy (P. F. Lovibond, 2004) and anticipatory 
arousal irrespective of stimulus valence (Weike, Schupp, & Hamm, 2007). Alternatively, 
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many studies also implement electromyogram (EMG) recordings of acoustic startle (e.g., 
Guthrie & Bryant, 2006; Jovanovic et al., 2005; Norrholm et al., 2011), which reflects 
subcortical fear networks, particularly afferent and efferent amygdala pathways to the 
brainstem (Davis & Whalen, 2001; Kindt & Soeter, 2013). Although both 
psychophysiological methods have shown robust effects in differential fear conditioning and 
extinction, a longitudinal study by Guthrie and Bryant (2006) revealed that only EMG-
recorded fear extinction impairments were a significant pre-trauma risk factor of PTSD 
symptoms in trainee firefighters. Replication of the studies in the current thesis (or failure to 
do so) using EMG-recorded acoustic startle would provide important insights into the role of 
subcortical arousal in these interactions. 
 Recent evidence in healthy participants suggests that conscious cognitive awareness 
of the CS-US contingency is necessary for fear conditioned SC responding, but not for 
conditioned startle data (Sevenster, Beckers, & Kindt, 2014). A strength of the current 
research is that self-report US-expectancy responses were obtained from participants 
alongside SCR throughout the fear conditioning and extinction paradigm. Participants who 
reported uncertain threat expectancy of the US (that is, US-expectancy ratings less than 60) 
during CS+ trials at the end of the fear acquisition phase were excluded from all analyses 
(Lommen, Engelhard, Sijbrandij, van den Hout, & Hermans, 2013). Nevertheless, future 
research would benefit from the inclusion of multiple physiological indices of conditioned 
fear responding for cross-validation (Sevenster et al., 2014). 
 The current program of research also showed discrepancies in the findings of SCR 
amplitude data, compared to self-report US-expectancy ratings. SCR amplitude data revealed 
significant group effects mainly in early extinction (Chapters 4-6), whereas group effects for 
US-expectancy data were limited to the late extinction phase. Specifically, the PTSD group 
displayed significantly greater threat expectancy during late extinction compared to the TC 
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and NTC groups, and this effect did not change as a factor of CS-type or trial. Despite this 
discrepancy, US-expectancy methods have been found to be an externally valid measure of 
human fear conditioning (Boddez et al., 2013). Although recent evidence suggests that CS-
US contingency awareness is necessary for fear conditioned SC responses (Sevenster et al., 
2014), Blechert and colleagues (2008) found that fear extinction occurs rapidly in SCR 
amplitude data, and slower in US-expectancy ratings. This pattern of effects across SCR and 
US-expectancy ratings might reflect more rapid psychophysiological responding despite 
sustained threat processing, reinforcing a need for targeted cognitive threat expectancy. 
 
7.4.3 Discrepant findings. 
 Due to between-group discrepancies in fear conditioning and extinction across the 
empirical chapters, moderation analyses included different indices of extinction learning. For 
example, Chapter three used a differential conditioned response (DCR) change score for the 
late extinction phase, while Chapters four and five used a DCR change score for the early 
extinction phase. DCR change scores provide an index of the change in responding between 
the CS+ and CS- across the experimental phase, whereby larger scores in extinction represent 
a greater decline in differentiation between the threat and safety signal (that is, better 
extinction learning). Alternatively, the extinction index used in moderation analyses for 
Chapter six involved a change score between trials 1 and 2 of early extinction, calculated 
separately for the CS+ and CS-. This change score was calculated as the pattern of effects for 
early extinction reflected rapid attenuation of SC responses from trial 1 to trial 2 for the TC 
and NTC groups, yet this change was not significant for the PTSD group. By trial 3, all 
groups were displaying comparative levels of fear responses. These respective extinction 
learning indices were calculated to reflect the nature of group effects in fear extinction for 
those chapters, and moderators were used in an attempt to explain relevant effects. The 
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extinction index used in Chapter six also provides useful information on conditioned 
responses to threat versus safety signals. A limitation of DCR change scores is that you 
cannot evaluate individual responding to the threat signal, as opposed to the safety signal. 
This is of particular importance due to the recent increase in research that emphasizes the 
importance of fear responding to safety signals (Jovanovic, Kazama, Bachevalier, & Davis, 
2012; Jovanovic & Norrholm, 2011; Jovanovic et al., 2010; Jovanovic & Ressler, 2010). 
 
7.4.4 Unconditioned stimulus reinforcement schedule. 
 The studies reported in the current thesis used a 100% reinforcement schedule, 
meaning that every presentation of the CS+ was reinforced by the US in the acquisition 
phase. At current, the field appears to be largely mixed, with some studies using partial 
reinforcement schedules (60-62.5%; e.g., Milad et al., 2009; Pace-Schott et al., 2013) and 
others using full reinforcement schedules (e.g., Jovanovic et al., 2014; Orr et al., 2012; Orr et 
al., 2000), with largely convergent findings between these studies. Whilst studies have 
examined the impact of full versus partial reinforcement schedules in healthy controls 
(Grady, Bowen, Hyde, Totsch, & Knight, 2016), no studies have examined the impact of full 
versus partial reinforcement in PTSD. Full reinforcement schedules in healthy controls, 
however, appear to result in rapid extinction learning (Grady et al., 2016), suggesting that 
reinforcement schedules of less predictable threat may enhance the sensitivity to identify 
effects. Interestingly, a partial reinforcement schedule followed by full reinforcement showed 
strong conditioned responding and prolonged extinction (Grady et al., 2016), suggesting that 
this US reinforcement schedule may be useful for future research. 
 Altering the reinforcement schedule during fear acquisition results in changes to the 
prediction error of the US. The prediction error signal refers to the discrepancy between 
expected and actual outcomes during fear learning (Li & McNally, 2014). Importantly, when 
Chapter 7: General discussion 219 
 
 
there are no errors in prediction and the expected outcome is encountered upon every trial 
(for example, such as the full reinforcement schedule used in the current research), the “US is 
not surprising and no increments in fear learning occur” (Li & McNally, 2014, p. 15). 
Increasing the prediction error (for example, implementing a partial reinforcement rate) 
enhances the unpredictability of the US, thus producing small increases in fear learning that 
may be more resistant to extinction. Rapid extinction learning, as seen in the current program 
of research, is likely due to the absence of prediction error during the acquisition phase, as 
the CS has never been presented in situations of uncertainty. In other words, participants may 
come to expect that during each given experimental phase, the US will either be encountered 
following all CS+ presentations, or none of them. Research shows that increasing US-
reinforcement ambiguity early in conditioning, followed by full reinforcement produces 
stronger fear acquisition and slower extinction learning (Grady et al., 2016). 
 
7.4.5 Early to late extinction SCR uptick. 
 The fear conditioning and extinction paradigm used in the current program of 
research involved a small 1-minute interval between the early and late extinction phases (as 
in Milad et al., 2005). During this interval, a prompt was displayed on the computer screen 
instructing participants to continue when ready. As seen in the graphical representations of 
fear conditioning and extinction results throughout this thesis, there is an uptick in SCRs 
from the last trial of early extinction to the first trial of late extinction for both the CS+ and 
the CS-. It is possible that this is a form of short-term spontaneous recovery. Previous 
research has examined reinstatement immediately following fear extinction in order to avoid 
any spontaneous recovery effects (Norrholm et al., 2006). Further, there is some uncertainty 
regarding the temporal difference between acquisition and extinction phases before 
spontaneous recovery might occur (Norrholm et al., 2008), suggesting this might explain the 
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uptick in SCRs between early and late extinction. An alternative explanation is that due to the 
on-screen prompt between early and late extinction, participants may be under the impression 
that the CS+/US contingency may have changed and that further mild electric shocks may 
occur. Future research would benefit from using a continuous fear extinction phase, which 
can be split during data entry for analysis purposes. 
 
7.4.6 Sample size and PTSD classification. 
 The PTSD Checklist-Civilian version (PCL-C; Weathers, Litz, Huska, & Keane, 
1994) is a 17-item self-report questionnaire that corresponds with the diagnostic criteria of 
the DSM-IV (American Psychiatric Association, 2000), and was used as the diagnostic 
instrument for PTSD in the current thesis. Diagnostic criteria for the DSM-IV were used as 
data collection began prior to diagnostic criteria for the DSM-V becoming available. The 
PCL-C provides diagnostic information, as well as an ordinal measure of symptom severity, 
with a score equal to, or greater than 50 representing clinically severe PTSD symptoms 
(National Center for Posttraumatic Stress Disorder, n.d.). While the majority of individuals 
classified as PTSD did meet diagnostic criteria for PTSD, some participants with subclinical 
symptoms (defined as having a PCL total score greater than 40; National Center for 
Posttraumatic Stress Disorder, n.d.) were included in the PTSD group to increase statistical 
power, but may have also weakened effects. Importantly, this would have had little impact on 
moderation analyses as an ordinal PCL total score was used as the primary outcome variable 
in these analyses. Future research would benefit from a larger sample size with exclusively 
clinical PTSD symptoms, in order to make robust conclusions on the relationship between 
fear extinction learning and clinical PTSD symptoms. 
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7.4.7 Sample characteristics. 
 PTSD is often comorbid with other psychiatric conditions, particularly depression. In 
the current program of research, an ordinal measure of depressive symptoms was obtained 
using the Depression Anxiety Stress Scale 21-item version (DASS; S. H. Lovibond & 
Lovibond, 1995). Where necessary, depression was included as a covariate and did not 
significantly alter the pattern of effects (for example, see section 3.8 of the current thesis). 
Including greater consideration of comorbidity may also have allowed conclusions to be 
drawn regarding the specific effects of PTSD compared to such comorbid disorders. Further, 
due to sample size restrictions and the variability of medications, these were not controlled in 
the current program of research. For example, medications such as oral contraceptives have 
been shown to temporarily impair fear extinction learning (Graham & Milad, 2013), and were 
not controlled for in the current thesis. Taking these factors into account with larger sample 
sizes will strengthen future research. 
 
7.5 Directions for Future Research 
7.5.1 Impairments in fear extinction memory. 
The research presented in the current thesis examined the relationships between key 
factors and fear extinction learning in PTSD. Previous research indicates that many 
individuals with PTSD do not show impairments in extinction learning ability (Milad et al., 
2008; Milad et al., 2009), but show deficits in the memory for fear extinction (Milad et al., 
2008; Milad et al., 2009; Shvil et al., 2014). That is, fear extinction may be learned 
effectively, but poorly recalled the following day. Further, the fear extinction account of 
PTSD proposes extinction as constituting a new memory trace that competes with the original 
fear acquisition trace (Myers & Davis, 2002). In some circumstances, the conditioning 
memory will override the extinction memory, resulting in the return of conditioned fear 
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expression (see Figure 2). We may expect to see stronger effects in fear extinction recall, as 
both sleep (Pace-Schott et al., 2015) and cortisol (Zoladz & Diamond, 2013) have notable 
effects on memory consolidation processes. Further, risk factors in the present thesis that 
showed no interactions with fear extinction learning (that is, negative appraisals and 
noradrenaline), may instead be associated with the consolidation of fear extinction memories. 
Indeed, increased NA is associated with enhanced emotional learning and memory processes 
(Mueller & Cahill, 2010), suggesting that NA may play a prominent role in fear extinction 
memory, rather than learning. Thus, a two-day extinction learning and recall paradigm may 
reveal NA activity (and other potential moderators) to be a significant moderator between 
fear extinction recall and PTSD symptoms. These interactions may also be assessed in 
relation to a number of fear return concepts, such as spontaneous recovery, fear renewal, and 
reinstatement (see Figure 2). Examining risk factors discussed in the current thesis in relation 
to each of these concepts would lead to important insights into how fear extinction operates 
to influence fear-related disorders.  
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Figure 2. Models suggestive of fear extinction to constitute the formation of a new memory. 
Panel (A) shows that fear extinction forms a new memory, as the acquired fear trace remains 
until extinction is learned. Spontaneous recovery (B) demonstrates that as time increases 
post-extinction learning, the conditioned response can return in increased magnitude. 
Contextual fear extinction research (C) shows that the acquisition of fear in one context (i.e., 
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context A) and extinction in a second context (i.e., context B) may allow ongoing conditioned 
fear responding in context A. Following successful fear extinction learning, re-experiencing 
the US in the absence of the CS may reinstate the conditioned fear response (D) (adapted 
from Myers & Davis, 2002, 2007). 
 
 
7.5.2 The genetics of impaired fear extinction in PTSD. 
As discussed in Chapter two, PTSD is associated with numerous biological, cognitive, 
and epigenetic features, some of which may be pre-trauma risk factors. Genetics is currently 
claimed to be one of the most promising fields of enhancing our understanding of PTSD risk 
and resilience (Zoladz & Diamond, 2013; Zuj, Palmer, Lommen, et al., 2016). For example, a 
candidate genotype discussed in Chapter two of the current thesis is FKBP5 (see section 
2.9.1), which regulates cortisol output and glucocorticoid sensitivity (Bomyea, Risbrough, & 
Lang, 2012), and may be an important precursor to altered cortisol and the hypersensitivity of 
glucocorticoid receptors in PTSD. With particular relevance to the findings of Chapter six, 
the significant moderation interaction between cortisol reactivity and fear extinction to safety 
signals may be modulated by underlying effects of FKBP5 expression on the molecular 
networks of the HPA axis. Future research investigating this research question, and others 
related to the candidate genotypes reviewed in Chapter two, may show important effects of 
genetics on the relationship between fear extinction and PTSD. 
 
7.5.3 Moderation versus mediation. 
 In the current program of research, moderation analyses were used to test hypotheses 
of the role of key variables in the relationship between fear extinction and PTSD symptom 
severity. Moderation is a regression-based analysis method, whereby the relationship 
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between a predictor variable and an outcome variable changes as a factor of the moderator 
(Hayes, 2013). That is, the predictor variable and moderator interact in their prediction of the 
outcome (see Figure 3A). An alternative statistical analysis method is mediation, whereby the 
predictor variable causes a change in the mediator, which in turn causes a change in the 
outcome variable (see Figure 3B). Mediation models are most useful when used in 
prospective longitudinal designs to determine the mechanism of change between a predictor 
variable (such as trauma exposure) and an outcome variable (such as PTSD symptoms). 
Importantly, the use of mediation analyses coupled with prospective longitudinal studies 
would be ideal for increasing our theoretical and clinical understanding of the temporal 
influence of risk factors in the trajectory from trauma exposure to PTSD symptoms. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Conceptual graphical representation of moderation (A) and mediation (B) models 
(adapted from Hayes, 2013). 
Moderator (M) 
Predictor (X) Outcome (Y) 
Mediator (M) 
Predictor (X) Outcome (Y) 
A. Moderation 
B. Mediation 
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7.6 Conclusions 
 The aim of the current thesis was to investigate the complexity of fear extinction in 
PTSD, by assessing the additional factors that may moderate the relationship between fear 
extinction learning and PTSD. The narrative review presented in Chapter two shows a 
number of biological and cognitive factors that appear to link fear extinction learning and 
memory to PTSD, however empirical research in these areas is lacking. Collectively, the 
original research presented in this thesis indicates that the relationship between impaired fear 
extinction learning and PTSD symptoms is complex, and involves multiple moderating 
factors – including hours-since-waking and cortisol reactivity, not to mention the influence of 
negative appraisals on PTSD symptoms independently of impaired fear extinction. While 
preliminary, the findings presented herein have important implications for exposure-based 
treatment methods for PTSD. These implications may simply involve strategically scheduling 
treatment shortly after sleep, or pharmacologically augmenting cortisol activity to enhance 
treatment benefit. While the current thesis used a within-session conditioning and extinction 
learning paradigm, these findings present novel questions for future research regarding 
moderators of the consolidation of extinction memories, and how these effects might 
importantly translate to a clinical setting. A similar program of research using primarily 
mediation models would compliment the findings of the thesis and would shed light on a 
number of issues in modeling PTSD etiology, and our understanding of the mechanisms of 
this disorder. 
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INFORMATION SHEET AND CONSENT FORM 
Study title: Identification of Cognitive and Genetic Predictors of Posttraumatic Stress Disorder 
 
Chief Investigator:    
Prof Kim Felmingham      Department: School of Psychology,  
      University of Tasmania 
                                   
Associate Investigators:  
Mr Daniel Zuj    Department: School of Psychology, UTAS 
Dr Matt Palmer    Department: School of Psychology, UTAS 
Professor James Vickers  Department: School of Psychology, UTAS 
 
Before you decide whether or not you wish to participate in this study, it is important for you 
to understand why the research is being done and what it will involve. Please take the time to 
read the following information carefully and discuss it with the researchers if you wish. 
 
What is the purpose of this study?  
You are invited to participate in a research study that will investigate predictors of 
Posttraumatic Stress Disorder (PTSD) symptoms following exposure to trauma.  Recent 
research suggests that impairments in fear extinction may be involved in PTSD, and genetic, 
cognitive and hormonal influences on fear extinction have been found.  No studies have 
examined the effects of genetic, cognitive, hormonal influences on fear extinction prior to 
being exposed to traumatic events, and subsequent PTSD symptoms.  
 
Why have I been invited to enter the study? 
You have been invited to participate in this study because you are enrolled in the Bachelor of 
Paramedic Medicine and will be exposed to traumatic events (ambulance work) as part of your 
practicum experience. 
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What does the study involve? 
If you agree to participate in this study, you will be screened for eligibility (you will need to be aged 
18-40, be of Caucasian background, and have no psychiatric or neurological history) and asked to 
sign the Participant Consent Form.  You will then come in for an assessment (which will take 
approximately 90 minutes) at the Cognitive Neuroscience Laboratory in the School of Psychology, 
UTAS prior to your first practicum placement.  In this assessment, you will complete the following 
components listed below.  Three and six months after your practicum placement, you will receive a 
follow-up phone call (each approximately 30 minutes) by an intern clinical psychologist to assess 
your level of PTSD symptoms, your mood and any current stressors and social support.    
 
Genetic Analysis 
You will be asked to provide a saliva sample for genetic (DNA) analysis by placing saliva into a small 
plastic tube.  This sample will be de-identified and given an ID number, it will be analysed for the 
BDNF, 5hTTLPR, COMT, PACAP and FKBP5 genotypes (which are all associated with fear processing 
and extinction) at the pathology labs in the School of Medicine, UTAS.   Following genotyping, the 
saliva sample will be immediately destroyed.  You will not be provided with individual information 
from this genetic analysis as these genotypes are not associated with any known disease states. 
 
Hormonal Analysis 
You will be asked to provide a saliva sample for hormonal analysis by placing saliva into a small 
plastic tube.  This sample will be de-identified and given an ID number, it will be analysed for the 
stress hormones (noradrenaline and cortisol) and estrogen (which are associated with fear 
extinction) at the pathology labs in the School of Medicine, UTAS.   Following processing, the saliva 
sample will be immediately destroyed.   
 
Clinical and Neuropsychological Assessment 
 You will be administered a number of questionnaires which will assess your mood, your previous 
trauma experience, and your psychiatric history. You will complete two cognitive assessments 
examining verbal and memory function.   These questionnaires and tests will take approximately 20 
minutes. 
 
Fear Conditioning and Extinction Task. 
You will then complete a standard fear conditioning and extinction task.    This task involves 
viewing different coloured circles on a screen (red, or blue), on presentation of some of these 
circles, you will be administered a mild electric shock.  You will set the level of shock before getting 
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commencing this task as feeling “uncomfortable but not painful.”  Your body arousal will be 
measured by recording your skin conductance from two small electrodes placed on your fingers.  
This is a widely used and standardized procedure to examine fear extinction.  
Follow-up Telephone Clinical Assessment 
Three and six months following your practicum placement, you will receive a 30 minute phone call 
from an intern clinical psychologist.  This phone call is designed to re-assess your PTSD symptoms, 
your mood, your current stressful life events and level of social support. 
 
Are there any risks?  
Some participants may feel a mild level of discomfort or anxiety in receiving the mild electrical 
shock as part of the fear conditioning and extinction task.  However, you can set the level of this 
shock that you feel comfortable with before commencing the study, so it is expected that you will 
feel minimal discomfort or arousal.  Your possible discomfort and distress will be monitored by the 
researcher (Daniel Zuj) who will be present throughout the task.  You may stop the study and 
withdraw from the study at any time without penalty.  Withdrawing from the study will not affect 
your treatment or potential treatment at the Centre for Traumatic Stress Studies in any way.   
If you do feel upset or uncomfortable at any point please let the researcher conducting your 
assessment know.  
Some individuals may feel slightly embarrassed by providing a saliva sample.  You can provide this 
sample behind a screen or in the bathroom if you request it. 
 
Are there any benefits? 
We cannot guarantee or promise that you will receive any benefits from this study. You may learn 
more about psychological research, you will have your psychological reactions to your practicum 
placement more closely monitored and you may gain further knowledge about PTSD after receiving 
group results from the study.   
 
What happens if I don’t want to take part in the study? 
Participation in this study is voluntary. It is completely up to you whether or not you participate. If 
you decide not to participate, it will not affect your current or future studies, or your relationship 
with the University of Tasmania. If you wish to withdraw from the study once it has started, you 
can do so at any time without having to give a reason and without penalty. 
 
How will my confidentiality be protected? 
Appendix A: Information sheet and consent form 238 
 
 
All aspects of this study, including results will be strictly confidential and only the researchers will 
have access to your personal information.  Any publication of results will only use de-identified 
information.  Confidentiality will be maintained at all times and information will not be made 
available to participants or others outside the study. Original data will be stored in a locked office, 
and entered into a database that will be password protected. Electronic data will de-identified 
using a unique ID number and stored on protected hard-drives within locked offices. Data is not 
analysed individually, but only as part of larger group comparative analyses.  
 
What happens with the results?  
If you give us your permission by signing the consent document, we plan to discuss/publish the 
results amongst the researchers on this project, the HREC for monitoring purposes, the funding 
body for monitoring purposes, peer-review journals, presentation at conferences or other 
professional forums. Results will also be discussed at community meetings and in consultation with 
refugee advisory groups we are collaborating with. You will be invited to participate in these 
discussions.  
You will receive information about your psychological functioning at the three and six month 
follow-up assessments. 
 
Will taking part in this study cost me anything, and will I be paid? 
Participation in this study will not cost you anything. In addition, you will be reimbursed $50 for 
completing the study to cover your expenses.  
 
How is this study being paid for? 
This study is being sponsored by the National Health and Medical Research Council (NHMRC).  No 
commercial bodies have an interest in this research project. 
 
Who should I contact if I have concerns about the conduct of this study? 
This study has been approved by the Tasmanian Health and Medical Human Research Ethics 
Committee. Any person with concerns or complaints about the  conduct of this study should 
contact the Research Office who is nominated to receive complaints from research participants. 
You should contact them on 02 9926 8106 and quote [HREC project No H0013412] 
 
Thank you for taking the time to consider this study. 
If you wish to take part in it, please sign the attached consent form. 
This information sheet is for you to keep.  
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CONSENT FORM 
Study title: Identification of Cognitive and Genetic Predictors of Posttraumatic Stress Disorder 
 
1.  I,................................................................................................................. 
of................................................................................................................ 
agree to participate as a subject in the study described in the participant information 
statement set out above. 
2. I acknowledge that I have read the participant information statement, which explains why I 
have been selected, the aims of the study and the nature and the possible risks of the 
investigation, and the statement has been explained to me to my satisfaction. 
3. Before signing this consent form, I have been given the opportunity of asking any questions 
relating to any possible physical and mental harm I might suffer as a result of my 
participation and I have received satisfactory answers. 
4. I understand that I can withdraw from the study at any time without prejudice to my 
relationship to University of Tasmania 
5. I agree that research data gathered from the results of the study may be published, provided 
that I cannot be identified. 
6. I understand that if I have any questions relating to my participation in this research, I may 
contact Professor Kim Felmingham or Mr Daniel Zuj on telephone - 62261965 who will be 
happy to answer them. You may also email: Kim.Felmingham@utas.edu.au and a researcher 
will be in contact with you.  
7. I acknowledge receipt of a copy of this Consent Form and the Participant Information 
Statement. 
 
Complaints may be directed to the Research Office, University of Tasmania, 62262764. 
 
 
Signature of subject    Please PRINT name   Date 
 
 
Signature of investigator   Please PRINT name  Date 
 
 
Signature of interpreter   Please PRINT name  Date 
 
 
